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ABSTRACT
Mechanical stimulation regulates chondrocyte function. In vitro studies show that 0.33
Hz mechanical stimulation of normal articular chondrocytes results in activation of an
a5(31 integrin dependent mechanotransduction pathway involving stretch-activated ion
channels, actin cytoskeleton, PKC, and tyrosine phosphorylation of focal adhesion
complex molecules. Subsequently, there is secretion of IL-4, membrane
hyperpolarisation and altered levels of aggrecan and MMP-3 mRNA. In contrast, OA
chondrocytes show a membrane depolarisation and no change in aggrecan or MMP3
mRNA levels.
Both normal and OA human articular cartilage use a5(31 integrin as a
mechanoreceptor, however, the molecular mechanism of integrin-mediated
mechanotransduction events remains obscure. This thesis focuses on the potential roles
of integrin-associated molecules, CD47/IAP, CD98 and their ligands, galectin-3, signal
regulatory protein a (SIRPa) and thrombospondin (TSP1) in a5pi integrin dependent
chondrocyte mechanotransduction. CD47, CD98 and galectin 3 are shown to be
expressed by chondrocytes in both normal and OA cartilage. Using the changes in
membrane potential as an indicator of chondrocyte response to mechanical stimulation
initial investigations showed CD98 had no identifiable role in chondrocyte
mechanotransduction, whereas CD47 and its ligands, TSP1 and SIRPa, showed critical
functions. Antibodies to CD47, TSP1 and SIRPa completely inhibited the
electrophysiological response of normal and OA chondrocytes to 0.33 Hz cyclical
mechanical stimulation.
Further examination of potential roles for CD47 showed that both normal and OA
chondrocytes expressed CD47 and its ligands in a similar pattern. In resting
chondrocytes, CD47 was coimmunoprecipitated with a5 integrin and TSP1 but not with
pi integrin and SIRPa. Following 1minute mechanical stimulation, chondrocytes
showed increased tyrosine phosphorylation of three major proteins of 125, 90 and 65 kD.
This tyrosine phosphorylation was inhibited by anti-CD47. PKCa translocation from
cytosolic compartment to particulate compartment following 30 seconds mechanical
stimulation, in the presence of anti-CD47 was also completely inhibited.
Interactions between CD47, a5 integrin and TSP1 appears to be important in the
regulation of the chondrocyte responses to mechanical stimulation, regulating down




1.1.0. HUMAN ARTICULAR CARTILAGE (HAC)
Articular cartilage is a highly specialized and uniquely designed biomaterial that forms
the smooth, gliding surface of the diarthrodial joints (Muir 1995). Adult articular
cartilage is avascular, aneural, and alymphatic, cell nutrition is derived primarily from
the synovial fluid. Nutrition in immature cartilage is aided by the presence of vascular
canals (Buckwalter and Mankin 1998).
Articular cartilage thickness normally ranges from 1 to 2 mm. This varies in relation to
age and the particular joint. In large joints in young people, articular cartilage thickness
may reach 5 to 7 mm (Poole et al 2001). The main functions of articular cartilage are
related to the mechanical properties of the extra cellular matrix (ECM) (Guilak et al
1999). Articular cartilage is a load-bearing connective tissue, and its mechanical function
involves not only transmitting the compressive joint loads to the underlying subchondral
bone but also providing a low-friction interface between the contacting cartilage surfaces
of the joint (Mankin et al 1994).
1.1.1. Composition of human articular cartilage
Articular cartilage is composed of chondrocytes and ECM. Articular cartilage is
synthesized by the sparsely distributed (approximately 2% of the total cartilage)
chondrocytes (Muir 1995). The greatest proportion of the ECM is water (65 to 80%). The
remainder of the ECM is mostly composed of collagen (10 to 30%) (Kuettner et al 1991),
and proteoglycans (PGs) (up to 10%) (Poole 1997). Type II collagen constitutes the
major structure component of articular cartilage. Aggrecan is the principal form of
proteoglycan molecule found in articular cartilage. The concentration of PGs is inversely
proportional to collagen concentration.
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1.1.2. Chondrocytes
Chondrocytes are differentiated from mesenchymal cells during embryonic development
and represent the only cell type in hyaline cartilage. Individual chondrocytes are located
in their lacunae within the matrix, each lacuna containing a single chondrocyte (Sandell
and Aigner 2001). Chondrocytes have the full complement of subcellular components.
Within the cell, the small nucleus, with dispersed chromatin and basophilic, surrounded
by a nuclear envelope, is situated eccentrically inside the cytoplasm. Golgi apparatus,
mitochondria, lysosomes, smooth and well-developed rough endoplasmic reticulum are
contained within the cytoplasm. These characteristics reflect the active role of
chondrocytes in synthesis and maintenance of the cartilage matrix. The phenotype of the
differentiated chondrocyte is characterized by the synthesis, deposition, and maintenance
of cartilage-specific ECM molecules, including type II collagen and PGs such as
aggrecan (Hauselmann et al 1994).
Chondrocytes in normal adult cartilage maintain a balance between synthesis and
degradation of ECM components. These cells are responsible not only for the generation
of ECM during growth and development, but also for the maintenance of tissue
homeostasis during adult life. The chondrocyte in mature articular cartilage exhibits
virtually no mitotic activity and a very low rate of matrix synthesis and degradation
(Hedbom and Hauselmann 2002).
Chondrocytes alter their metabolic activity in response to local demands. Chemical
signals and mechanical pressure can both result in an increase in production of ECM by
chondrocytes (Guilak et al 1995).
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1.1.3. Extracellular matrix (ECM) of human articular cartilage
Articular c artilage h as unique biomechanical properties, both in terms of stiffness and
elasticity (Kerin et al 2002). Articular cartilage matrix consists of two basic components:
collagen network and PGs. PGs are composed of the large aggregating PG aggrecan,
small PGs, and non-collagenous matrix proteins (Table 1.1). In terms of the physical
properties of cartilage matrix, tensile strength comes from collagen network (Kempson et
al 1973), which hinders expansion of the viscoelastic aggrecan component, providing
compressive stiffness (Kempson et al 1970, 1976; Maroudas 1976).
1.1.3.1. ECM Collagens
The endoskeleton of hyaline cartilage composed of collagen fibrils that form an
extensive network. These fibrils vary in diameter, from approximately 20 nm in the
superficial zone to 70 to 120 nm in the deep zone. The fibrillar network consists mainly
of type II collagen, together with other collagens, predominantly types IX, and XI.
Several other types of collagen common to other kinds of cell are also present in cartilage
(Table 1.1), but their function in cartilage is not certain (Bruckner and Rest 1994; Muir
1995; Poole et al 2001). Although collagen types VI, IX, XI, XII and XIV are minor
components, they appear to have important structural and functional properties (Goldring
2000).
Type II collagen forms the bulk (approximately 90%) of the collagen fibrils that form an
extensive network throughout the matrix. This molecule is composed of three identical
chains that form a triple helix form (Poole et al 2001). Type VI collagen forms a highly
branched filamentous network (Keene et al 1988). It has only been found in the
pericellular matrix (PCM), directly surrounding the chondrocyte (Poole et al 1988,1992).
Type IX collagen is present in the fibril. Its distribution may be limited in the adult to
pericellular sites and represents approximately 2% of the total collagen (Poole et al
2001). This collagen type binds covalently to the surface of collagen type II fibres and
prevents the addition ofmore collagen type II molecules. Since collagen type IX allows a
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bridging of collagen type 11 fibres it enhances the mechanical stability o f the network
(Kuettner 1992; Ostergaard and Salter 1998).
Type XI collagen is present within and on the surface of the fibril. This collagen appears
to be located within the interior of collagen type II fibres and may be involved in
determining the final diameters of collagen type II fibres (Kuettner 1992; Ostergaard and
Salter 1998).
1.1.3.2. ECM proteoglycans
Articular cartilage matrix also contains a large number of other components that are
important for matrix cohesion, chondrocyte functions, assembly and repair of cartilage.
Articular cartilage proteoglycans are composed of:
1. Large aggregating PG aggrecan and the small non-aggregating PGs (leucin-rich core
PGs)
2. The non-collagenous glycoproteins (GPs)
1. The primary PG of articular cartilage matrix, aggrecan, is a very large molecule of
high buoyant density that aggregates with hyaluronic acid (HA) and is known as
aggrecan. Aggrecan gives the tissue the ability to resist mechanical compression. The
core protein of aggrecan is made up of three globular (G) domains. Both G1 and G2, at
amino-terminal end of the molecule, are separated by an interglobular domain. G3
domain at the carboxy-terminal end, separated from G2 domain by glycosaminoglycan
(GAG), the keratan sulfate and chondroitin sulfate, attachment regions (Ilic et al 1998).
The GAG chains, which consist of numerous carboxy and sulfated groups, become
negatively charged when dissolved in the interstitial fluid. The presence of these charges
gives rise to repulsive forces and osmotic gradients so t hat a swelling pressure exists
within the tissue. This swelling pressure will influence the hydration state of the tissue,
as well as the mechanical response to impressive loading or deformation (Guilak et al
1999). Link protein stabilises a noncovalent interaction between aggrecan and HA
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through the G1 globular domain of the core protein to form a large macromolecular
aggregate (Heinegard and Hascall 1974; Poole et al 1980).
The small non-aggregating PG (leucin-rich core PG) decorin (Yamaguchi et al 1 990),
biglycan (Scott 1996), versican (Grover and Roughley 1993), fibromodulin (Hedbom and
Heinegard 1993), perlecan (Sundarhaj et al 1995), and lumican (Grover et al 1995), have
also been detected in articular cartilage matrix (Table 1.1).
Decorin (Heinegard and Oldberg 1989) is involved in regulation of important biological
functions like matrix organization, cell adhesion, migration and proliferation (Iozzo et al
1999). Decorin is found in the interterritorial matrix (Miosge et al 1 994). Biglycan is
localized mainly pericellularly and may have important functions in modulating
morphogenesis and differentiation (Bock et al 2001). Versican, with 263 kD size,
contains G1 and G3 domains (as in aggrecan) that binds to HA through G1 domain
(Grover and Roughley 1993). Fibromodulin (Hedbom and Heinegard 1993) might be
involved in collagen organization and also in growth factor binding. Perlecan has a core
protein of-260 kD and contains both heparan sulfate and chondroitin sulfate side-chains.
Lumican, like fibromodulin, contains keratan sulfate chains and modulates collagen fibril
formation.
2. The non-collagenous GPs, include fibronectin (Fn) (Galant et al 1985), chondrocalcin
(Poole et al 1984), tenascin (Salter 1993), thrombospondin (TSP)(Miller and McDevitt
1988), cartilage oligomeric matrix protein (COMP) (Hedbom et al 1992), and anchorin C
II (Pilar Fernandez et al 1988) (Table 1.1).
Fibronectin (Fn) is a G P of several isoforms that i s expressed in the PCM of n ormal
articular cartilage (Potts and Campbell 1996). The biosynthesis and accumulation of Fn
by normal articular cartilage has also been confirmed by extraction studies (Brown and
Jones 1990). Chondrocalcin has an affinity for hydroxyapatite and may be involved with
calcification of cartilage matrix (Poole et al 1984; Hinek et al 1987). Tenascin is a large
ECM glycoprotein with a hexameric structure, known to have important functions in
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processes such as wound repair and embryogenesis during bone and cartilage formation.
Immunohistochemical studies have localised tenascin to chondrocytes and ECM of the
superficial zone and upper part of the middle zone in normal articular cartilage (Salter
1993). TSP is an ECM protein that displays a complex variety of biological activities
(see 1.5.2.6.1 page 63).
COMP belongs to the TSP protein family (Oldberg et al 1992) with a molecular size of
-120 kD and is localized preferentially to the deep zone of articular cartilage (Heinegard
et al 1998). This noncollagenous protein, is implicated in the development and proper
function of cartilage tissue (Recklies et al 1998). Anchorin CII (cartilage annexin V)
contains four internal repeats of 70-80 amino acids (AA), each with shorter, highly
conserved 17- AA sequences. Anchorin CII is synthesized and secreted by chondrocytes
and binds to the outer surface of cell membrane (Pfaffle et al 1990). A major function of
anchorin CII appears to be to bind specially to collagen II fibres, possibly attaching them
to the chondrocyte surface. Anchorin CII has the potential for providing a
mechanoreceptor to the cells, transmitting signals to chondrocytes (Fernandez et al 1988;
Heinegard and Oldenberg 1989; Poole et al 2001).
1.1.3.3. Cell surface proteins
In addition, the presence of some important cell membrane proteins in ECM has been
reported. These proteins include syndecan, CD44 and a variety of integrins (al, 2, 3, 5,
10; pi, 3, 5).
Syndecan is a member of a family of heparan sulfate proteoglycans that are associated
with the cell surface. These macromolecules contain a hydrophobic membrane-spanning
domain, a short cytosolic domain, and an extracellular domain. Syndecans are known to
interact with several matrix molecules, and thus are thought to serve as structural and
functional links between the cell surface and the surrounding extracellular matrix. These
interactions are required for biological activity, because these factors must first interact
with the heparan sulfate chains of the syndecans before they can interact with their high-
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affinity signaling receptors. Syndecans seem to play important roles in modulating
cellular activities, including cell proliferation and differentiation in a variety of cells
including chondrocytes (Bernfield et al 1992; Pfander et al 2001).
CD44 is a single-pass transmembrane receptor expressed by many cell types including
chondrocytes (Knudson et al 1996; Chow et al 1995). In chondrocytes, CD44 represents
the primary receptor responsible for hyaluronan (HA) binding (Knudson and Knudson
1993; Knudson et al 1996). The binding of HA to CD44 in cartilage facilitates the
retention of large, highly hydrated, HA/PG/link protein aggregates at the surface of
chondrocytes (Knudson and Loeser 2002).
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Table 1.1. Cartilage matrix proteins (Goldring 2000)
Collagens



















Integrins (al, 2, 3, 5, 10; pi, 3, 5)
-COMP, cartilage oligomeric matrix protein
* Some membrane proteins identified in ECM.
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1.1.4. Human articular cartilage (HAC) Heterogeneity
Articular cartilage is a remarkably heterogeneous tissue in which the composition of
ECM (Bayliss et al 1983; Burkhardt et al 1995), the numbers and morphology of
chondrocytes (Mitrovic et al 1983), the thickness of cartilage (Armstrong and Gardner
1977), and the susceptibility to cytokine-induced damage (Hauselmann et al 1996) vary.
These are greatly influenced by factors such as zone of depth within section of cartilage,
joint type, topography within a joint, as well as age and presence of OA (Ostergaard and
Salter 1998).
1.1.4.1. Zonal heterogeneity
The shape, size, and arrangement of the chondrocytes vary according to their location
within the articular cartilage. It is established that chondrocytes behave differently,
depending on their position within the different zones of the cartilage matrix (Poole
1984; Aydelotte et al 1988; Aydelotte and Kuettner 1988). The matrix surrounding the
chondrocytes of articular cartilage varies in its organization and each zone (region) has
unique structural and biochemical characteristics (Eggli et al 1988; Zanetti et al 1985;
Poole et al 2001).
Articular cartilage can be divided into four separate zones: surface, superficial, middle
and deep. The surface, which is bathed by synovial fluid, is composed of about three
layers thick chondrocytes that are flattened and aligned parallel to the surface.
The superficial chondrocytes are surrounded by a very polarized organization of thin
collagen fibrils that generally run parallel to each other and to the articular surface,
providing the highest tensile properties found in articular cartilage (Akizuki et al 1986;
Kempson et al 1973). Superficial specialized chondrocytes synthesize a molecule called
superficial zone protein (Schumacher et al 1999) that is also known as lubrican,
providing almost frictionless articulation provided by articular cartilage (Poole et al
2001).
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In the middle zone, chondrocytes appear larger and more round, with an apparently
random distribution within the matrix. Extensive ECM rich in the proteoglycan aggrecan
and large diameter of collagen fibrils that arranged randomly are other characteristics of
the midzone.
Within the deeper zones, the cells form in columns, lying perpendicular to the cartilage
surface, as do the collagen fibres. Cell density is at its lowest but aggrecan content and
fibril diameter are maximal, although collagen content is minimal (Venn 1979).
Several distinct regions in mid and deep zones, pericellular matrix (PCM), territorial, and
interterritorial matrices have been recognized (Poole et al 1 984). All chondrocytes are
surrounded by a narrow (approximately 2pm wide) pericellular region in which few
collagen fibrils are detected. At the ultrastructural level PCM is more amorphous in
appearance. Here, numerous molecules are concentrated including type VI collagen
(Keene et al 1988) and the proteoglycans decorin (Poole et al 1986) and aggrecan
(Poole et al 1980).
A territorial r egion s urrounds this pericellular region, which is present throughout the
articular cartilage (Poole et al 1982). In the deep zone, there is a clearly identifiable third
region of structure, distinguishable by the ultrastructure of aggregates of proteoglycan
(Poole et al 1982). This region is called the interterritorial region. It is the part of the
matrix most remote from the chondrocytes. The bulk of the tissue is made up of the
interterritorial matrix, which consists primarily of water and electrolytes including Na+,
2+
CP, and Ca . The remaining portion is composed of collagen, mainly type II, and the
proteoglycan aggrecan, with smaller amounts of other proteins and glycoproteins (Guilak
et al 1999). The basophilic ' tidemark ' marks the boundary between the deep zone and
the underlying layer of calcified cartilage, which abuts on the bone tissue.
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1.1.4.2. Functional heterogeneity in chondrocytes
Since joints experience a wide range of loading conditions, the biomechanical properties
of cartilages vary between joints (Froimson et al 1997; Treppo et al 2000; Shepherd and
Seedhom 1999) and with position and depth (Athanasiou et al 1995) on the same normal
joint surface. It has been shown that chondrocytes from various joints show different
response to anabolic and catabolic cartilage mediators (Kang et al 1998; Eger et al 2002;
Dang et al 2003).
Eger et al (2002) have shown that PG synthesis by ankle chondrocytes was higher than
by the knee chondrocytes. IL-ip was approximately eight times more effective with knee
than ankle chondrocytes in reducing PG synthesis. There are also significant differences
between knee and ankle chondrocyte response to proteoglycan loss in the presence of a
second catabolic mediator, fibronectin-fragment (Fn-fs). It has been previously shown
that Fn-fs inhibited PG synthesis in both bovine and human cartilage (Xie et al 1993).
The 29 kD Fn-fs causes a greater degree of PG loss (30-50%) from knee cartilage than
from ankle cartilage in explant culture. This loss occurs within 7 days in the knee, while
PG loss is less evident and less consistent in the ankle even after 28 days of culture
(Kang et al 1998). Other reports have shown that primary cultured ankle chondrocytes
within alginate beads have a greater ability than knee chondrocytes to synthesize matrix
components (Hauselmann et al 1996).
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1.2.0. OSTEOARTHRITIS (OA)
Osteoarthritis is a slowly developing joint disease that effects approximately 15% of the
world's adult population with pain and disability (Cole and Kuettner 2002). Studies have
shown that approximately 6% of the adult population is affected by symptomatic knee
OA. In those over the age of 65, this percentage increases to almost 10% (Felson et al
1987).
OA is not a single disease entity, but r epresents a disease group with rather different
underlying pathophysiological mechanisms (Aigner and Mckenna 2002). OA is a result
of both mechanical and biologic events that uncouple the normal balance between
degradation and synthesis by articular cartilage chondrocytes and ECM (Mollenhauer
and Erdman 2002).
OA can be divided into two main classes, primary and secondary OA (Gardner 1992).
Primary or idiopathic OA can be further subdivided into localised and generalised forms.
These forms of primary OA are characterised by not having known causes, even though
the generalised form does carry a heritable predisposition. In contrast, secondary OA is
characterised by having a demonstrable cause such as injury, mechanical dysfunction,
immunoinflammatory disease, infection, nutritional or metabolic disorder, endocrine
disorder or other insult. The distinction between primary and secondary may, however,
not always be easy (Ostergaard and Salter 1998).
1.2.1. Cartilage changes in OA
In contrast to normal articular cartilage, which is smooth, with a homogenous shiny
surface appearance, OA cartilage is often yellowish or brownish and is typically soft. The
surface shows roughening in the early stages and overt fibrillation and matrix loss in the
later stages until the ebumated subchondral bone plate is visible (Aigner and Mckenna
2002). A replacement of the normal cartilage by an appearance similar to that of cut
velvet is called fibrillation (Byers et al 1970).
21
A macroscopic pathoanatomical grading system was developed for the cartilage and bone
changes of OA joints by Collins (1949). This system consists of 5 grades: Grade 0,
normal, smooth articular cartilage; grade I, superficial flaking and surface fibrillation of
cartilage in area of pressure and movement; grade II, more extensive destruction of
cartilage excluding denuding of bone; grade III, denudation of bone in one or more
pressure areas and obvious marginal osteophytes; and grade IV, denudation from large
area with ebumation of bone and prominent osteophytes (Collins 1949; Collins and
McElligott 1960).
The macroscopic pathoanatomical grading system (Collins and McElligott 1960) was
later modified by Collins and Meachim (1961), and Mankin et al (1971). The
macroscopic grading system (Collins 1949; Collins and McElligott 1960), which has
been used for pathological grading in the present study, is described in chapter 2 (see
Table 2.1, page 87).
1.2.2. Chondrocyte changes in OA
Chondrocyte changes during the OA disease can be basically summarized in two
categories. First, the chondrocytes can undergo cell death, or they can proliferate to
compensate for cell loss. Second, chondrocytes activate or deactivate their synthetic-
anabolic activity (metabolic activation and hypoanabolism).
1.2.2.1 Cell proliferation and programmed cell death (apoptosis)
Lacuna emptying and cell cloning are typical histological features of OA cartilage
(Stockwell 1971). In contrast to normal articular cartilage, which has essentially no
proliferation, several studies (Mankin et al 1971; Rothwell and Bentley 1973) have
shown that there is a very low proliferatrive activity in OA chondrocytes. The increased
proliferative activity of chondrocytes, which is found primarily in the upper cartilage
zones, might be due to better access of chondrocytes in these zones to proliferative
factors from the synovial fluid due to fissuring or loosening of the collagen network
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(Meachim and Collins 1962). Alternatively, damage to the collagen matrix integrity,
which is particularly impaired in the upper zones of OA cartilage (Hollander et al 1995),
might contribute to the proliferative activity of OA chondrocytes. Chondrocyte
proliferation resulting in a higher cellular content could represent a cellular reaction to
cartilage destruction, but this is unlikely to represent efficient tissue repair (Aigner and
McKenna 2002), as the clusters in the very upper zone do not appear to add significantly
to matrix anabolism (Aigner et al 1997). Based on the observation of significant numbers
of empty lacunae at the light microscope level and cellular debris-like material at the
ultrastructural level in OA cartilage, some authors have s uggested that cell death is a
central feature in OA cartilage degeneration (Vignon et al 1976; Aigner and McKenna
2002). Aigner et al (1997) have demonstrated that apoptosis occurs in OA cartilage, but
at a v ery 1 ow r ate. M ajor c ell d eath w ould easily 1 ead t o a failure i n cartilage matrix
turnover, because chondrocytes are the only source of matrix components synthesis in
articular cartilage (Aigner and Mckenna 2002).
1.2.2.2. Metabolic activation and hypoanabolism
Chondrocytes attempt to repair the damaged matrix by increasing their anabolic activity
(Ryu et al 1984; Sandy et al 1984). Despite the increased biosynthetic activity of
chondrocytes, a net loss of PG content is one of the hallmarks of all stages of OA
cartilage degradation (Collins 1960; Mankin 1972, 1981; Aigner et al 1992). This leads
to the assumption that overall enzymatic degradation ofmatrix components might be the
reason for the metabolic imbalance in OA cartilage (Aigner et al 1997). Aigner et al
(1997) have demonstrated that hyperactivity of matrix synthesis is restricted to the
chondrocytes of the middle and deeper zones of OA cartilage, where the ECM is
histochemically still intact and no major loss of proteoglycan is detectable.
OA chondrocytes upregulated the cell adhesion molecules such as CD44 in deep zone
(Ostergaard et al 1997b) and |31 expression (Loeser et al 1995). Aberrant expression of
a2, a4, P2 integrins, which are not expressed in normal cartilage, is also documented in
OA cartilage (Ostergaard et al 1998).
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1.2.3. ECM changes in OA
The earliest biochemical change in human OA is an increase in water content due to the
altered network of collagen fibers (Bollet 1967). In OA cartilage, a number of
biochemical studies have demonstrated enhanced synthesis of ECM components such as
fibronectin (Miller et al 1984), type VI collagen (Swoboda et al 1998) and tenascin
(Salter 1993).
Degradation processes appear to be specifically prominent in surface zone and around the
chondrocytes in osteoarthritic cartilage (Dodge and Poole 1989; Bank et al 1997). Matrix
metalloproteinases (MMPs) that degrade articular cartilage matrix molecules have a
crucial role in causing progressive joint degeneration. Enhanced levels of many MMPs
including MMP-3 (stromelysin) (Goldring 1999, 2000), MMP-7 (matrilysin) (Ohta et al
1998), membrane-type I (MTl)-MMP (Imai 1997), MMP-8 (collagenase-2) (Shlopov et
al 1997; Chubinskaya et al 1996), MMP-13 (collagenase-3) (Moldovan et al 1997) and
aggrecanase (Lohmander et al 1993) have been reported to accompany the increased
matrix degradation in OA cartilage. Active stromelysin (MMP-3) serves as an activator
of latent collagenases. The collagenases implicated in type II collagen degradation
include collagenase 1,2, and 3(MMPs 1,8, and 13, respectively) and membrane type 1
(MTl)-MMP (MMP-14) (Goldring 2000). MMP-13 (collagenase-3) is a very potent
degrader of type II collagen (Reboul et al 1996). The expression ofMMP-13 in the deep
zone of OA cartilage and its ability to more effectively degrade type II collagen suggest a
major role for this enzyme in cartilage degradation (Mitchell et al 1996). While MMP-3,
MMP-8, and MT1-MMP all have the capacity to degrade aggrecan (Lark et al 1997;
Buttner et al 1998), there is evidence that degradation at the aggrecanase cleavage site is
primary event in chondrocyte-mediated catabolism of aggrecan (Lark et al 1997).
Protein and mRNA for ADAM-10 (A Disintegrin-like And Metalloproteinase-like
domain) (Chubinskaya et al 1998), and ADAM-15 (Bohm et al 1999) were found in the
most fibrillated areas of OA cartilage, especially in the clusters. The levels of the tissue
inhibitor of metalloproteinases (TIMP)-l are also elevated in OA synovial fluid and
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correlated with the MMP levels, possibly reflecting chondrocyte attempts to balance
excessive proteinase activities (Ishiguro et al 1999; Goldring 2000; Hedbom and
Hauselmann 2002).
Catabolic cytokines such as IL-1 and tumour necrosis factor-a (TNF-a) (Lotz et al 1994)
are upregulated by OA chondrocytes (Webb et al 1997; Goldring 2000).
Beside changes in the quantitative amounts and in the degradation of cartilage
components, alterations of cartilage components or the expression of molecules, which
are not present in normal articular cartilage, also appear to be important phenomena.
Studies have reported the appearance ofmolecules in OA cartilage such as collagens type
I (Nimni and Deshmukh 1973), IIA (Aigner et al 1999), and III (Aigner et al 1993) which
are barely seen or are undetectable in normal articular cartilage.
1.3.0. MECHANOTRANSDUCTION
1.3.1. Mechanical forces and chondrocytes
Physical forces play an important role in modulating cell functions.
Mechanotransduction, the process by which cells transduce physical force-induced
signals into biochemical responses, is critical for mediating adaptations to mechanical
loading (Ko and McKulloch 2001). Chondrocytes in articular cartilage utilize mechanical
signals in conjunction with other environmental and genetic factors to regulate their
metabolic activity. This capability provides a means by which articular cartilage can alter
its structure and composition to meet the physical demands of the body. A number of
different approaches have been used to investigate the role of physical stimuli in
regulating cartilage and chondrocyte activity, ranging from in vivo studies to in vitro
experiments at the cellular and molecular level (Guilak et al 1999). In this regard two
things should be noted:
First, physical forces applied to cells should be quantified in specific physical terms such
as stress, strain, shear, tension and compression (Liu et al 1999). Second, the physical
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response of tissue and/or cell (cartilage, chondrocyte) to loading is complex and involves
many factors including tissue and cell deformation, change in hydrostatic pressure, and
fluid flow (Hall et al 1991). The relatively small size of an individual cell and the
complexity of cellular morphology are such that, in most circumstances, the forces
applied to individual cells can not be precisely classified (Liu et al 1999).
1.3.2. Terminology used in mechanical stimulation
Strain is a measure of deformation per unit length of a body. It is a ratio of a
deformation and an initial length.
Tensile strain is an increase in length per unit length of material along a given line,
while compressive strain is the decrease in length per unit length.
Shear strain is the change in angle in the deformed state between two lines that were
vertical in the undeformed state (Armstrong et al 1992; Woo et al 1992).
1.3.3. Mechanical loading of articular cartilage
Human articular cartilage experiences wide ranges of force during normal joint loading.
Loading of articular cartilage will generate a c ombination o f t ensile, compressive and
shear stress in the material (Kempson et al 1973; Akizuki et al 1986).
With daily a ctivity, cyclic forces imposed on diarthrodial joints create complex, time-
varying stress and strain fields throughout articular cartilage. High contact pressures in
the joint cause fluid to be exuded and imbibed cyclically (Mow et al 1984). Most fluid
exchange occurs at the superficial layers where flattened chondrocytes predominate due
to confined boundary conditions of cartilage and limited permeability (Setton et al 1993).
Below the superficial layers, there is less fluid exchange, and the cells in the middle and
deep layers of cartilage exhibit a rounded shape that is maintained in the high
compressive hydrostatic stresses created in these areas. In some regions (under and near
the margins of the joint contact area and near the layer of calcified cartilage [Wong and
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Carter 1990a,b]), normal activity creates significant distortional stresses. In these
locations, a potential exists for physical damage to the matrix. Distortional stresses are
associated with distortional strains that may cause chondrocytes to deform into a more
ellipsoidal shape. This distortion, which can occur without fluid exchange, potentially
could alter cartilage homeostasis (Giori et al 1993).
The joint forces are transmitted across the joint by the generation of pressure over the
contact area of the two opposing cartilage surfaces. In common daily activities (like
walking and running) the joint contact area sweeps quickly over some region of the
articular surfaces. The magnitudes of the contact pressure at any one location may
typically go from zero to a large value and then back to zero in some fraction of a second
(Wong and Carter 2003). The joint pressures imposed by these intermittent loads
introduce very high cyclic hydrostatic pressure in the bound and unbound intercellular
fluid phase of cartilage, known as the interstitial fluid. The loading of the interstitial fluid
component of cartilage can ultimately be credited both for providing the excellent
lubrication between the two cartilage layers and also for distributing and transmitting the
joint forces to the underlying bone tissues in an efficient manner (Ateshian and Wang
1995).
In animal models, immobilization of a limb (Akeson et al 1987; Behrens et al 1989;
Langeskiold et al 1979; Smith et al 1992), abnormally high or unusual joint forces (Radin
et al 1991), and ligamentous instability (Brandt et al 1990) initiate degradation of
cartilage and impair joint function. Preliminary studies have shown that immobilization
of one forelimb of canine knees (Palmoski et al 1980) can result in a massive reduction in
the rate of cartilage proteoglycan synthesis. Similar observations have been reported in
immobilized joints of rabbits (Eronen et al 1978; Akeson et al 1973).
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1.3.4. In vitro methods for applying mechanical stimulation to human
articular cartilage
Because of the complexity of the in vivo environment, study of cellular responses to
mechanical stimulation has relied heavily on the development and use of in vitro systems
designed to mimic the in vivo situation. A major goal is establishing in vitro systems
reflecting the in vivo differentiation patterns of OA chondrocytes in order to further
analyze the disease process and to develop experimental systems to delay, stop, or even
reverse it (Aigner and McKenna 2002).
1.3.4.1. Cell and tissue culture methods
There are three main classes of in vitro model systems commonly used in the
investigation of mechanical loading of cartilage.
1.Chondrocyte culture of primary cells and cell lines in monolayer (see chapter 2 page
94). Studies relating biological and physical stimuli at the cellular level to the load-
induced biological response of chondrocytes, such as altered secretion of matrix
macromolecules, could provide key information in understanding cartilage remodelling
processes. The frequency, amplitude, and spatially dependent response found in previous
studies could be the result of regulatory mechanisms including cell deformation, cell-
matrix interactions near the cell m embrane, connective transport of soluble mediators,
and load-induced electrical fields (Buschmann et al 1999). Phenotypic changes are a
central feature of c hondrocytes in vivo and in vitro, particularly in monolayer culture
(Aigner and Mckenna 2002). In cell culture, artifactual conditions can arise due to
flattened cell morphology and the absence of a pericellular matrix (Wong and Carter
2003). A major disadvantage of this approach is that the cells, which are attached to the
plastic o f t he c ulture d ish, u sually r emain p henotypically s table for o nly a few w eeks
(Thonar et al 1986).
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2. Three-dimensional (3D) culture: To overcome the difficulties ofmonolayer culture,
many researchers have seeded chondrocytes in three-dimensional (3D) constructs (Lee
and Bader 1997; Wong and Carter 2003). In 3D cultures the cells maintain their
morphology and phenotype, and will rebuild their matrix with many characteristics of the
in vivo cells (Hauselmann et al 1996; Aigner and Mckenna 2002). A unique 3D cell
stretching device, originally designed by Skinner et al (1992), was further developed into
a computerized Bio-Stretch System by Liu et al (1999).
I. Agarose: To overcome the problems of primary cell and explant culture (see below),
different groups have used the 3D model system involving chondrocytes embedded in
agarose (Buschmann et al 1995; Lee and Bader 1997; Chowdhury et al 2001). The
entrapment of chondrocytes within agarose (Benya et al 1978; Bruckner et al 1989) or on
agarose (Archer et al 1990) has been applied in a number of studies. Most of the PGs are
retained in the vicinity of the cells and accumulates with time, a matrix that appears to
share many of the physicochemical properties of normal cartilage matrix (Buschmann et
al 1992). The maintenance of chondrocyte phenotype during long-term culture in agarose
gels allowed the development of a mechanically functional cartilage-like matrix
(Buschmann et al 1992).
II. Alginate beads: Several studies have shown that chondrocytes also can be entrapped
in alginate, a linear polysaccharide (mannuronic acid-guluronic acid) n which forms a gel
in the presence of calcium or other divalent cations (Kupchik et al 1983; Guo et al 1989;
Hauselmann et al 1 992). The a lginate-based culture system appears to offer all of the
advantages of the agarose system (Hauselmann et al 1992). However, as the gel can be
solubilized by the addition of a chelating agent, it is relatively easy to separate the cells
surrounded by a tightly bound cell-associated matrix from the interterrtorial matrix
components, which is further-removed from the cells (Hauselmann et al 1992, 1994). In
this method the chondrocytes are enzymatically released from their matrix and then
resuspended in alginate without allowing the cells to dedifferentiate, in order to increase
29
cell number. In the alginate beads with 40,000 chondrocytes/ bead, the cells maintain
their chondrocyte phenotype (Hauselmann et al 1996).
3. Explant cultures (exvivo). As articular carilage explants can be maintained in steady
state for several weeks (Handley et al 1986), this type of culture system has been used
not only to examine how newly synthesized radiolabeled molecules are incorporated into
the existing cartilage matrix but also how they are turned over (Campbell et al 1984). For
example, the average half-life of PGs in explants of articular cartilage from different
sources and ages varies from 10 to 25 days (Campbell et al 1984; Handley et al 1986),
this average half-life is b elieved to be shorter than that in vivo (Maroudas and U rban
1980). Thus, this in vitro model system enables the chondrocytes to remain in their
native ECM environment. In addition, well-defined and controlled loading conditions
can be applied to explants and the resulting effects on cell-mediated synthesis and
degradation of ECM can be quantified. Cartilage explants can be subjected to axial
compression, resulting in fluid flow and accompanying flow-induced ECM changes, or
placed under hydrostatic pressure or pure tissue shear, which can result in essentially no
volume change or intra tissue fluid flow. Such mechanical stimuli can be applied to
stimulate the ranges of matrix deformation, fluid flow, and pressure that are caused by
joint loading. To elucidate the effects of load on biosynthesis and gene expression by
chondrocytes, explant culture is frequently used (Palmoski and Brandt 1984; Sah et al
1989, 1994; Kerin et al 2002). A disadvantage of the explant culture system is that the
newly synthesized aggregating PG, aggrecan, molecules can be recovered in high yield
only by using solvents, which cause the dissociation of the large molecular mass
aggregates (Campbell et al 1984).
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1.3.4.2. Types and effects of loading on articular cartilage in vitro
1.3.4.2.1. Effect of hydrostatic pressure (HP) on articular cartilage in vitro
The influence of hydrostatic pressure on chondrocyte and cartilage behaviour has been
examined in several earlier studies (Veldhuijzen et al 1979,1987; vanKampen et al 1985;
Hall et al 1991). Hydrostatic pressure is one of the several physicochemical factors,
which operate in articular cartilage subjected to loading. Among these factors only
hydrostatic pressure can be studied in a relatively pure form, independent of the others.
Hydrostatic pressure induces no fluid flow or tissue deformation, which would bring
about the other factors (Parkkinen et al 1993; Hall et al 1991).
A computer-controlled pressure chamber has been designed to subject both primary
chondrocyte cell cultures and explants of bovine articular cartilage to cyclic hydrostatic
pressure. The sealed petri dishes are placed within specially designed rack into the
pressure chamber, located in the upper part of stainless steel cylinder. A hydraulic
cylinder is under the pressure chamber. The oil flow generated by the hydraulic pump is
conducted into the hydraulic cylinder through hydraulic valves (proportional pressure
control and proportional regulator valve). The pressure of the oil is regulated by a
proportional pressure valve. Both valves are driven by computer-controlled electronic
amplifiers. A peristaltic pump is used to fill the chambers and to circulate the water
through the pressure and reference chambers (Parkkinen et al 1993).
Parkkinen et al (1993) have demonstrated that cyclic hydrostatic pressure influences the
PG synthesis rate in both culture systems. Both stimulatory and inhibitory responses
were induced, depending on the culture conditions and testing regimens. Cyclic HP
(5MPa) decreases proteoglycan synthesis in chondrocyte monolayers when applied at
0.0167, 0.05, 0.25, and 0.5 Hz but stimulates proteoglycan synthesis when applied to
cartilage explant at 0.5 Hz. At 30 MPa, continuous but not cyclic HP alters chondrocyte
Golgi apparatus and decreases PG synthesis.
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Smith et al (1996) by using high density primary cultures of bovine chondrocytes, have
investigated the effects of hydrostatic pressure (lOMPa) on mRNA and extracellular
matrix synthesis. The cells were exposed to hydrostatic pressure applied intermittently at
I Hz or constantly for 4 hours in serum-free medium or in medium containing 1% fetal
bovine serum. Signal levels of aggrecan, types I and II collagen, and p-actin mRNA were
analyzed by northern blots and quantified by slot blots. PG synthesis was quantified by
radiolabled sulfate uptake into cetylpiridinium chloride-precipitable glycosaminoglycans,
and cell-associated aggrecan and type II collagen were detected by immunohistochemical
techniques. In serum-free medium, intermittent HP increased aggrecan mRNA signal by
14% and constant pressure decreased type II collagen mRNA signal by 16% (p< 0.05). In
the presence of 1% fetal bovine serum, intermittent pressure increased aggrecan and type
II collagen mRNA signals by 31% (p< 0.01) and 36% (p<0.001), respectively, whereas
constant HP had no effect on either mRNA. Intermittent and constant pressure stimulated
GAGs synthesis 65% (p<0.001) and 32% (p<0.05), respectively. Immunohistochemical
detection of cell-associated aggrecan and type II collagen was increased in response to
both intermittent and constant pressure (Smith et al 1996, 2000).
1.3.4.2.2. Effects of compression on human articular cartilage in vitro
The chambers for applying static and dynamic compression on explant culture have been
initially modified by Sah et al (1989). Loading is done within polysulfone compression
chambers, housed in a standard incubator and designed to maintain compression rods in
an orientation perpendicular to each chamber's base. The compression rods translated
relatively large displacements into defined compressive forces that were transmitted to
the cartilage disks, which were positioned between two flat-ended, impermeable loading
platens fashioned out of polysulfone. By regulating the nature (waveform, frequency, and
amplitude) of the external displacements, disks (chondrocyte/agarose (CA) or tissue
blocks in explant) were subjected to either static or dynamic compressive loads (Sah et al
1989; Li et al 2001).
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A number of groups (Palmoski and Brandt 1 984; Sah et al 1 989; Larsson et al 1 991;
Parkkinen et al 1992; Grodzinsky et al 2000) have studied the effects of both static and
intermittent compression on full-thickness plugs of articular cartilage. Larsson et al
(1991) applied both static and cyclical compression on full thickness explants of bovine
articular cartilage at high frequency (2s of load with 2 s intervals of no load) and low
frequency (60s of load with 60s intervals of no load), at 1 MPa. High frequency load had
a stimulatory effect on protein and PG synthesis while low frequency and static load
showed decreased synthesis.
The r esults from d ifferent groups w ere v ariable a nd d epended o n t he sp ecific 1 oading
protocol and specimen geometry. Different frequencies of cyclical compression produce
differences in metabolic activity within the cells, although the results may vary for
various cells.
To use the compression system for 3D cultures, further alterations were applied by
Buschmann et al (1995). Several groups have utilised a system involving the culture of
isolated chondrocytes embedded in agarose gel (Buschmann et al 1995; Lee and Bader
1997; Lee et al 1998a, Knight et al 1998). The application of static or dynamic
compressive loading to the chondrocyte/agarose system results in cell deformation and
frequency dependent alterations in cell metabolism.
The effects of static and dynamic loading over a range of frequencies (0.3-3 Hz), all
within the physiological range, were investigated by Lee and Bader (1997). Three major
markers of chondrocyte metabolism, namely PG synthesis, cell division, and protein
synthesis, were assessed. Static and low-frequency strain (0.3 Hz) inhibited the synthesis
ofGAG, while a frequency of 1 Hz stimulated synthesis. Static compression reduced the
level of cell proliferation, whereas dynamic compression at all frequencies induced an
increase in chondrocyte proliferation (Lee and Bader 1997).
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1.3.4.2.3. Effects of fluid-induced shear stress (FISS) on articular cartilage in vitro
A cone viscometer system (Bussolari et al 1982) has been used to apply fluid-induced
shear on primary high density monolayer cultures of adult human and bovine
chondrocytes. This system was chosen as the optimal method for applying a uniformly
distributed shear stress to all the cells. It was a 145mm diameter cone with a cone angle
of 0.5°, was rotated within the cell culture medium at 200 revolution per minute (rpm).
The tip of the cone was fixed at 1 mm above the cells. The rate of rotation of the cone
was maintained and monitored using an electronic motor c ontroller, the acquisition of
final speed was essentially instantaneous. This system applied a uniform level of shear
across the plate with little or no turbulence. The level of fluid-induced shear applied to
chondrocytes has been calculated to range from 1.6 Pa near the centre of the plate, 2.2 Pa
at the edge of cone (Smith et al 1995).
Smith et al (1995) applied the fluid-induced shear for periods of 24, 48 and 72 hours.
High density cultures of normal bovine, normal human and human OA chondrocytes
were exposed to fluid-induced shear at 0.5 Hz using a cone viscometer. They have
reported that chondrocytes subjected to shear stress showed alteration in chondrocytes
morphology and orientation, two-fold increased GAG synthesis, large monomers of PGs,
increased GAG synthesis, the chain length of GAG, 10-fold increased prostaglandin E2
(PGE2) secretion and 9-fold increased in TIMP-1 mRNA. In contrast, mRNA levels for
the neutral metalloproteinases, collagenase, stromelysin, and 72 kD gelatinase, did not
show such major changes. In another study, Smith et al (2000) have assessed the cellular
response of normal and OA human and normal bovine articular chondrocytes to FISS at
1 Hz. They have reported that IL-6 mRNA expression occurs in chondrocytes from
osteoarthritic cartilage but not in normal chondrocytes by using northern blot analysis.
Applying FISS at 1 Hz to primary high-density cultures of chondrocytes increased IL-6
mRNA signal 4-fold at 1 hour and 10-15 fold at 48 hours compared with unsheared
control cultures.
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Studies focused on the mechanisms by which shear stress alters signalling pathways in
chondrocytes (Das et al 1 997; Smith et al 2000). It has been shown that shear stress
increased nitric oxide (NO) production by chondrocytes, and the shear-induced change in
matrix macromolecule metabolism was influenced by nitric oxide synthesis, G protein
activation, and phospholipase C activation. They have also shown that in cultured OA
chondrocytes, in the presence of shear stress the NO levels were increased 4-fold
following 24-hour exposure period (Das et al 1997; Smith et al 2000).
1.3.4.2.4. Stretching or cyclic tensile force (CTF) by using Flexercell Strain Unit
A computerized, pressure-operated instrument, Flexercell Strain Unit, has been used to
apply mechanical stretching on different cell types. The apparatus (Banes et al 1985;
Fukuda et al 1997) consists of computer-controlled vacuum unit and a baseplate to hold
the culture dishes. Frequency, stretch rate, and degree of elongation of the substrates are
all controlled by computer. According to supplier's manual, there is a linear relation
between the vacuum level (kPa) and maximal percentage elongation of cells. When a
precise vacuum level is applied to the system, the culture plate bottom is deformed to a
known percentage elongation, which is maximal at the edge and decreases to the centre.
The strain is translated to cultured cells and causes the deformation of cells. When the
vacuum is released, the bottoms of dishes return to their original conformation.
Holmvall et al (1995) by using the Flexer system subjected bovine chondrocytes to 18
kPa stress (15 cycles/min, 2 sec on/ 2 sec off, 24% elongation) for 3 h. Mechanical
stimulation of these cells increased the mRNA levels of both collagen type II and
aggrecan but not the pi integrin. They have also applied the same regime on cultured
chondrosarcoma cells (105KC) on collagen type-II coated and uncoated dishes (in the
presence of serum). They found that the mean mRNA expression of a2-integrin subunit
increased in collagen type II coated dishes and a5 increased to a significant level in
uncoated dishes.
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In another experience, cultured articular chondrocytes (Fukuda et al 1997) on flexible-
bottomed culture dishes were exposed to mechanical stretching by the Flexercell
technique. They reported that 2 kPa of cyclic mechanical stimulation (3 sec on/ 357 sec
off) (0.003 Hz) increases PG synthesis, while 10 kPa of mechanical stimulation (3 sec
on/ 3 sec off) (0.17 Hz) decreases PG synthesis.
Fujisawa et al (1999) applied two types of pressure (5 kPa and 15 kPa) and three kinds of
frequency (high frequency, 30 cycles/min, 1 sec on/ 1 sec off; middle frequency, 1
cycle/2 min, 1 sec on/119 sec off; and low frequency, 1 cycle/4 min, 1 sec on and 239 sec
off) to chondrocytes by using this unit. Five or 15 kPa of high frequency of cyclic tensile
force induced the expression of interleukin-1 (IL-1), matrix metalloproteinase (MMP)-2
and -9 mRNA, and increased the production of pro- and active-MMP-9. The degradation
of PG induced by high frequency of CTF. Moreover, reducing the frequency of CTF
from high to low decreases the inhibition of PG synthesis (Guilak et al 1999).
The results obtained from different groups show variation between experiments. The cell
density, force magnitude and frequency, the type of chondrocytes, are some of the
variables that could affect the response of cultured cells.
Salter et al (Wright et al 1992, 1997; Millward-Sadler et al 1999, 2000; Lee et al 2000;
Salter et al 2001, 2002) using a technique that allows the application of controlled
mechanical stimulation induced stretch to cultured chondrocytes (see 2.5 and 2.7, pages
97 and 111), analyzed mechanotransduction pathways in human articular chondrocytes.
In these experimental system, chondrocytes derived from normal adult articular cartilage
from human knees show numerous reproducible electrophysiologic, molecular, and
biochemical responses to 0.33 Hz cyclical mechanical stimulation. These responses
include changes in membrane potential (Wright et al 1 992, 1 996, 1 997), activation of
stretch-activated ion channels (SAC) (Wright et al 1992, 1997), protein tyrosine
phosphorylation of paxillin, ppl25FAK and P-catenin (Wright et al 1997; Lee et al
2000), increased sulphate incorporation (Bavington et al 1996), IL-4 release (Millward-
Sadler et al 1999), increases in aggrecan mRNA, decreases in MMP3 mRNA (Millward-
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Sadler et al 2000) and substance P (SP) release (Millward-Sadler et al 2003). They have
also shown that the mechanical-induced signalling pathway involves the actin
cytoskeleton, phospholipase C (Salter et al 2001, 2002) and protein kinase C (Lee et al
2002).
1.3.4.3. Tensegrity: A model mechanism for mechanotransduction
Little is known about how cells convert the mechanical signals into an
electrophysiological and/or biochemical response. How different mechanotransduction
components (e.g, stretch-induced ion channels, signalling molecules, cytoskeleton
(CSK), and integrins) within the context of the structural complexity of living cells play
their roles is still elusive. Based on tensegrity model, the overview of mechano¬
transduction will be a process that cells can convert any form of force application to
cellular and tissue adaptation by using a hard-wired cellular circuits. When each form of
mechanical force is exerted on a cell, three different types of cell sensor will be activated
including mechanosensitive ion channels, integrins and CSK and stretched-activated
enzymes. Hard-wired circuits link the ECM and CSK to control a series of effector
functions. These include reinforcement of cell-cell and cell-matrix connections, cell
proliferation and differentiation, ECM remodelling and cell migration (Figure 1.1).
Thus, any external mechanical force acting on the cells is balanced between tensile actin
filaments (from CSK) and the ECM anchoring proteins in the focal adhesion plaques.
The CSK may be viewed as mechanical filter, the same chemical or mechanical input
will produce a different output (cellular response) depending on the geometry and
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Figure 1.1. Intercellular mechanotransduction mediates cellular and tissue adaptations to




Integrins are a family of cell-surface GPs that act as receptors for ECM proteins, or for
membrane-bound counter-receptors on other cells (Aplin et al 1998). The name of
integrins refers to their function of integrating the cells' ECM to the cells' interior
(cytoskeleton) (vanderFlier and Sannenberg 2001). Each integrin is made up of a and P
subunit. Both the a and p subunits are type I transmembrane glycoproteins. In mammals
18 a and 8 p subunits have been shown to combine into 24 different dimers (Plow et al
2000).
Integrins are asymmetric molecules comprised of a ligand binding globular, ~ lOnm
diameter head, and two extended tails that contain carboxy terminal portions of a and P
subunits and their transmembrane domains (Springer 1997). Most integrins have a large
extracellular domain (approximately 1200 amino acids in a subunits and 800 amino
acids in P subunits) and a much shorter cytoplasmic domain with 50 residues or less
(vanderFlier and Sannenberg 2001). The exception is the P4 subunit that has a
cytoplasmic domain of over 1000 residues (Suzuki and Naitoh 1990). Certain P subunits,
P1, P3 and p4, can undergo alternative splicing of the cytoplasmic domain and this may
play a role in the regulation of integrin signalling. The P4 cytoplasmic domain also
undergoes proteolytic processing. The small cytoplasmic domains of integrins have no
intrinsic catalytic capacity (Damsky and Werb 1992; Hynes 1992; Ruoslahti 1991).
Integrin cytoplasmic domains are key nexus of interaction between the extracellular
environment and intracellular structures and signalling cascades. Both a and p subunit
cytoplasmic domains make important contributions to various aspects of overall integrin
function including cytoskeletal organization, cell motility, signal transduction, and
modulation of integrin affinity for ligands (activation) (Green et al 1998; Aplin et al
1998).
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Several cytoplasmic proteins including talin, a-actinin, and possibly focal adhesion
kinase (FAK) bind directly to the pi cytoplasmic domain and contribute to integrin-
cytoskeletal interactions (Burridge and Chrzanowska-wodnika 1996; Yamada and Geiger
1997). The P cytoplasmic domain is also important in signal transduction, particularly
integrin activation of FAK (Bauer et al 1993; Tahiliani et al 1997). P cytoplasmic
domains have played a critical role in a variety of cellular processes including
endocytosis (VanNhieu et al 1996), cross talk between integrins (Blystone et al 1995),
assembly of fibronectin fibrils (Wu et al 1995), and cell motility (Pasqualini and Hemler
1994).
The a subunit cytoplasmic domain inhibits certain functions of the P subunit. Binding of
a ligand to the integrin relieves this inhibition, possibly by allowing the subunits to swing
apart like a hinge (Burridge and Chrzanowska-Wodnicka 1996; Hughes et al 1996). The
a cytoplasmic domains also can strongly influence cell motility (Bauer et al 1993; Chan
et al 1992).
1.4.2. Integrin signalling
Since ligand binding is regulated by signals from within the cell and also triggers cellular
responses, mechanisms must exist to propagate information back and forth between the
cytoplasmic tails and the globular heads. This overall process is referred to as integrin
signalling. A didactic distinction is often made between inside-out and outside-in
signalling denoting those reactions initiated by the binding of one or more agonists to
their membrane receptors, leading to the conversion of integrin from low affinity/avidity
receptor to a high affmity/avidity receptor. Inside-out signalling can have two distinct
components that are often difficult to distinguish in practice:
1) affinity modulation, which implies a stmctural change intrinsic to the heterodimer that
results in a greater strength of ligand binding, and
2) avidity modulation, which implies a change in the functional affinity of the interaction
between receptor and ligand due to chelate or rebinding effects (Neri et al 1996).
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Outside-in signalling denotes reactions initiated by integrin ligation and clustering, and
these must be co-ordinated with signals emanating from other plasma membrane
receptors (eg, growth factors, cytokines, and G-protein-linked receptors) (Sastry and
Horwitz 1996; Juliano 1996). Integrin signals help to regulate a host of postligand
binding events, the particular pattern varying with the cell and the integrin (Shattil et al
1998).
Integrins do not have intrinsic kinase activity but instead they initiate cell signalling
through the recruitment of adapter proteins including paxillin, talin, vinculin, and
caveolin (Hynes 1992; Miyamoto et al 1995; Burridge et al 1996; Aplin et al 1999;
Giancotti 2000). These proteins and others such as focal adhesion kinase (FAK) and
proline-rich tyrosine kinase 2 (pyk2) interact with the integrin cytoplasmic tails when
integrins are bound to ECM ligands which induce a conformational change in the
receptor subunits. The interaction of integrins with ECM molecules results in the
clustering of integrins and the formation of focal adhesion complexes, where integrins
link the ECM and cytoskeleton (Howe et al 1998; Hughes and Pfaff 1998). The
formation of these integrin-associated signalling complexes is closely linked to the
cytoskeleton. Many of the signalling p roteins recruited into the complex are activated
through tyrosine phosphorylation (Loeser 2002).
1.4.3. Integrin ligand binding
Various cell types use the affinity and avidity modulation to regulate ligand binding to
integrins, and the relative contribution of each varies with the integrin and the cell type
(Diamond and Springer 1994; vanKooyk and Figdor 1997; Aplin et al 1998). The ligand
binding regions of integrins have been explored with chemical cross-linking, monoclonal
antibodies, mutation, and most recently, molecular modelling and X-ray crystallography
(Loftus et al 1994; Qu and Leahy 1995; Springer et al 1997). Three regions are
particularly important:
I) A series of several repeats of approximately 60 amino acids in the N-terminal portion
of the a chain, each containing a putative Ca2+ binding site
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II) An inserted domain (I- domain) of approximately 200 amino acids found in several a
chains and containing a nucleotide binding fold and a divalent cation coordination site
III) An I-domain like region of approximately 250 amino acids found in the N-terminal
region of the P subunit. Less information is available about the I-domain-like region in
the P subunit, however, molecular modelling and mutagenesis support its ligand-binding
role (Loftus and Liddington 1997).
Integrins likely undergo dynamic structural changes as part of the ligand binding process
including relative movements of subunits and of domains, and conformational changes
within domains. Integrins can exist in various affinity states for their ligands, structural
changes t hat o ccur i n moving from 1 ow-1 o h igh-affinity s tates (or v ice versa) c an be
detected by certain monoclonal antibodies (Loftus and Liddington 1997).
The a/p pairings specify the ligand-binding abilities of the integrin heterodimers.
Although the ligands for integrins are often large ECM proteins such as collagen,
laminin, vitronectin, or fibronectin, some integrins recognize rather short peptide
sequences within the larger protein, for example, the RGD (Arg-Gly-Asp) sequence
found in fibronectin and vitronectin. Because of this, there has been considerable interest
in the pharmaceutical industry in developing short peptides or peptidomimetics that can
interdict integrin functions in a variety of disease processes including coagulation
disorders, inflammation, and cancer (Ruoslahti 1996).
1.4.4. Expression of integrins in human articular cartilage
Initial studies were performed to characterize which integrins were expressed by adult
articular chondrocytes and which cartilage ECM proteins served as chondrocyte integrin
ligands. Work from several laboratories has revealed that chondrocytes express a variety
of integrins (Salter et al 1992, 1995; Woods et al 1994; Loeser et al 1995, 2000; Loeser
2002; Knudson and Loeser 2002) (Figure 1.2). Using immunohistochemical staining of
adult human articular cartilage, Salter et al (1992) noted that the a5pi integrin was a
prominent chondrocyte integrin with variable and weaker expression of alpland
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a3pi.Using a combination of immunofluorescence, immunoprecipitation, and FACS
(Fluorescence activated cell sorter) analysis, Woods et al (1994) demonstrated that adult
human chondrocytes express aipi,a5pi, and aVp5 integrins accompanied by weak
expressed of a3pi and aVp3. Relative to adult chondrocytes, fetal chondrocytes and
chondrosarcoma cells have higher levels of a2pi and a6pi intergins (Holmvall et al
1995; Salter et al 1995). Loeser et al (2000, 2002) noted that primary adult chondrocytes
do express a2 at low levels but expression is stimulated in immortalized and fetal cells.
Compared to histologically normal cartilage, increased immunostaining for chondrocyte
integrins has been observed in OA cartilage, with a particular increase noted in alpl in
monkey cartilage with OA-like changes (Loeser et al 1995) and the appearance of
a2pinoted in OA cartilage in human femoral heads (Ostergaard et al 1998).
The aipi,a2pi (Durr et al 1993; Enomoto et al 1993; Loeser et al 1995, 2000) and
alOpi (Camper et al 1998) integrins can all serve as receptors for type II collagen.
Although the aipi integrin partially mediates chondrocyte adhesion to type II collagen,
the recent discovery of alOpi by affinity chromatography using type II collagen
suggests that this integrin may be a key receptor for type II collagen (Camper et al 1998).
The alpl integrin also mediates adhesion of chondrocytes to type VI collagen (Loeser et
al 2000) and to cartilage matrix protein (matrilin-1) (Makihira et al 1999). In addition to
collagen, a2pican mediate binding to chondroadherin (Camper et al 1997).
The a5pi integrin serves as the primary chondrocyte Fn receptor (Loeser et al 1995)
while aV-containing integrins bind to vitronectin and osteopontin (Loeser 1993) and
may serve as alternative Fn receptors. It is likely that not all of the integrins expressed by
chondrocytes have been described and the potential exists for additional integrin-matrix


















Figure 1.2. Chondrocyte integrins and their lignads. The members of the pi and aV
integrin subfamilies reported to be expressed by chondrocytes are shown along with the
ECM proteins which have been demonstrated to bind to the specific integrin subunits.
(CMP, cartilage matrix protein; ECM, extracellular matrix) (Knudson and Loeser 2002).
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1.4.5. Evidence for involvement of a5pi integrin in chondrocyte
mechanotransduction
In addition to mediating adhesive interactions, integrins play a further important role on
mechanical stress-induced signals. Specifically, it has been shown that integrins like
a5pl and aVP3 are essential for mechanotransduction of hemodynamic forces into
biochemical signals (Urbich et al 2002).
Wright et al (1997) have shown that the membrane potential response of both normal and
osteoarthritic chondrocytes to 0.33 Hz cyclic mechanical stimulation was significantly
reduced when cells were preincubated with anti-pl (P4C10) and anti-a5 integrin
(BIIG2) antibodies. In contrast antibodies against other subunits had no effect on the
membrane response. These observations are consistent with a role for a5pi integrin, the
classical fibronectin receptor, in the mechanotransduction process, potentially as a
mechanoreceptor. This idea supported by the observations that RGD containing peptides,
which block integrin signalling, prevent the changes in aggrecan and MMP3 mRNA
levels that occur following m echanical stimulation of normal chondrocytes (Millward-
Sadler et al 2000; Salter et al 2002). These data have been suggested that a5pi integrin
acts as a chondrocyte mechanoreceptor in both normal and osteoarthritic cartilage (Salter
et al 2001).
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1.4.6. Integrin-mediated signalling pathways
The signalling pathways activated by integrins have been identified through the analysis
of biochemical events that are triggered by integrin engagement, and by the identification
of proteins that associate with focal adhesion complexes. Some of the critical integrin-
mediated signalling pathways can involve protein tyrosine phosphorylation, SH2-SH3
signalling molecules, serine-threonine kinase activation and calcium concentration.
1.4.6.1. Protein tyrosine phosphorylation
Protein tyrosine phosphorylation is one of the earliest events detected in response to
integrin activation. Studies in platelets provide the first evidence that integrin receptors
can regulate agonist-induced tyrosine phosphorylation (Clark et al 1994, 1995).
Subsequently, t yrosine phosphorylation h as been shown to b e a common and perhaps
ubiquitous response to integrin engagement in many cell types including fibroblast,
carcinoma cells, and leukocytes (Juliano and Haskill 1993; Hynes et al 1992; Arroyo et
al 1994). The ability of tyrosine kinase inhibitors to inhibit the formation of focal
adhesions suggests a role for tyrosine phosphorylation in the signalling pathways linked
to integrin receptors (Burridge et al 1992). As integrins have no intrinsic enzymatic
activity of their own, they must interact with other proteins to generate signals (Damsky
and Werb 1992). Several protein tyrosine kinases have been implicated in integrin
signalling events by virtue of their integrin-dependent activation or their localization to
focal contacts. The focal adhesion kinase (FAK) appears to play a central role in integrin-
mediated signal transduction. This kinase is tyrosine phosphorylated, and its tyrosine
kinase activity enhanced, upon integrin engagement (Schaller and Parsons 1994).
Integrin-induced phosphorylation of FAK requires the cytoplasmic domain of the
P integrin subunit, and clustering of chimeric integrin receptors expressing several
P cytoplasmic domains is sufficient to induce FAK phosphorylation (Schaller and
Parsons 1994; Lukashev et al 1994). It has been shown that FAK can bind to peptides
from the pi, P2, and P3 subunits. However, FAK cannot be coimmunoprecipitated with
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these subunits, suggesting that either the interaction is weak or there is no direct
association during the localization of FAK to focal adhesion plaques (Dedhar and
Hannigan 1996). In addition, calcium transients and protein kinase C (PKC) activity may
be required as costimulatory events for FAK phosphorylation (Vuori and Ruoslahti 1993;
Pelletier et al 1992; Shattil et al 1994). The targeting of FAK to focal adhesions appears
to involve multiple binding interactions. A COOH-proximal focal adhesion targeting
(FAT) sequence is necessary and sufficient to localize FAK or a FAT-containing
chimeric protein to focal adhesions (Hidebrand et al 1993), whereas NH2-proximal
sequences of FAK can bind to synthetic peptides derived from several P cytoplasmic
domains(Schaller, unpublished data). The cytoskeletal protein paxillin also associates
with FAK through a COOH-terminal sequence of FAK distinct from the FAT domains
(Hidebrand, unpublished data). FAK tyrosine phosphorylation sites can serve as binding
sites to couple FAK with cellular proteins that contain SH2 domains (Schlaepfer et al
1994; Pawson 1995).
1.4.6.2. SH2-SH3 adapter proteins
Several proteins that associate with integrin-nucleated protein complexes contain
modular domains, termed Src homology 2 (SH2) and 3 (SH3) that specifically mediate
protein-protein coupling. SH2 domains bind to proteins through interactions with specific
peptide motifs containing phosphotyrosine, whereas SH3 domains bind to short proline-
rich peptide motifs on their protein targets (Pawson 1995). These domains play critical
roles in intermolecular interactions that couple proteins associated with membrane
receptor complexes. Members of the Src family, which contain an SH3 and SH2 domain,
have also been implicated in integrin signalling events. Activated Src associates with
integrin-dependent cytoskeletal complexes in platelets and fibroblasts (Clark et al 1994;
Schlaepfer et al 1994). This localisation appears to be dependent on the Src SH3 domain
(Kaplan et al 1994), possibly through interaction with proline-rich sequences with
paxillin (Weng et al 1993). The localisation of Src family kinases to focal adhesions may
also be mediated by their SH2 domains, which bind to the FAK autophosphorylation site
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(Okamura and Resh 1994). One such protein, growth factor receptor-bound protein 2
(Grb2), links activated receptor tyrosine kinases, is associated with FAK in an integrin-
dependent manner (Clark and Brugge 1995).
Src homology 2 domain-containing protein tyrosine phosphatase-2 (SHP-2) is a
nontransmembrane protein tyrosine phosphatase (PTP) that is involved in integrin-
mediated signalling pathways such as tyrosine phosphorylation. SHP-2 plays a critical
role in growth factor and cytokine signalling pathways (Oh et al 1999). It has been
shown that a fraction of SHP-2 moves to focal contacts upon integrin engagement and
that binds to SHP substrate-1 (SHPS-1), a transmembrane GP with adhesion molecule
characteristics. This protein is also known as signal regulatory protein-a (SIRP-a)
(Fujioka et al 1996) (see 1.5.2.6.2, page 68). Oh et al (1999) have shown that SHP-2,
acting via SHPS-l/SIRPa, acts as a critical positive component in integrin signaling.
1.4.6.3. Serine-threonine kinase families
Serine-threonine kinase families such as protein kinase C (PKC) and mitogen-activated
protein (MAP) kinases are also activated upon integrin stimulation, and inhibitors of
PKC block cell attachment and spreading in certain cell systems (Vuori and Ruoslahti
1993; Nakamura and Nishizuka 1994; Schlaepfer et al 1994).
The PKC isoenzymes can be classified into three groups:
I) The conventional PKCs (cPKCs) a, (31, (311, y are activated by negatively charged
phospholipids, diacylglycerol (DAG) or phorbol ester, in a Calcium-dependent manner.
II) The novel PKCs (nPKCs) 5, 8, 0, p/L and p also require negatively charged
phospholipids, but not Calcium for activation.
III) The atypical PKCs (aPKCs) AA and C, do not require Calcium, DAG, or phorbol
ester, but only negatively charged phospholipids.
The isoenzymes are characterized by differences in the various domains, called C1-C4.
CI domain forms the DAG binding site. This domain is immediately preceded by an
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autoinhibitory pseudosubstrate sequence. The C2 domain contains the recognition site for
acidic lipids and, in some isozymes, the Ca2+-binding site. The C3 and C4 domains form
the ATP binding and substrate-binding sites.
In comparison to cPKCs, the Calcium binding domain (C2) is lacking in nPKCs and
aPKCs. cPKCs and nPKCs contain two zinc fingers in the phorbol ester binding site
(CI), aPKCs are characterized by a single zinc finger. In PKCp, the pseudosubstrate
domain is lacking.
The different PKC isoenzymes are expressed in a tissue-dependent fashion and most cells
express multiple isoforms (Dekker and Parker 1994). PKC isoforms are targeted to
different cellular compartments on cell stimulation (Haller et al 1995). They also bind to
cytoskeletal proteins and to other subcellular compartments (Kiley and Parker 1995) and
phosphorylate different substrates (Hofmann 1997). PKCs are implicated in various
biological functions including signal transduction, cell proliferation and differentiation.
Various groups have shown that PKC may be activated by integrin- mediated signalling
(Vuori and Rouslahti, 1993; Chun et al 1996; Lewis et al 1996; Haller et al 1998; Wrenn
and Herman 1995; Ng et al 1999). A unique feature of PKC regulation is that prior to
stimulation of the cell, the inactive form of PKC is thought to be diffusely distributed
throughout the cytosol, or may be localized to specific regions or structures of the cell.
Following stimulation, PKC isoforms are observed to translocate from inactive pools to
their active cell loci such as cell membrane where it associates with membrane
phospholipids (Haller et al 1990). Several cell membrane proteins have been recognized
that bind only activated PKC isozymes termed receptors for activated C-kinase (RACKs)
(Mochly-Rosen et al 1991).
Several reports have indicated that the PKCa is translocated from the cytosol (cytosolic
compartment) to the cell membrane (particulate compartment) after activation (Khalil et
al 1994; Jensen et al 1996; Haller et al 1998b; Li et al 2002; Lee et al 2002).
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Lee et al (2002) have recently reported that within 30 sec mechanical stimulation at 0.33
Hz rapidly activates PKCa in cultured articular chondrocytes by translocating the
PKCa from the cytosol to the particulate fraction. They have also demonstrated that
mechanotransduction via integrins is necessary for association between
RACKl/PKCa and pi integrin following 0.33 Hz cyclical mechanical stimulation.
PKC seems also to play a role in the formation of focal adhesions (Jaken et al 1989;
Lewis et al 1996). Because both PKC and ppl25FAK localize to the plaques, a relation
between these enzymes with various experiments has been investigated. Different studies
in Chinese hamster ovary (CHO) cells (Vuori and Ruoslahti 1993), fibroblast cells
(Woods and Couchman 1992), platelets (Haimovich et al 1996) and muscle cells
(Disatnik and Rando 1999) have reported the association between PKC activation and
FAK tyrosine phosphorylation.
1.4.6.4. Intracellular Calcium regulation
Integrin engagement can also induce an increase in intracellular Calcium concentration
([Ca2+]i), a key regulator of intracellular signalling via multiple integrins, though the
exact response appears to be specific to the integrin, ligand, and cell type (Juliano et al
1993; Schwartz et al 1994). [Ca2+]i acts as a regulator of different cellular processes
including gene expression and cell proliferation (Berridge 1993).
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1.5.0. CELL MEMBRANE INTEGRIN-ASSOCIATED
PROTEINS
1.5.1. Interaction between integrins and other cell membrane proteins
In addition to interacting with molecules on neighboring cell or ECM (trans), integrins
can also form associations with other receptors on the same cells (cis) to form
multireceptor complexes. These complexes recruit signalling molecules to sites of cell-
cell or cell-matrix adhesion, such as focal complexes or focal adhesions. So far, there is
little evidence that integrins can signal through exclusive, integrin specific pathways.
Instead, they appear to cooperate with other cell surface receptors to influence a variety
of signalling pathways. These complexes of integrins and partner receptors can be
formed either in response to or independent of integrin activation and ligation. The
classes of receptors known to be associated both physically and functionally with
integrins are shown in Table 1.2. Most of the associations involve extracellular domains
(Porter and Hogg 1998).
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Table 1.2. Cell membrane proteins associated with integrins (Shattil et al 1998;






























Gao et al 1996
Fenczik et al 1997
Brisson et al 1997
Maecker et al 1997
Berditchevski et al 1996
Tachibana et al 1997
Sincock et al 1997
Wei et al 1996
Xue et al 1994, 1997
Xue et al 1994
Berditchevski et al 1996
Wary et al 1996
Abbreviations: IAP, integrin-associated protein; GPI, glycosylphosphatidylinositol;
TM4SF, transmembrane-4 superfamily; uPAR, urokinase plasminogen activator
receptor; EMMPRIN, extracellular matrix metalloproteinase inducer.
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1.5.2. Recognition and expression of integrin-associated protein (IAP)/
CD47
Initially, B6H12 protein was purified from placental membranes and platelet (Gresham et
al 1989; Brown et al 1990). The molecular mass of the B6H12 protein on SDS-PAGE
was 50 -55 kD under reducing conditions. Campbell et al (1992) defined B6H12 protein
as ovarian tumor-specific antigen 3 (OA3) for ovarian carcinoma cell line OVM1.
To recognize this molecule, a number of monoclonal antibodies (mAbs) and polyclonal
Abs prepared using the purified placental protein as immunogen (Brown et al 1990;
Rosales et al 1992; Mawby et al 1994; Lindberg et al 1994). Brown et al (1990) produced
a panel of mAbs and one polyclonal Ab and compared their function with B6H12. Fifty
kD glycoprotein was first described as a molecule associated with P3 integrin chain on
placenta and platelets and called integrin associated protein (IAP) (Brown et al 1990).
IAP was widely expressed in hematopoietic cells (erythrocytes, lymphocytes, platelets,
monocytes, and neutrophils) and promonocytic and promyelocytic cell lines (U937 and
HL60). Other studies reported (Rosales et al 1992; Mawby et al 1994) that tissues such
as placenta, surface epithelia, liver, brain, and even cells that did not express integrins,
including erythrocytes, showed highly expressed level of IAP. Antibodies that
recognised OA3, B6H12 and IAP, were later shown to recognize CD47 (Lindberg et al
1994).
1.5.2.1. Structure and in vivo alternatively spliced forms of CD47
CD47 is a unique Ig superfamily member with an amino-terminal Ig variable (IgV)
extracellular domain, a carboxy-terminal five membrane-spanning domain, and a short
cytoplasmic tail with four alternatively spliced forms (Lindberg et al 1993; Reinhold et al
1995) (Figure 1.3). The IgV homology suggested the disulfide linkage. The extracellular
domain composed of about 120 amino acids (AA). The carboxy terminus is located on
the inside of the cell membrane and consists of about 152 AA. Four isoforms of mRNA
derived by alternative splicing at the intracytoplasmic tail (~30 AA).
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Human CD47 has five potential N-glycosylation sites in the EC domain, three of these
sites are glycosylated in erythrocytes, leading to its broad migration at 45-60 kD on SDS-
PAGE. However, in leukocytes and platelets, CD47 runs as a band of 47-55 kD (Yuan et
al 1996). These results suggest type-specific cell glycosylation may be responsible for
the differences in the apparent molecular weight.
Four distinct complementary DNAs (cDNAs) for OV-3 antigen were first reported in
ovarian tumor cells (Campbell et al 1992) and the identical results obtained in human and
murine tissues (Lindberg et al 1993). The cDNAs differ from each other by increasingly
long extensions at the 3' end of the c oding region. Since the carboxy terminus of the
protein is intracytoplasmic (Lindberg et al 1993) each of these cDNAs would code for
protein with a different length intracytoplasmic tail, which are termed forms 1-4, based
on increasing length. Each longer cytoplasmic tail came from the addition of a short
peptide sequence to the extreme carboxy terminus of the protein. Each of these additional
peptide sequences was encoded by a short exon. The three exons encoding the additional
extensions of forms 2-4 were 32bp, 25bp, and 36bp, respectively (Lindberg et al 1993).
Each of these exons and the one encoding the form 1 cytoplasmic tail ended in G. The
common exon encoding the 3' UT, which is identical for each form, began AATAAC.
For forms 1,3, and 4, the splice with the 3' G of the preceding exon led to a glutamate as
the carboxy-terminal amino acid of the predicted protein, followed by a stop (TAA or
TAG) codon. For form 2, the frame was shifted and the final AA, NN, were encoded in
the same exon as the 3' UT sequences prior to a new stop codon. Because the cDNAs all
contained identical 3' UT, the different coding regions represented alternative splicing of
the IAP gene (Reinhold et al 1995).
Four isoforms of mRNA derived by alternative splicing at the intracytoplasmic tail (-30
AA). It has been shown that IAP form 1 has a 4 AA intracytoplasmic extension, encoded
on the same exon as the final transmembrane domain, form 2 a 16 AA extension, form 3
a 23 AA extension, and form 4 a 34 AA extension (Figure 1.3)(Lindberg et al 1993;
Reinhold et al 1995).
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All 4 isoforms of IAP mRNA are expressed at varying levels in a variety of cells and
tissues. RT-PCR and immunohistochemical studies have shown tissue-specific
expression of different IAP isoforms in human and murine tissues. Thymus and spleen
expressed predominantly form 2 mRNA, while brain expressed from 4 to a much greater
degree than any other form. Form 2 and form 4 are the most abundant IAP splices
variants made in vivo (Reinhold et al 1995).
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Figure 1.3. Structural model for CD47. The model is based on predictions from the
primary sequence, as derived from cDNA sequence, as well as homology to known
members of the Ig superfamily (IgSF). The extracellular N-linked glycosylation sites are
shown. The disulfide linkage (c-c) is indicated. The Ig variable (IgV) extracellular
domain is followed by five transmembrane segments terminating in a cytoplasmic tail
that is alternatively spliced, giving rise to four isoforms, the longest of which, form 4, is
shown in its entirely (Lindberg et al 1993; Brown and Frazier 2001).
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1.5.2.2. CD47 functions
Since IAP is ubiquitously expressed (Brown et al 1990; Rosales et al 1992; Reinhold et
al 1995), its function has been inferred from the effect of antibody inhibition, in a
number of cells mainly in myeloid and endothelial cells. IAP was first identified as the
target of antibodies that block ECM-induced activation of neutrophils (PMN) and
monocytes (Brown et al 1990). Anti-IAP mAb B6H12 inhibited PMN transendothelial
migration, PMN and endothelial cell chemotaxis to RGD-containing proteins, and PMN
adhesion to entactin (Cooper et al 1995). In addition, anti-IAP mAbs inhibit an increase
intracellular calcium concentration seen when endothelial cells spread on vitronectin
(Vn) in an aV-dependent manner (Schwartz et al 1993). Further, anti-CD47 mAbs can
block integrin-stimulated phagocytosis (Blystone et al 1995) and transepithelial (Parkos
et al 1996) migration of polymorphonuclears. CD47 knockout mice have a severe host
defense defect (Lindberg et al 1996). The cross-linking of CD47 with two mAbs anti-
CD47, namely B6H12 and Brie 126, showed a strong comitogenic effect on the
proliferation of human T lymphocytes stimulated through a specific pathway, but another
anti-CD47 mAb, namely 2D3, was ineffective (Ticchioni et al 1997). Salter et al (1997)
have shown that anti-CD47 Brie 126 inhibited the hyperpolarisation response of human
bone cells (HBC) following 0.33 Hz cyclical mechanical stimulation but had no effect on
the response of bone cells at 0.104 Hz stimulation. Ticchioni et al (1997) have shown
that signal delivered by CD47 within T cells, induces the phosphorylation on tyrosine of
several proteins. CD47 is involved in a number of cellular and molecular functions, some
ofwhich are listed in Tables 1.3 and 1.4.
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1.5.2.3. CD47-integrin interactions and signalling
CD47 forms a physical complex with certain integrins (Brown et al 1990; Gao et al
1996a,b; Wang and Frazier 1998), and blockade of IAP with mAbs inhibits some aspects
of integrin signalling (Lindberg et al 1996). Within the plasma membrane of platelets and
most cell types, CD47 can associate with and modulate the activity of several families of
integrins. Some studies of platelet activation and spreading and chemotaxis of nucleated
cells indicated that CD47 initiates a signalling pathway to upregulate integrin function,
that is, inside out signalling (Blystone et al 1995; Gao et al 1996a; Chung et al 1997,
1999; Wang and Frazier 1998).
The ligation of CD47 with cell binding domain (CBD) domain of thrombospondin (TSP)
causes an increase in the affinity and/or avidity of aVp3 integrin. The presence of TSP
or its CD47 agonist peptide in medium of cultured C32 melanoma cells causes rapid and
intense tyrosine phosphorylation (Gao et al 1996; Frazier et al 1999; Green et al 1999).
CD47 binds specifically to its agonist peptide from TSP, activates the platelet integrin
anbP3, resulting in platelet spreading on immobilized fibrinogen, stimulation of platelet
aggregation, and enhanced tyrosine phosphorylation of focal adhesion kinase (Chung et
al 1997). Recently Lagadec et al (2003) have shown interaction between platelet CD47
and endothelial TSP1 under flow activates anbP3 integrin and promotes platelet-EC
adhesion. The effect of a2pi-mediated chemotaxis requires CD47 and its ligand TSP.
CD47 may alter the affinity state of a2pi, either by direct physical interaction (Wang
and Frazier, 1998) or via inside out signaling (Wang et al 1999; Chung et al 1999).
Recently it has been shown that CD47 and a4pl integrin are colocalized on microvilli of
K562 erythroleukemia cells (Abitorabi et al 1997), and CD47-dependent arrest of T cells
on inflammatory endothelium could be blocked by antibodies that prevent a4pi integrin
binding to vascular cell adhesion molecule (VCAM-1) (Ticchioni et al 2001). Moreover,
it has been shown that CD47 expression is required for stimulation of T cell motility and
expression of MMP-2 stimulated by a4pi integrin ligand. An antibody to CD47 also
blocked the motility response to an a4pi integrin ligand (Li et al 2002). Therefore, at
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least CD47 and a4pi integrin could be functionally associated in T cell chemotaxis
(Barazi et al 2002).
It has been shown that in human erythroleukemia cell line K562, a5pi integrin-mediated
phagocytosis, was inhibited in the presence of function blocking mAb anti-CD47
(B6H12). This modulation of a5piintegrin phagocytosis was affected by aVp3 signal
transduction (Blystone et al 1995). In addition, Barazi et al (2002) have recently shown
that B6H12 physically associated with a4pi integrin and functionally has inhibitory
effect on a5pi integrin role in integrin-mediated adhesion in Jurkat T cells. Therefore,
they reclassified B6H12 as a function-modifying Ab for CD47 (Barazi et al 2002).
Fujimoto et al (2003) have recently reported a novel mechanism of affinity modulation of
integrin. They have provided evidence that the extracellular Ig domain of CD47 when it
binds to TSP-1 can interact with anbP3 integrin and change anbP3 to a high affinity state
without the requirement of intracellular signalling.
Graf et al (2002, 2003) have recently demonstrated that different types of cells use a
common molecular machinery for the mechanosensitive regulation. They also have
shown that different external forces induce the same biochemical response in each cell.
The proteins involved in this process are, a member of integrin family (such as aVp3 in
fibroblast and endothelial cells), IAP/CD47 and TSP-1.
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1.5.2.4. CD47-integrin complex signals via heterotrimeric Gi protein
A relatively stable complex containing CD47 and heterotrimeric Gi proteins is observed
in C32 melanoma cells and platelets. It has been shown that different integrin aP
heterodimers associating with CD47 can couple to Gi protein- dependent pathways.
Treatment of cells with pertussis toxin (PTX) eliminated the co-immunoprecipitation of
CD47 and Gi (Frazier et al 1999). Aside from the physical association of integrins,
CD47, and Gi proteins, other factors support the concept of a functional association in
which CD47 communicates directly with Gi. This complex integrity is absolutely
dependent on cholesterol (Green et al 1999). Incubation of the aVp3-CD47-Gi complex
with p-methyl-cyclodextrin to remove cholesterol causes complete disruption of the
protein complex.
Treatment of platelets with TSP peptide initiates a precipitous drop in intraplatelet cAMP
levels. This signalling event is common to all of the agonists that activate platelets
through G protein-coupled receptors (Shattil et al 1994). A similar fall observed in
intracellular cAMP in other cell types that respond to TSP-1 stimulation with integrin
activation (Adams 2001). Since most other receptors that activate heterotrimeric G
proteins are members of the heptaspanin family (7TMS model), one appealing model for
activation by CD47/integrin holds that the five membrane-spanning segments of CD47
and two membrane-spanning domains of the heterodimeric integrin form a seven-
transmembrane receptor. Ligation of this complex with an adhesive ligand or TSP could
activate GTPase activity in a manner analogous to that of conventional heptaspanins
(Gao et al 1996; Frazier et al 1999; Brown and Frazier 2001).
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1.5.2.5. Integrin-independent CD47 signalling
Although, as mentioned above, association of CD47 with certain integrins was found to
modulate their function, some signal transduction through CD47 is integrin-independent
(Cooper et al 1995; Frazier et al 1999; Ticchioni et al 1997; Reinhold et al
1997;Waclavicek et al 1997; Wu et al 1999; Liu et al 2001). Most of these reports are
related to T cell costimulation. Ticchioni et al (1997) have shown that cross-linking of
CD47 with two mAbs, namely B6H12 and Brie126, has a strong effect on proliferation
of peripheral T lymphocytes, and CD47 is not associated with integrins. Reinhold et al
(1997) have reported that T cell activation by CD47 is independent of integrins. They
showed that in Jurkat cells, ligation of IAP costimulated IL-2 production, and this effect
was not mimicked by ligation of any integrin on the cell.
Liu et al (2001) have recently reported that the mechanism of CD47-mediated regulation
of PMN transmigration is integrin-independent. They have used a panel of functionally
inhibitory mAbs against the specific PMN integrins and did not observe any significant
effect on PMN transepithelial migration. In addition, no physical association has been
found between CD47 and PMN integrins.
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Table 1.3. CD47 functions in various cell types
Cell or tissue type Biological function/s Reference/s
Placenta, PMN, platelet Cell adhesion
Phagocytosis/ chemotaxis
Brown et al 1990;
Senior et al 1992
Ovarian tumor cells Ovarian tumor marker Campbell et al 1992
Endothelial cells Calcium influx Schwartz et al 1993
Neutrophil Neutrophil migration Cooper et al 1995




Chung et al 1997
Lagadec et al 2003
Bone cells Mechanical stimulation Salter et al 1997
Jurkat cells and 3.L2 cells IL-2 production
Co-stimulated proliferation
Reinhold et al 1997
T cells Comitogenic effect
Tyrosine phosphorylation
Ticchioni et al 1997
VSMC Chemotaxis Wang et al 1998, 1998
Rat brain Synaptogenesis Jiang et al 1999
Rat brain Synaptogenesis Jiang et al 1999
Mouse splenic red pulp Phagocytosis inhibition Oldenborg et al 2000,2001
Memory T cells Downregulation of
proliferation
Brooke et al 1998
Seiffert et al 2001
Dendritic cells cytokine production Latuor et al 2001
Macrophage Cell fusion Saginario et al 1998;
Han et al 2000
1. Murine Pro-B cell
(Ba/F3)
Cell aggregation Babic et al 2000
T cell Cell accumulation Ticchioni et al 2001
PMN (Neutrophil) Tyrosine phophorylation Liu et al 2001, 2002
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1.5.2.6. CD47 ligands
So far, two important n atural ligands of CD47, thrombospondin-1 (TSP-1) and signal
regulatory protein-a (SIRPa), have been described.
I.5.2.6.1. Thrombospondin-1 (TSP1)
Thrombospondins (TSPs) comprise a family of five genes encoding proteins designated
TSP-1 through TSP-5. Platelet thrombospondin, or TSP-1 as it is known, is the
prototypic member of this family. The complete cDNA sequence of TSP-1 provided the
basis for detail studies of the structure-function relationships of this complex and
interesting molecules.
Thrombospondin-1 (TSP-1) is a trimeric glycoprotein consisting of three identical
monomer chains. Molecular cloning of TSP-1 revealed that each subunit of the trimer
consists ofmultiple domains: N- and C-terminal globular domains, a region of sequence
with similarity to procollagen, and three types of repeated motifs, designated type I, type
II, and type III repeats (Lawler 1986). Molecular cloning of TSP-2, -3, -4 and cartilage
oligomeric matrix protein (COMP or TSP-5) indicates that the TSPs can be divided into
two subgroups on the basis of their molecular architecture ( Adams 2001).
TSP-1 and -2 (subgroup A) have the same set of structural domains. By contrast, TSP-3,
-4 and -5 (subgroup B) lack the type I repeats and the region of homology with
procollagen, but contain an additional type II repeat. TSP-5 also lacks the N-terminal
globular domain. Subgroup A proteins are trimeric and have identical domain structures,
while subgroup B are pentameric.
TSP1, -450 kD trimeric matrix glycoprotein, was first described as an a-granular
protein secreted by platelets upon thrombin activation. TSP1 is also synthesized by a
number of cells including smooth muscle cells (Wang and Frazier 1998), endothelial
cells (EC) (Sheibani and Frazier 1995) and articular chondrocytes (Miller and Mc Devitt
1988; DiCesare et al 1994). TSP1 binds to a large number and wide variety of receptors.
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Proteolytic digestion of TSP1 and expression of domains are recombinant or synthetic
peptides has enabled identification of several sequences that support these interactions.
There are at least six distinct receptors for TSP. These receptors include:
1. The heparin-binding domain (HBD) in the N-terminal domain, which binds to PGs
and sulfatides (Gartner et al 1984)
2. Procollagen domain (PC) (Lawler et al 1988)
3. A region within the type I repeats, which binds to CD36 (Asch et al 1992)
4. A region within the type II repeats
5. The Arg-Gly-Asp (RGD) sequence within the last of the type III repeats, calcium-
binding domain, which bind to integrins such as aVp3 and anb|33 (Lawler et al 1988;
Karczewski et al 1989)
6. Carboxy-terminal domain, named the C-terminal cell-binding domain (CBD),
including a minimal sequence (Arg-Phe-Tvr-Val-Val-Met-Trp-Lvs). named 4N1-1, and
more soluble peptide (Lys-Arg-Phe-Tyr-Val-Val-Met-Lys-Lys), named 4N1K, both
contain VVM motif that bind to IAP or CD47 (Kosfeld and Frazier 1993; Gao et al 1994,
1996).
A major cell attachment site was identified in the extreme C-terminal domain "cell-
binding domain" (CBD) of TSP-1 (Kosfeld and Frazier 1992). Using synthetic peptides,
the cell-binding activity was localized to two sequences both containing the unlikely
adhesion motifVVM. One of these peptides, 4N1 or RFYVVMWK, is highly conserved
in all species and isoforms of TSP (Kosfeld and Frazier 1993). It has been shown that
CD47 acts as a receptor for 4N1K motif of TSP. The CD47-binding sequence is well
conserved in all TSP isoforms, suggesting that all TSP family use CD47 as a receptor.
The interaction of CD47 and TSP-1 has been shown to trigger downstream intracellular
signalling pathways including caspase-independent cell death in chronic lymphatic B cell
leukocyte clones (Mateo et al 1999), rapid decrease in intacellular cAMP level (Frazier et
al 1999; Wang et al 1999) and inhibition of ERK activities in smooth muscle cells (Wang
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et al 1999). However, Tulasne et al (2001) have recently shown that CD47-null platelets
can be stimulated to aggregate by 4N1K.
TSP-1 is a ligand for several integrins, including aVp3 and anbP3 on platelets (Chung et
al 1997), a3pi on neurons (DeFreitas etal 1995), a4pi and a5pi on T lymphocytes
(Yabkowitz et al 1993a), a3pland a4pl on breast carcinoma cells (Chandrasekaran et al
1999; Krutzsch et al 1999). TSP-1-integrin interactions appear to mediate numerous
TSP-1 functions (Table 1.4).
TSP1 mediates activation-dependent T cell adhesion through binding to a4pl and a5pi
integrins (Yabkowitz et al 1993a). When C32 human melanoma cells attach to a sparsely
coated vitronectin substratum, TSP and 4N1K dramatically stimulate the rate of aVp3-
dependent cell spreading (Gao et al 1996b). Further, 4N1K peptide is a chemoattractant
ofECs migrating on a gelatin/RGD-containing matrix to which they attach via aVp3
(Gao et al 1996a).
In several biological settings, the binding of CD47 to TSP1, its cell binding domain, or
the agonist peptide 4N1K can stimulate the activation of integrins to higher affinity/
avidity state. For example, 4N1K peptide stimulates spreading on fibrinogen-coated
surfaces and induces aggregation of platelets via activation of the integrin a nbP3 as
judged by the enhanced binding of the ligand mimetic mAb PAC-1 (Chung et al 1997).
The chemotaxis of vascular smooth muscle cells (VSMC) toward soluble collagen is also
stimulated by 4N1K. In this case, a2pl, a collagen receptor, is modulated by CD47
(Wang et al 1998). Recently it has been shown that the extracellular Ig domain of CD47
when binds to TSP-1 can interact with otnbP3 integrin and change anbP3 to a high affinity
state without requirement of intracellular signalling (Fujimoto et al 2003). However,
Tulasne et al have previously shown that CD47-null platelets can be stimulated to
aggregate by 4N1K (Tulasne et al 2001).
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TSP1 is known to be present in articular cartilage (Miller and Me Devitt, 1988; DiCesare
et al 1994). Using immunohistochemistry and mRNA expression, the pattern of
TSP1 expression in human normal and osteoarthritic cartilage has been reported (Pfander
et al 2000). They have reported that TSP-1 is predominantly expressed in middle zone
chondrocytes in normal and mild OA cartilage. In severe OA reduced matrix staining of
TSP1 and significant reduction in TSP-1 mRNA compared with mild OA are
demonstrated.
TSPs are implicated in the regulation of the motility, proliferation, and differentiation of
many cell types (Frazier 1991; Bornstein and Sage 1994). For example, TSP-1 blocks
angiogenesis by inhibiting the chemotaxis and proliferation of EC and promoting their
differentiation into capillaries (Frazier 1991; Sheibani and Frazier 1995).
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Table 1.4. Summary of functional properties attributed to the TSP-CD47 interaction
Cell type Effect References
Fibroblast Calcium mobilization Tsao and Mousa 1995
Melanoma cells Spreading,
Tyrosine phophorylation
Gao et al 1996 a, b
Platelets Aggregation Chung et al 1997
VSMC Spreading Wang et al 1998
Granulosa cells (GC)
Luteal cells (LC)
Autocrine fashion Higuchi et all999
T-Lymphoma cells Activation of Ras and MAP
kinase
Wilson et al 1999
Monocytes Inhibition of IL-12
production
Armant et al 1999
Human melanoma cell line
C32 (ATCC, CRL 1585)
Decrease intracellular cAMP Frazier et al 1999
Smooth muscle cells (SMC) Inhibition ofERK Wang et al 1999
B lymphocyte Apoptosis Mateo et al 1999
T Lymphocyte TCR activation Li et al 2001
Platelet Platelet adhesion Lagadec et al 2003
Platelet Platelet aggregation Fujimoto et al 2003
Fibroblast and Endothelial
cell
Mechanosensitive function Graf et al 2002, 2003
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1.5.2.6.2. Signal regulatory protein a (SIRP a) (CD172a)
Signal regulatory proteins (SIRPs) belong to IgSF and relate to integrin signalling
cascades. One o f the SIRPs (Fujioka et al 1 996; Yamao et al 1 997), Src homology 2
domain-containing protein tyrosine phosphatase substrate 1 (SHPS-1), is also known as
SIRPal (Kharitonenkov et al 1997), BIT (brain Ig-like molecule with tyrosine-based
activation motifs) (Sano et al 1997), P84 (Comu et al 1997), MFR (macrophage fusion
receptor) (Saginario et al 1998) MyD-1 (Brooke et al 1998) and CD172a (Kharitonenkov
et al 1997).
SIRPs appear ubiquitously expressed as Ig-like transmembrane glycoproteins composed
of two subgroups, SIRPa and SIRPP, that overall constitute a subfamily within the Ig SF.
Among SIRPs, SHPS-1 was first identified as a novel tyrosine phosphorylated protein
that binds to Src homology 2 (SH2)-containing protein tyrosine phosphatases, SHP-1 and
SHP-2, in v-Src-transformed fibroblasts (SR-3Y1 cells) (Fujioka et al 1996). Various
mitogens such as epidermal growth factor (EGF) and platelet-derived growth factor
(PDGF) induce the tyrosine phosphorylation of SHPS-1 to recruit the tyrosine
phosphatases and several SH2-containing adapters to the plasma membrane
(Kharitonenkov et al 1997).
A protein of the SIRP family, like other IgSF members, consists of three domains: The
extracellular domain, the transmembrane domain and the intracellular domain. The
extracellular domain is further divided into three Ig- like regions, an amino-terminal Ig
variable (V) region and two Ig constant (C) regions. The second and third IgC can be
removed by alternative splicing. At least 15 human members (Kharitonenkov et al 1997),
varying in the form of subtle amino acid differences in the IgV region, have been
identified in the SIRP family. Two subfamilies termed SIRPa and SIRPP are
distinguished by the length of the cytoplasmic region.
The cytoplasmic region of the SIRPa subfamily proteins contains two immunoreceptor
tyrosine-based inhibitory motifs (ITIMs) and a proline-rich region near the carboxy-
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terminus, which represent a binding site for Src homology 3 (SH3) domain-containing
molecules (Kharitonenkov et al 1997; Saginario et al 1998). Phosphorylation of the
ITIM-associated tyrosine residues enables recruitment of SHP-1, SHP-2 and SH2
domain-containing inositol phosphatase, which in turn dephosphorylates specific protein
substrates involved in mediating various physiological effects.
SHPS-1, has relative molecular weight of 90-120 kD and is differentially glycosylated in
a species and tissue specific manner (Kharitonenkov et al 1997). SHPS-1 contains
potential N-glycosylation sites and a large number of serines and threonines that can
serve as O-glycosylation sites (Fujioka et al 1996; Yamao et al 1997 et al Saginario,
1998 et al Adams, 1998). Because the differential pattern of SHPS-1 glycosylation, the
species-specific difference ofmolecular weight may be due to the number of potential N-
glycosylation sites that are found: 15 times in rats (Fujioka et al 1996), 17 times in mice
(Yamao et al 1997; Comu et al 1997) and 5 times in humans (Yamao et al 1997). For
example the molecular weight (MW) of SIRPa in myeloid cells, 110 kD and in neuronal
cells, 85-90 kD has been reported. The tissue-specific difference of glycosylation may be
due to the galactosylation capacity. It has been shown that the differential galactosylation
of SHPS-1 determines its cellular binding specificity (Van den Nieuwenhof et al 2001).
SHPS-1 is ubiquitously expressed in all tissues examined (heart, brain, spleen, lung,
liver, muscles, kidney, and testis), being most abundant in the brain and the spleen
(Kharitonenkov et al 1997). Using immunohistochemistry with a specific anti-SHPS-1
antibody, it has been shown that SHPS-1 is strongly expressed in myeloid cells
(macrophages, monocytes, granulocytes, dendritic cells) and neurons (Adams et al 1998).
Tsuda et al (1998) have shown indirectly the interaction between integrin engagement by
ECM proteins and induction tyrosine phosphorylation of SIRPa and suggested that
SIRPa might be a member of the group of proteins that are at focal adhesion contacts
and undergo tyrosine phosphorylation in response to the interaction of integrins with the
ECM. Oh et al (1999) have reported that SHP-2/ SIRPa complex can act as a critical
positive component in integrin signalling. Inagaki et al (2000) have demonstrated that
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SIRPa plays crucial roles in integrin-mediated cytoskeletal reorganization, cell motility
and the regulation of Rho, and that it also negatively modulates growth factor-induced
activation ofMAP kinases.
SHPS-1 can act as a ligand for CD47 in various biological functions. Jiang et al (1999)
have first discovered in mouse neuronal cells, that SHPS-1 and CD47 form a heterophilic
binding pair that was involved in bi-directional signalling at the synapse. Studies by
Seiffert et al (1999) revealed that the extracellular regions of human SIRPa adhere to a
number of primary hematopoietic cells and cell lines and they also identified human
CD47 as a prominent extracellular ligand.
The Ig domain of CD47 and the amino-terminal Ig domain of SHPS-1 can bind directly
to each other and binding is sufficient to mediate transcellular bi-directional signalling
via respective cytoplasmic regions (Lienard et al 1999; Oldenborg et al 2000; Han et al
2000; Babic et al 2000; Vernon-Wilson et al 2000; Latour et al 2001). The SIRPa/CD47
interaction was first described in mouse where the binding of recombinant mouse SIRP
to cells could be blocked by a CD47 mAb (Jiang et al 1999) and later shown to be
conserved in rat and human (Vemon-Wilson et al 2000). The SIRPa/CD47 pair
represents a novel IgSF interaction between the three-IgSF domain SIRP and CD47 with
its single IgSF domain. Most of the sequence variation among SIRPa members lies in
their IgV domain and this difference may account for the varied binding affinity of
SIRPa proteins to CD47. However, there may be additional ligands for a single receptor
or group of receptors of SIRPa . SIRPp does not bind to CD47 (Seiffert et al 2001).
On normal red blood cells, CD47-SHPS-1 complex appears important in preventing
excess blood cell clearance or autoimmune hemolytic anemia (Oldenborg et al 2000;
2001). SIRPa was involved in a variety of cellular functions in different cell types.
Some of these are shown in Table 1.5.
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Table 1.5. SIRP a functions in different cells
Cell type Effect References
Fibroblast NIH3T3 MAPK activation Kharitonenkov et al 1997
Rat alveolar macrophage NO synthesis inhibition
(NO production)
Adams et al 1998
Memory T cell T cell proliferation Brook et al 1998
NIH3T3 MAPK activation Takada et al 1998
Myoblast C2C12 Myogenesis Stofega et al 1998
Fibroblastic cells Integrin-mediated tyrosine
phosphorylation
Tsuda et al 1998
Macrophage Scaffold protein Timms et al 1999
Mast cell activation Inhibition of cytokine
synthesis
Lienard et al 1999
Neuron (Rat brain) Synaptogenesis Jianget al 1999
Rat cerebral cortical neuron Neural survival Araki et al 2000
Mouse splenic red pulp
macrophage
Inhibition ofphagocytosis,
red blood cell self-
recognition
Oldenborg et al 2000, 2001
Pro-B cells (Ba/F3) Cell aggregation Babic et al 2000
Myoblast Differentiation Kontaridis et al 2001
T cell T cell activation Seiffert et al 2001
Dendritic cells (DC) Cytokine production Latour et al 2001
Murine macrophage Cell fusion Saginario et al 1998; Han
et al 2000; Vignery et al
2000
B Lymphocytes B Lymphocyte-EC
adhesion
Yoshida et al 2002
Neutrophil PMN transmigration Liu et al 2002
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1.5.3.0. CD98, 4F2 antigen, Fusion Regulatory Protein-1 (FRP-1)
1.5.3.1. Structural features of CD98
Early studies of peripheral blood T lymphocytes implicated CD98 (4F2 antigen) in the
regulation of cellular activation but did not define a specific function for this antigen
(Haynes et al 1981). CD98 is a disulfide-linked -125 kD heterodimer composed of a
glycosylated ~85-kD heavy chain (HC) (designated CD98) and a nonglycosylated 40-kD
light chain (LC). The 4F2 Ab recognized an antigenic determinant on the polypeptide
backbone of the HC. The cDNA for the HC of human CD98 was cloned (Lumadue et al
1987; Quackenbush et al 1987; Teixeira et al 1987). The p redicted p rotein encodes a
glycosylated protein of 529 AA containing a single transmembrane segment (amino acids
83-106). The protein has an extracellular carboxyl terminus and an internal amino
terminus and has been classified as a type II transmembrane GP (Warren et al 1996).
So far, six alternative cDNAs encoding associated light chains have been identified. Four
of which are associated with L-type amino acid transport activity (LAT) (Verrey et al
1999). The light chains are able to associate to the heavy chain through a disulfide bond,
giving rise to different heterodimers (Mastroberardino et al 1998). The light chains are
markedly hydrophobic proteins of 502-535 AA and contain 12 putative transmembrane
domains. They are linked to CD98 HC through an extracellular cysteine that participates
in disulfide bound formation (Pfeiffer et al 1998). All light chains identified function as
AA transporters when associated with the HC and the substrate specifity of the
heterodimer depends on the nature of the LC. The molecular features, tissue distributions
and functional properties of the six LCs, LAT-1 (Mastroberardino et al 1998);LAT-2
(Pineda et al 1999; Segawa et al 1999); y+LAT-1, y+LAT-2 (Torrents et al 1998); xCT
(Nakamura et al 1999) and SPRMI (Mastroberardino et al 1998) have been demonstrated
(Deves and Boyd 2000).
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1.5.3.2. CD98 expression
CD98 is expressed ubiquitously and highly conserved between species. Although it is
expressed at low levels on the surface of quiescent cells, CD98 expression is rapidly up-
regulated after cellular activation (Azzarone et al 1985; Suomalainen 1986; Parmacek et
al 1989). For instance, CD98 is strongly expressed on human embryonic and newborn
fibroblasts but expression gradually diminishes from 100 to 1% on fibroblasts from
normal adults (Azzarone et al 1985). CD98 is reconstituted to high levels on many tumor
cell types (Dixon et al 1990) and furthermore, overexpression of CD98 on NIH3T3 cells
has been shown to result in cellular transformation (Hara et al 1999). CD98 is also
expressed on normal proliferating tissue such as the basal layer of squamous epithelia
(Patterson et al 1984) and on cells having secretion or transport functions (Tabata et al
1994).
1.5.3.3. CD98 functions
Previous studies suggested that an intercellular signalling pathway mediates the action of
CD98 (Warren et al 1996; Okamoto et al 1997; Tabata et al 1997). Tyrosine kinase
inhibitors inhibit CD98 activity in hematopoietic cells, suggesting that tyrosine kinase
activity may be an early signal transduction pathway activated by CD98 (Warren et al
1996). There is also evidence that CD98 is involved in the regulation of intracellular
calcium concentration through the Na+/ Ca2+ exchanger, although its effect seems to be
cell type specific (Michalak et al 1986; Posillico et al 1987; Freidman et al 1994).
CD98 HC appears to be correlated to cell proliferation in several different tissues such as
skin, on a variety of different cell types (Gottlieb et al 1985), and intestinal epithelium
(Azzarone et al 1986). CD98 HC has also been suggested to play a role in cell
differentiation in hemato-lymphopoietic cell (Warren et al 1996). It has been
demonstrated that HC acts as unique and h ighly specific regulator o f integrin affinity
(Fenczik et al 1997).
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Anti-CD98 promotes monocyte-monocyte interactions that ultimately lead to polykaryon
(multinucleated giant cell) formation (FRP-1), a phenotype associated with chronic
inflammatory conditions (Ohta et al 1994; Ohgimoto et al 1996). Compelling evidence
also exists for connection between CD98 and virus-induced cell fusion. Antibodies to HC
of CD98 promote cell fusion induced by Newcastle disease virus and by human
immunodeficiency virus (HIV) (Ohgimoto et al 1995).
The dimers, obtained from linking of CD98 HC with five different LCs, are the minimal
functional units for transport activity. All the CD98 HC linked transporters (except rat
LAT-2 which is able to perform net transport) appear to function as highly coupled
amino acid exchangers, but the specificity depends on the associated light chain (Pineda
et al 1999).
Rintoul et al (2002) have recently shown that cross-linking CD98 stimulates PI3-kinase,
as well as its product PI (3,4,5) P3, and its downstream effector, PKB. The finding that
treatment with 4F2 activated PI 3-kinase, PI (3,4,5) P3, and PKB in a PI3-kinase-
dependent manner suggests that cross-linking CD98 promotes integrin-like intracellular
signalling.
1.5.3.4. CD98-integrin interactions
Several lines of evidence suggest that CD98 may modulate the functions of integrins. For
example, the (31 integrins may act together during T cell co-stimulation (Warren etal
2000). A genetic screen revealed that CD98 may indirectly influence integrin affinity for
ligands. CD98 HC was shown to rescue a dominant suppression of integrin function,
which results from overexpression of a fragment of the P subunit. The experimental
strategy used a Chinese hamster ovary (CHO) cell line that expresses a chimeric
integrin, which is constitutively active. The chimera contains an extracellular and
transmembrane domains of anbp3 integrin fused to the cytoplasmic domains of a6Api
integrin; i 11 hus has t he 1 igand b inding p roperties o f anbP3 and i s a ctivated t hrough
a6Api cytoplasmic binding domain. Overexpression of the pi cytoplasmic domain in
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the form of Tac-chimera resulted in suppression of integrin signalling. Suppression was
interpreted as resulting from the titration by the overexpressed p 1 subunit of proteins
forming an " integrin activation complex". Consistently, expression of Tac-pi in
fibroblast cell lines interfered with cell spreading, migration, fibronectin matrix assembly
and integrin activation. Cotransfection of the cells containing the chimeric integrin with
CHO cell cDNA expression library and Tac-pi showed that CD98 HC was able to
complement the suppression and suggested that CD98 is a regulator of integrin function
(Fenczik et al 1997).
It has been shown that anti-CD98 mAb appeared to modulate integrin-dependent
adhesion (Fenczik et al 1997; Chandrasekaran et al 1999; Deves et al 2000). In addition,
Abs to both CD98 and a3pi integrin prompted cell fusion (Ohta et al 1994) and Abs to
pi and P2 integrins blocked monocyte cell-cell function and aggregation functions
induced by anti-CD98 mAb (Tabata et al 1994).
It has been demonstrated that like CD98, the a3pi integrin has been implicated in amino
acid transport (McCormack et al 1995). Kolesnikova et al (2001) have demonstrated for
the first time that CD98 constitutively and specifically associates with intact
pi heterodimers. Specific CD98-integrin interaction occurs in the context of low density
protein-lipid microdomains, possibly resembling lipid rafts (Simons and Ikonen 1997;
Brown and London 1998).
It has also been reported that the pro-adhesive and chemotactic activities of the
extracellular matrix protein, TSP-1, for breast carcinoma cells are mediated
by a3pi integrin and regulated by CD98 HC and insulin-growth factor (Chandrasekaran
et al 1999). Integrin a3pl is maintained in an inactive or partially active state in these
cell lines, but can be activated by exogenous stimuli including serum, insulin, and
ligation o f C D98 H C b y divalent Abs. The e ffect o f C D98 H C c lustering o n i ntegrin
activation may be due to clustering of associated integrin or may involve specific signal
transduction from CD98 HC. Although a functional association between CD98 and pi
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integrin in the cell membrane has been described previously (Fenczik et al 1997; Warren
et al 2000), until recently there was no clear data showing physiological interaction
between CD98 and pi integrin. Recently, Zent et al (2000) have shown that CD98 can
associate with isolated cytoplasmic portions of some pi integrin isoforms. Studies from
other groups showed the similar results in different cell lines and chimeric piintegrins
(Merlin et al 2001; Kolesinkova et al 2001; Rintoul et al 2002). Very recently,
Miyamoto et al (2003) have provided the first evidence of a specific association between
CD98 and pi integrin (e.g a4pi) in human T lymphocytes by using immunofluorescence
and immunoprecipitation.
1.5.3.5.0. CD98 ligands
In addition to integrins, Galectin-3 and CD 147 have been demonstrated as ligands for
CD98.
1.5.3.5.1. Galectin-3, Mac-2
The galectin family of proteins consists of P-galactoside binding lectins containing
homologous carbohydrate recognition domains (CRDs). Membership in this family
required fulfilment o f two key criteria: (a) binding affinity for P-galactosides, and (b)
conserved sequence elements in the carbohydrate-binding site. To date, 14 mammalian
galectin family members have been identified (Barondes et al 1994 a, b; Hughes 2001),
with the most extensively studied members being the MW 14 kD (galectin-1) and the
MW 30 kD (galectin-3) proteins. Galectin-3 has previously been designated variously as
Mac-2, a macrophage surface antigen (Ho and Springer 1 982), IgE-binding protein (s
BP), for its IgE-binding activity (Liu et al 1985; Albrandt et al 1987; Robertson et al
1990), CBP35 (carbohydrate-binding protein 35)(Roff and Wang 1983), CBP30 (Mehul
et al 1994), L-29 (Leffler et al 1989), and L-34 (Raz et al 1989, 1991).
Galectin-3 consists of two distinct structural domains: an amino-terminal half is made of
a small N-terminal domain consisting of proline- and glycine-rich repeats, and the
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carboxyl-terminal half with a globular structure encompassing the carbohydrate-binding
site (Hermann et al 1993). Galectin-3 is a non-glycosylated protein and, as a member of
lectins, is specific for |3-galactosides, to which they bind in a Ca2+ independent manner
(Barondes et al 1994a). Like other members of this family, galectin-3 lacks a signal
sequence, and is secreted via a pathway independent of the Golgi apparatus (Lindstedt et
al 1993; Sato et al 1993). In addition to the characteristic carbohydrate recognition
domain, galectin-3 has a unique amino-terminal domain, which can be digested by
collagenase and matrix metalloproteinases-2 and -9 (MMP-2 and MMP-9) in vitro (Hsu
et al 1992; Ochieng et al 1994, 1998). The amino-terminal domain of galectin-3 is
thought to be important for self-oligomerization, and hence for its functional
multivalency (Massa et al 1993).
Galectin-3 normally distributes in epithelia of many organs and various inflammatory
cells, including macrophages, as well as dendritic cells and Kupffer cells (Flotte et al
1983). Galectin-3 is expressed in numerous cell compartments of the eukaryotic cells,
and appears to play specific functions at each of these locations. Galectin-3 has been
found in the cytosolic compartment (Gritzmacher et al 1988), where it participates in the
control of apoptosis, possibly through an interaction with the Bcl-2 protein (Akahani et al
1997). Depending on cell types and proliferative states, a significant amount of this
lectin c an a lso b e d etected i n t he n ucleus, w here i ts e xpression i s c orrelated w ith c ell
proliferation (Moutsatsos et al 1987). In addition, one study has demonstrated that
galectin-3 could facilitate splicing of pre-mRNA (Dagher et al 1995). Galectin-3 is also
associated with the plasma membrane (Sato and Hughes 1994), and can be secreted
extracellularly (Sato et al 1993,1994; Lindstedt et al 1993). At these locations, it
mediates cell-cell and cell-matrix interactions through its ability to bind to a variety of
glycoconjugates (Ochieng et al 1992; Sato and Hughes 1993; Inohara and Raz 1995,
Inohara et al 1996; Warfield et al 1997).
The implication of galectin-3 during malignancy progression has been first indirectly
suggested by numerous s tudies focusing on the e xpression of this molecule in several
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cancers, such as colon (Lotz et al 1993), breast (Castronovo et al 1996), ovarian (Van den
Brule et al 1994), and uterine (Van den Brule et al 1996) carcinomas. Contradictory
observations have been reported (Castronovo et al 1 999). Recent studies indicate that
these discrepancies could be explained by a more rigorous analysis of galectin-3
expression and subcellular localization, as particularly described in the case of colon
cancer. Preliminary data indicated that decreased (Lotz et al 1993) or increased (Irimura
et al 1991; Schoeppner et al 1995) expression of galectin-3 in colon carcinoma cells
correlates with disease progression. A recent study demonstrated initial down-regulation,
with increased cytoplasmic expression of galectin-3 at more advanced stages (Sanjuan et
al 1997). Additionally, Lotz et al (1993) reported that exclusion of galactin-3 from the
nucleus correlates with progression from normal mucosa to adenoma and carcinoma.
It has been previously shown that in the midgestation mouse embryo, the major site of
galectin-3 expression is the cartilage (Fowlis et al 1995). Subcellular distribution of the
protein in growth plate chondrocytes of fetal and neonatal mice is mainly cytoplasmic,
with high amounts detectable in mature and early hypertrophic cells (Colnot et al 1999).
These results suggested an intracellular function for galectin-3 in terminal differentiation
of chondrocytes. Galectin-3 is recognized in the cytoplasm of proliferative, mature, and
hypertrophic chondrocytes in the growth plate cartilage of developing long bones (Colnot
et al 1999). Colnot et al (1998, 2001) have also described several defects in chondrocyte
differentiation in the long bones of galectin-3 null mutant embryos, both at the cellular
and at the molecular level. The most striking abnormalities were observed at
chondrovascular junction that indicated an acceleration of cell death in the absence of
coordinated angiogenesis.
Several specific cell surface receptors including integrins and other cell adhesion
molecules and matrix components including certain glycoforms of laminin and
fibronectin have been shown to bind galectin-3 in vitro (Table 1.6), supporting the idea
that galectins binding to such receptors in vivo have diverse and important extracellular
functions (Liu et al 1993; Barondes et al 1994; Kasai and Hirabayashi 1996).
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Galectin-3 binds to CD98 HC in both a human T cell line (Jurkat) and in murine
macrophages (WEHI-3) (Dong and Hughes 1996), but a direct link between galectin-3
binding to this surface antigen and its biological effect has not been demonstrated. They
suggested that galectin-3 may play a role in cell-cell adhesion (Bao and Hughes 1995;
Dong and Hughes 1996). The same authors have used a mutant epithelial cell line and
shown that galectin-3 binding, but not the binding of other lectins tested, is thus
specifically abolished (Bao and Hughes 1999). In these mutant epithelial cells, growth is
markedly aberrant, suggesting that one role of the normal galectin-3 receptor, at least in
epithelia, is to transduce signals following lectin binding that act as negative regulators
of cell growth thus allowing orderly elongation and branching morphogenesis of the
epithelium in culture (Bao and Hughes 1999).
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Table 1.6. Ligands for galectin-3 (Hughes 1999)
Ligand Source/cells Reference/s
Matrix Laminin-1, 5, 10/11? Placenta Ochieng et al 1995
Fibronectin Fetal Sato et al 1992
Tenascin-C, R Brain Probstmeir et al 1995
Mac-2BP Brain, breast tumors Rosenberg et al 1991;
Koths et al 1993
aipi Adenocarcinoma Ochieng et al 1998
Integrins aMp2 (CD1 lb/18) Macrophage Dong and Hughes 1997
Membrane N-CAM, LI, MAG Mouse Brain Probstmeir et al 1995
LAMP-1,2, Mac-3 Ubiquitous Dong and Hughes 1997
CEA Tumor antigen Ohannesian et al 1995
NCA-160 Neutrophils Yamaoka et al 1995
CD98 HC Macrophages, Jurkat Dong and Hughes 1997
Others Mucin Colon cancer Bresalier et al 1996
AGE Ubiquitous Vlassara et al 1995
IgE Mast cells Liu et al 1993
IgE receptors
Fc receptors Various Liu et al 1993
LPS Endotoxins Mey et al 1996
N-CAM and LI, neural adhesion molecules; MAG, myelin associated glycoprotein;
LAMP 1, 2, lysosomal associated-membrane proteins; Mac-3, a mouse macrophage
differentiation antigen; CEA, carcinoembryonic antigen; NCA-160, A neutrophil
receptor and human carcinoembryonic antigen-related glycoprotein; AGE, Advanced
glycation end (AGE) products, the reactive derivatives of neo-enzymatic glucose-protein
condensation reactions.
80
1.5.3.5.2. CD147, Extracellular Matrix Metallo Proteinase Inducer (EMMPRIN)
EMMPRIN activity was initially discovered in a series of studies performed by Dr
Biswas et al (1984, 1985) in which they demonstrated stimulation of interstitial
collagenase (MMP-1) production in cultures of tumor cells and fibroblasts. These studies
led to identification of a factor (TCSF, tumor cell-derived collagenase stimulatory factor)
that is associated with the surface of tumor cells and that stimulates synthesis in human
fibroblasts (Biswas and Nugent 1987). In various species GPs homologous to CD147
have been identified (Table 1.7) including basigin and M6. It was proposed that M6
antigen might stimulate MMP production in arthritis as well as cancer (Biswas et al
1995).
CD147 is a highly glycosylated transmembrane GP of 50-60 kD having typical features
of a type integral membrane protein of the IgSF. It contains two extra-cellular Ig
domains, a transmembrane domain, and a 39-amino acid cytoplasmic domain (Biswas et
al 1995). Within 246 amino acid residues deduced from cDNA cloning five potential N-
glycosylation sites have been identified. The protein belongs to the IgSF having two Ig
domains with characteristic sandwich p-sheets stabilized by disulfide bridges. Within the
postulated single transmembrane region three leucines are repeated every seventh amino
acid residue. This sequence is characteristic of leucine zippers found in DNA binding
proteins and has been identified in the glucose transporter and ion channels (McCormak
et al 1989; White et al 1989). In addition, the presence of a glutamic acid residue in the
transmembrane region suggested that the protein might functionally interact with other
membrane proteins (William et al 1988).
Structural analyses have demonstrated that the transmembrane and cytoplasmic domains
of EMMPRIN are highly conserved among species, suggesting that these regions are of
functional importance. The conserved properties of the trans-membrane region, i.e., a
central charged residue and a leucine zipper motif, suggested that intramembrane
interactions with other proteins are likely to occur (Fossum et al 1991; Kasinrek et al
1992; Miyauchi et al 1991).
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Accordingly, interaction of EMMPRIN with several other components of cell
membranes has been demonstrated. Recent reports have identified some striking parallels
between CD147 and CD98. CD147 associates physically with pi integrins in the
membrane (Berditchevski et al 1997), as does CD98 with isolated cytoplasmic
pi domains (Zent et al 2000). Moreover CD 147 was recently found to co-
immunoprecipitates with pi integrins (a3pi and a6pi), and co-localize with these
integrins in areas of cell-cell contact, within the plasma membrane of HT1080
fibrosarcoma cells (Berditchevski et al 1997).
CD147 molecule is broadly expressed on human peripheral blood cells, endothelial cells,
and cultured cells of hemopoietic and non-hemopoietic origin. In T cells, its expression
level is dependent on the differentiation state. Thymocytes are strongly expressed CD147
(Kirsch et al 1997). Significant expression ofCD147 has also been reported in neoplasms
of the bladder, liver, and lung (Muraoka et al 1993).
CD147/EMMPRIN was initially identified on the surface of human cancer cells and
shown to stimulate adjacent stromal cells to produce and activate several MMPs (Guo et
al 1998; Guo et al 1997; Sun and Hemler 2001), including MMP-1, MMP-2, MMP-3,
membrane type 1MMP (MT1-MMP), and MT-2-MMP (Guo et al 1997; Sameshima et al
2000).
MMP synthesis in fibroblasts in response to stimulation by EMMPRIN is a relatively
slow process, taking 24-48 h to reach maximum (Lim et al 1998). It has been noted that
different fibroblast populations differ widely in their response to EMMPRIN (Guo et al
1997); this difference may be is related to varying degrees of expression of a putative
receptor.
Treatment of human lung fibroblasts with purified EMMPRIN leads to phosphorylation
of the mitogen activated protein (MAP) kinase p38, and induction ofMMP-1 synthesis is
partially dependent on activity of this kinase but not extracellular signal-regulated
kinase-1/2 (ERK1/2) or stress activated protein kinase/c-jun aminoterminal kinase
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(SAPK/JNK) (Lim et al 1998). EMMPRIN stimulation ofMMP production in fibroblasts
is also dependent on N-glycosylation of its extracellular domains. Since partially
glycosylated EMMPRIN is relatively inactive, it is likely that all three glycosylation sites
in the two Ig domains must be occupied for full activity (Guo et al 1997; Sun and Hemler
2001). EMMPRIN also acts as a chaperone for assembly of lactate transporters in the
plasma membrane (Kirk et al 2000; Wilson et al 2002).
A knock out has been produced in which basigin, the murine homolog of EMMPRIN, is
lacking (Igakura et al 1998). Basigin-null embryos exhibit numerous defects, including
inefficient implantation. Since MMPs are known to be involved in implantation
(Alexander et al 1996; Vu and Werb 2000), defective implantation may result from
misregulation ofMMP production due to lack of basigin stimulation.
Many physiological functions in which EMMPRIN may participate have also been
suggested by other studies. Systems in which EMMPRIN is likely to be important
include chaperone functions (Kirk et al 2000), calcium transport (Jiang et al 2001),
neutrophil chemotaxis (Yurchenko et al 2002), and blood brain barrier development
(Schlosshauer 1993). A likely molecular function for EMMPRIN, other than induction of
MMP production, is mediation of adhesive cell interactions (Toole 2003).
Recent work has shown that annexin II acts as a binding partner for CD 147 (Guo and
Toole unpublished results; Toole 2003). Annexin II is a Ca2+-dependent, lipid-binding
protein that is commonly found intracellularly but, under some circumstances, is also a
prominent cell surface component, e.g on endothelial cells (Hajjar et al 1996), neurons
(Jacovina et al 2001), and cancer cells (Tressler et al 1993). Annexin II usually occurs as
a tetramer containing two subunits of a 36-kD heavy chain and two subunits of an 11 kD
light chain.
83




Kataoka et al 1993
Nabeshima et al 1991
5A11 (chick) Fadool and Linser 1993b
HT7 (chicken) Seulberger et al 1990, 1992
Neurothelin (chicken) Schlosshauer and Herzog 1990
Basigin (mouse) Miyauchi et al 1991
MRC OX-47 (rat) Fossum et al 1991
M6 (Human leukocyte
activation antigen)




Biswas et al 1995
CE9 (rat) Nehme et al 1993
gp42 (mouse) Altruda et al 1989
Hab 18G (Human hepatoma) Jiang et al 2001
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1.6.0. HYPOTHESIS AND AIMS
Articular chondrocytes are subjected in vivo, to frequent and repetitive mechanical loads
(Knudson and Loeser 2002). Chondrocyte mechanotransduction is activated in normal
human articular chondrocytes by 0.33 Hz cyclical mechanical stimulation, which results
in membrane hyperpolarisation and changes in gene expression, has been partially
elucidated. The chondrocyte mechanotransduction is integrin-mediated and involves
tyrosine kinases, PKC activation, IL-4 secretion and substance P secretion.
It has been shown that a5(31 integrin has a critical role in chondrocyte
mechanotransduction and may act as a chondrocyte mechanoreceptor (Wright et al 1997;
Salter et al 2001). Integrins are able to link the ECM with the cytoskeleton and cell
signalling proteins (Hynes 1992; Shyy and Chien 1997). Since integrins, generally lack
intrinsic enzymatic activity of their own, therefore they must interact with other proteins
to generate signals (Damsky and Werb 1992). Evidence suggests that signal transduction
through integrins depends on both integrins and integrin-associated proteins (Wright et al
1996; Hogg and Porter 1998; Shattil et al 1998). There are a variety of cell membrane
molecules such as CD47 and CD98 that can interact with different types of integrins in
each cell type and are potentially involved in regulating integrin-mediated
mechanotransduction (Hogg and porter 1998; Shattil et al 1998).
Hypothesis
CD47 and CD98 and their ligands have role(s) in chondrocyte mechanotransduction
Aims
The aims of this work were:
I) To establish in vivo expression of CD47, CD98 and galectin-3 in normal and OA
articular cartilage (chapter 3).
II) To identify potential roles for CD47, CD98 and ligands in chondrocyte
mechanotransduction (chapters 4 and 5).
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CHAPTER TWO
2.0. MATERIALS AND METHODS
2.1. Tissue sources and handling
All human articular tissues were obtained during arthroplasty from patients who were
undergoing knee and hip joint surgery and also from ankle joints from below knee
amputation for peripheral vascular disease. The tissues were handled in a class I tissue
culture hood. Laboratory coat, gloves and oversleeves were worn when handling
biological tissue. If a given tissue was found to be infected, the joint was incinerated and
hood fumigated.
2.2. Assessment of cartilage for osteoarthritis (OA)
The articular surface was assessed and graded macroscopically for the presence or
absence of osteoarthritis using the Collins/McElligott system (Collins McElligott 1960;
Midwood and Salter 1 998) (Table 2.1). Two sets of full thickness pieces of cartilage
were taken for histological confirmation of normal cartilage or OA changes. One set was
snap frozen in liquid nitrogen immediately and stored in cryovials at -80°C for frozen
sections. Another set was fixed in 4% formalin for embedding in paraffin wax.
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Table 2.1. Collins macroscopic grading of osteoarthritis (OA)
COLLINS GRADE CRITERIA
0 No cartilage degeneration
I Limited Patches of fibrillation or softening in central area of
articular cartilage
No area ofwhole thickness cartilage loss
No recognisable marginal osteophytosis
No detectable synovial inflammation
II Large areas of fibrillation and Assuring without denuding
bone.
Early marginal chondro-osteophytosis
III At least one area (30% or less) of whole thickness cartilage
loss with extensive fibrillation, Assuring and bone exposure.
More generalized synovial disease and obvious marginal
osteophytosis
IV Extensive cartilage loss and bone exposure
Ebumation and bone grooving, destruction of intra-articular
ligaments, and fibrosis or atrophy of synovial fringes.
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2.3.0. IMMUNOHISTOCHEMISTRY (IHC)
2.3.1. Avidin-Biotin-Conjugated (ABC) immunoperoxidase method with
frozen sections
Cryostat sections (4-6 pm) were cut using a Bright cryostat and mounted on poly L-
lysine (PLL) coated glass slides. Then the sections were allowed to come to room
temperature and fixed with acetone for 10 minutes. The sections were kept at -20 °C
before use. Before staining, the sections were left in room temperature for 30 minutes
and washed by phosphate buffered saline (PBS) for 10 minutes. Endogenous peroxidase
activity was blocked with 1% hydrogen peroxide in distilled water for 10 minutes,
followed by washing in running tap water.
To avoid non-specific binding of antibodies, sections were incubated with normal rabbit
serum (NRS) (Diagnostics Scotland) diluted 1 in 5 in PBS (NRS/PBS, 1:5) for 30
minutes (100pi per section). The primary antibody was diluted in NRS/PBS at the
indicated concentration. Sections were incubated with diluted antibody (50pl per section)
for 60 minutes at room temperature. After twice washing with PBS for 5 minutes each,
sections were then incubated with NRS/PBS for 30 minutes. Diluted appropriate
secondary biotinylated antibody (DAKO) in NRS/PBS (1:300) was then added for one
hour at room temperature and followed by a further two washes with PBS. Sections were
then incubated with avidin-biotin-conjugated (ABC) (3 drops on each slide) for 30
minutes at room temperature. Slides were then washed twice with PBS and antibody
binding visualized using diaminobenzidene (DAB) with 0.1% hydrogen peroxide (H2O2)
as the peroxidase substrate for 3 min. The sections were then washed with running tap
water, counterstained with Harris's hematoxyllin for 3 0 sec, made blue by dipping in
Scott's water (STWS), dehydrated in a graded ethanol series, cleared in xylene, and
mounted. All steps were performed at room temperature. The procedure was carried out
using a Shandon Sequenza (Thermo Shandon coverplate™) to achieve consistency of
staining quality and to decrease sections from floating off.
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2.3.2. Paraffin sections
Before staining, paraffin sections of normal and OA cartilage were deparaffinized in
xylene for 5 minutes and rehydrated in descending grades of alcohol to water. To block
endogenous p eroxidase activity s ections were i ncubated w ith 0.3% h ydrogen p eroxide
(H202) in methanol for 15 minutes. Then sections were rinsed in tap water and placed in
a vertical staining rack in a water container to prevent sections from drying out.
2.3.2.1. Antigen Retrieval (AR)
The metal rack containing dewaxed, rehydrated sections was placed over the top of the
50x10 mm magnetic bead in 2-litre glass beaker of the Jenway hot plate stirrer. It was
filled w ith 1 1 itre 1 mM EDTA b uffer s olution c ontaining 0.1% Tween 20 (Invitrogen
Life technologies). After leaving the buffer on stirrer for 30 minutes the pH was adjusted
to 8.00 by adding 1 M NaOH. Then the heater was turned on and temperature set to 65°C
for overnight incubation. The next day, the rack containing sections was placed in a
water tap container until the automatic immunostaining instrument was ready.
2.3.2.2. Immunostaining
The immunostaining method was applied using DAKO ChemMate ™ Detection Kit,
Peroxidase/DAB, and Rabbit/Mouse with the DAKO automatic immunostaining on the
TechMate™ instruments. Stained sections were washed in tap water, dehydrated in a
graded ethanol series, cleared in xylene, and mounted. All steps were performed at room
temperature.
2.3.3. Procedure controls
The specificities of the staining were confirmed by controls. In all experiments of IHC a
negative control was used. Negative controls were provided by omitting the primary
antibody by substituting NRS/PBS or non-immune immunoglobulin Gs (IgG) from the
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same species for the primary antibody. Cryostat or paraffin sections of normal human
tonsil were used as positive controls.
2.3.4. Optimal dilution of primary antibody
For each antibody preliminary studies were performed to optimise staining procedures,
and find the standard working titre of antibody. In subsequent studies, sections were
treated with the dilution of antibody that maximised specific staining and minimized
non-specific reactivity. Various dilutions of each antibody (1:10, 1:50, 1:100, 1:500, and
1:5000) were applied and compared. Antibodies and the optimal dilutions used in
immunohistochemistry experiments are shown in Table 2.3.
2.3.5. Positive staining
Positive staining was recognized as a dark brown colour associated with the cytoplasmic
membrane or cytoplasm. As chondrocytes were either strongly positive or negative no
grading of the positivity was made. Areas that showed folding of the cartilage or
exhibited non-specific background staining were not scored.
2.3.6. Zones of full thickness articular cartilage and microscopic
evaluation
For immunohistochemical evaluation, the normal and OA cartilage were classified in
three groups including, normal (Collins grade 0), smooth intact cartilage; mild OA
(Collins grade I and II); and severe OA (Collins grade III and IV). To evaluate the results
immunoreactivity was assessed by the relative numbers of positive and negative
chondrocytes in different zones of cartilage including, surface zone (3 cell thick layer),
superficial zone (top 25%), middle zone (50% thick between superficial and deep) and
deep zone (bottom 25%). Because in severe OA, the surface is substituted by fibrillation
and clustering chondrocytes, the immunoreactivity of clones was assessed.
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Immunoreactivity was scored on a five-point scale. In this scoring system, 1, no staining;
2, more cells negative than positive; 3, equal positive and negative; 4, more cells positive
than negative; and 5, all cells positive. This scale was applied for each zone separately.
The criteria were used for immunohistochemical evaluation of sections are summarized
in Table 2.2.
Only sections of intact cartilage that clearly displayed the correct vertical orientation and
thus contained various zones were considered for further examination. Sections were
excluded for evaluation because of artefact alterations or because of excessive non¬
specific b ackground s taining. E valuation w as c arried o ut t hree t imes for e ach s ection.
The cases studied are shown in Table 2.3.
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Table 2.2. The histological/histochemical system was used to assess the
immunohistochemical staining of normal and OA sections
1. Classification of healthy and diseased joints
A. Normal Smooth intact cartilage
(Collins grade 0)
B. Mild OA Roughening and cartilage loss
(Collins grades I & II)
C. Severe OA Areas of complete cartilage loss and bone
exposure
(Collins grades III& IV)
2. Zonation of intact cartilage with no degeneration
a. Surface Three cell thick layer
b. Superficial Top 25%
c. Mid Middle 50%
d. Deep Bottom 25%
3. Zonation of cartilage with degenerative changes
a. Assessment degenerative surface Clones immunostaining
b. Superficial Top 25%
c. Mid Middle 50%
d. Deep Bottom 25%
4. Scoring scale
Criteria Grade
A. No staining 1
B. More cells negative than positive 2
C. Positive cells = Negative cells 3
D. More cells positive than negative 4
E. All cells positive 5
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Table 2.3. Cases studied and antibodies used for IHC assessment ofCD47, CD98 and












22 (11M/9F)* 20 (10M/9F)* 27 (13M/9F)*
Knee joint 13(7M/4F)* 11 (6M/4F)* 9 (4M/2F)*
Hip joint 9(4M/5F) 9 (4M/5F) 14 (6M/6F)*










*, more information not recorded .
M, male; F, Female
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2.4. CHONDROCYTE CULTURE
2.4.1. Primary articular chondrocytes
Isolated articular cartilage from hip joint, different anatomical regions of the knee joint
and ankle were pooled (Table 2.4). Normal and OA cartilage were kept separately.
Cartilage was cut into small pieces with scalpel and incubated in anti-microbial solution
(see appendix II) for 1 hour at room temperature (20 C). Then the cartilage fragments
were washed twice with sterile PBS and sequentially digested by 0.25% trypsin (Gibco,
Paisley, UK) for 30 minutes and 3 mg/ml collagenase type H (Sigma) for up to 48 hours
or until digestion was complete in 95% air/ 5% C02 incubator at 37° C.
Extracted chondrocytes were collected using a sterile pastette and strained through a
sterile strainer to remove undigested cartilage fragments. Then the cell suspension was
centrifuged at 1000 revolution per minute (rpm) for 10 minutes, the supernatant
discarded and the pellet resuspended in PBS. This was repeated twice more to give three
PBS washes. The cells were then resuspended in 10ml Iscove's modified Dulbecco's
medium (Sigma) supplemented with 10% fetal calf serum (FCS) (Sigma), 100 I.U/ml
penicillin (Gibco), 100 pg/ml streptomycin (Gibco). Suspended cells were then filtered
through a 70 micron cell sieve (Falcon, Becton Dickinson UK) to remove large cell
clumps and pieces of debris. The cells were counted using a hematocytometer. Cells
were seeded in complete media at a density of lxl04 cells/ml (for electrophysiology) or
2x105 cells/ml (for protein extraction) in 58mm petridishes (Nunc, USA) and cultured in
a humidified 5% CCf atmosphere at 37° C. Primary, non-confluent, 1-2 week cultures of
chondrocytes from normal or osteoarthritic articular cartilage were used in all
experiments. Morphologically, the cells studied were typically flattened with a polygonal
cell shape and did not show the fibroblastic appearance. The day (16-20 hrs) before
experiments were carried out, the culture medium containing serum was replaced by
serum-free medium.
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1. Femoral condyle FN FA
2. Tibial plateaux TN TA




3. Fibula Fib -
C. Hip joint
1. Femoral head F/H, N F/H, OA
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2.4.2. Immortalised human chondrocyte cell line
The human chondrocyte cell line was generously provided by Dr Goldring (Beth Israel
Deaconess Medical centre, New England Baptist Bone and Joint Institute, and Harvard
Medical School, Boston, Massachusetts). C20/A4 cells were established by transfection
of primary cultures of juvenile costal chondrocytes with vectors encoding Simian Virus
40 large T antigen and selection in suspension culture over agarose (Goldring 1994).
Stable cell lines were generated that exhibited chondrocyte phenotype, continuous
proliferative capacity in monolayer culture in serum-containing medium, and expression
of mRNAs encoding chondrocyte-specific collagen II, IX, and XI and proteoglycans
when cultured in an insulin-containing serum substitute (1% v/v, Nutridoma-SP,
Boehringer Mannheim Biochemicals, Germany).
Using a sterile needle with syringe, different cryopreserved passages (P7, P8, P 10) of
C20/A4 cells in freezing medium (see below) were suspended in 45 ml Dulbecco's
modified Eagle's medium (DMEM) (Sigma) in a large culture flask (Nunc). The medium
was supplemented with 10% fetal calf serum (Sigma), 100 I.U/ml penicillin and 100
pg/ml streptomycin (Gibco). Then the cultured cells were grown in a 95% air and 5%
o
CO2 at 37 C. Every 3 days the medium was changed (feeding).
2.4.2.1. Splitting of adherent cells for seeding or storage cells
To seed at a defined density or cryopreserve cells, the medium was poured off and
adherent cells were washed with sterile PBS. Then the cells were incubated with 2 ml
trypsin (Gibco, Paisley, UK) for 5 minutes or 10 ml 0.02% EDTA for 10 minutes at
o
37 C. The flask was tapped to release cells and detachment or rounding up was checked
using phase contrast microscope. The floating cells were then resuspended in complete
media and centrifuged at 1000 rpm for 10 minutes at 10 C. The supernatant was
discarded and the cell pellet resuspended in sterile PBS and centrifugation was repeated.
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For seeding, the final cell pellet was resuspended in 5-10 ml media and filtered through
70-micron cell sieve to remove clumps. The cells were counted using a
haematocytometer and then seeded at 2x105 cells/ml (for protein extraction) in 58mm
petridishes (Nunc, USA) in complete media.
To cryopreserve cells, the cell pellet was resuspended in 1 ml (1ml per flask) freezing
medium, consisting of 50% DMEM, 40% FCS and 10% DMSO (dimethyl sulfoxide)
(Sigma). Suspended cells in freezing media were immediately aliquoted into labeled
cryogenic storage vials (Nunc). To start freezing slowly, the cryovials were wrapped in
blue roll and frozen in -80 °C freezer overnight. The next day, vials were transferred to
liquid nitrogen storage.
2.5.0. Induction of cyclical mechanical stimulation
The system used to mechanically stimulate the cells (Figure 2.1 and 2.2) is a
modification of that described previously (Wright et al 1992, 1996). Flexible, plastic 58-
mm tissue culture dishes (Nunc, USA) were placed in a sealed polypropylene stimulation
chambers with inlet and outlet ports. The culture dish was supported on six horizontal
pins inserted into a cylinder attached to the base of the pressure vessel (Figure 2.1 and
2.2). The culture dish made a tight fit with the top of the cylinder, the fit being further
enhanced by the presence of a rubber O - ring. An 8 ml volume space (chamber B)
existed between the base of the culture dish and the base of the chamber. Gas entered the
space from the main chamber (chamber A, volume 89ml) via 18 holes each 2.2 mm in
diameter in the cylinder. The chamber was pressurized with Nitrogen (or Helium) gas
from a cylinder, the frequency being dictated by an electronic time controlling the inlet
and outlet valves.
In this system, the space above the dish is larger than the space below the dish. When
pressure is applied to the system, the base of the culture dish becomes distorted because
the time constant for equilibration of pressure above and below the dish is different
because of differences in volumes of the spaces involved and the relative inaccessibility
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of the space below the dish for entering gas. The cells on the petri dish are subjected to
both an increase in pressure and an increase in stretch as a result of deformation of the
base of the dish (Salter et al 2000). Cyclical mechanical stimulation of this system
induces deformation and strain on the base of plastic tissue culture dish and its adherent
cells due to a differential rate of rise of pressure above and below the culture dish. In this
system, a pressure of 1 Bar above atmospheric pressure, which results in approximately
4000 microstrain (pstrain) on the base of the dish, was used. The standard stimulation
regime used was a frequency of 0.33 Hz (2 seconds on, 1 second off) at 37°C (Wright et
al 1992).
To assess intracellular signalling following mechanical stimulation, for defined periods
(0, 30 sec, lmin, 5min, lOmin) cultured chondrocytes were subjected to cyclical
mechanical stimulation (see 2.6.2 and 2.6.3). Each experiment was carried out with

















Figure 2.1. Apparatus for the induction of cyclic mechanical stimulation. Nitrogen gas
entered the system from a nitrogen cylinder, via a pressure regulator, which controlled
the inlet and outlet valves. A delay/timer allowed variation in duration of pressure pulse
and time between pulses. The pressure in the system was monitored by a digital
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After indicated mechanical stimulation and/or required conditions, the medium was
poured off and cells were immediately washed twice with 10 ml ice-cold PBS containing
ImM Na3Vo4 (Sigma). Cells were immediately lysed in situ with 500 pi ice-cold lysis
buffer at 4°C for 15 min. Lysis buffer contained ImM Na3Vo4 (Sigma) in PBS, 1%
Igepal (Sigma), and protease inhibitor cocktail tablet (Boehringer Mannheim). Lysates
were collected by scraping the base of the culture dish with a cell scraper (Grenier bio-
one) at 4°C. Supernatants were collected after centrifugation at 13000 rpm for 15 min.
The whole cell lysates were stored at -80°C for future use, including separate storage of a
20 pi aliquot of the lysate for protein determination. The protein concentration was
determined using Follin-Lowry assay method (Lowry et al 1951) (see 2.6.4).
2.6.2. Assessment of tyrosine phosphorylation
Following mechanical stimulation at 0.33 Hz for defined periods (1 minute and 5
minutes), protein extraction was carried out. To assess the role of CD47 in the induction
of protein tyrosine phosphorylation, in separate experiments chondrocytes were
incubated with lpg/ml anti-CD47 (Brie 126) for 10 min prior to mechanical stimulation.
To maximise the inhibition effect of sodium orthovanadate on protein phosphotyrosyl-
phosphatases, activation of sodium orthovanadate protocol (Upstate procedure:
http:// www.upstate.com/misc/protocols.asp?prot=activation) was applied. 200 mM
solution of sodium orthovanadate was prepared and pH adjusted to 10 using IN NaOH
and/or IN HC1 until the solution was yellow. Then the yellow solution was boiled for
approximately 10 min until it turned colourless left at room temperature and again the pH
adjusted to 10 until became colourless. This solution was used to make ImM sodium
orthovanadate in PBS.
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2.6.3. Assessment of PKCa activation
To assess the role of CD47 in PKCa activation, cultured chondrocytes were incubated
with lpg/ml anti-CD47 (Brie 126) for 10 min prior to mechanical stimulation.
Immediately after defined periods (30 sec, 1 min, 5 min, and 10 min) of mechanical
stimulation, the cells were washed once with ice cold PBS. Then cells were scraped into
buffer A containing 20 mM Tris-HCl, PH 7.6, 2 mM EGTA, 2 mM EDTA, 0.33 M
sucrose, 100 pM Na3V04, 20 mM NaF and protease inhibitors cocktail. Extracts were
then sonicated on ice 3-5 times for 5 seconds each time at 5 sec intervals. Then sonicated
lysates were centrifuged at 13000 rpm for 30 min at 4°C. The supematants were
collected as cytosolic fractions and the pellets (particulate fraction) were re-suspended in
buffer B containing 20 mM tris-HCl, pH 7.6, 2 mM EGTA, 2 mM EDTA, 0.1% Triton
X-100, 100 pM Na3VC>4, 20 mM NaF and protease inhibitors cocktail. Equivalent
amount (40 pg) of cell extracts were separated on a 10% polyacrylamide gel under
reducing conditions.
2.6.4 Lowry determination of protein concentration
Bovine serum albumin (BSA) (Sigma) standards increasing in concentration from 0 to
200 pg/ml (0, 10, 25, 50, 75, 100, 150, and 200) were set up in triplicate and vortexed.
Sample tubes were setup in triplicate by adding 5 pi sample to 195 pi 0.1N NaOH.
Blank tubes containing 200 pi 0.1 N NaOH were also set up in triplicate. The tubes were
vortexed to mix the sample. To all tubes, 1 ml of alkaline carbonate solution was added,
the tubes were then vortexed and allowed to stand at room temperature for 10 minutes.
To each tube 10 pi Folin's reagent (Sigma) was added, the tubes were vortexed and
allowed to stand at room temperature for 30 minutes. An aliquot of 200 pi of each
sample was transferred to a 96 well tissue culture microplate (IWAKI, Japan) and the
absorbance was read on a Dynatech MR 500 microplate reader at 570 nm. The software
BioLinx 2.20 using a standard curve of BSA protein concentration calculated the average
concentration for each triplicate sample (Lowry et al 1951).
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2.6.5. IMMUNOPRECIPITATION
2.6.5.1. Immunoprecipitation for tyrosine phosphorylation
Appropriate protein amounts (lmg protein for primary cells and 500pg protein for
C20/A4 cell line) from whole cell extracts were made up to 1ml with fresh ice-cold lysis
buffer (Appendix II). Then 25 pi anti-phosphotyrosine-agarose (Sigma) was added to
each tube. The tubes were incubated at 4°C for at least four hours on a rotating device.
The tubes were then centrifuged at 13000 rpm for 15 minutes at 4°C and the supernatants
were discarded. The beads, containing immunoprecipitated complex, were washed twice
with ice-cold lysis buffer and once with 1ml ice-cold PBS containing ImM Na3Vo4,
centrifuged and supernatants discarded. Then, the immunoprecipitated beads were
solubilized in equal amounts (25pl) electrophoresis sample buffer 2x (ESB2x) (see
Appendix II) and 10% SDS (Sodium Dodecyl Sulphate), boiled in water bath for 5
minutes, and loaded onto 8% reducing acrylamide gel for western blotting analysis (see
Appendix II). The blots were immunoblotted with anti-phosphotyrosine-HRP conjugated
(Amersham Life Science) (1:1000) or anti-FAK (Santa Cruz) (1:500).
2.6.5.2. Assessment of cell membrane receptors association
To minimize the non-specific background staining and preclearing, protein A/G resin
(cytosignal™ research product) was mixed with equal amounts of normal rabbit serum
(NRS). The beads obtained from this mixture were resuspended in lmg protein of cell
extract for overnight on a rotating device and then centrifuged at 13000 rpm for 5 min at
A °
4 C. The supernatant was made up to 1ml by adding fresh ice-cold lysis buffer. Indicated
amounts of anti-CD47 or anti-piintegrin antibodies (2 pg/ml) and protein A/G resin (30
pi per 1ml lysate) were added to the supernatant and incubated for overnight on a
°
rotating device at 4 C. To immunoprecipitate CD47 and its associated ligands anti-CD47
CC2C6 (25 pi /ml) (mouse Ig Gl, kindly provided by Dr. FI.J.Buring, University of
Tubingen, Germany) or 1F7 (2pg/ml) (mouse IgGl; kindly provided by Frederik P.
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Lindberg, Washington University) were applied. Immunoprecipitated plintegrin and its
complex were obtained by using 2 pg/ml anti-Plintegrin ,clone JB1A (Chemicon). The
°
immunoprecipitated proteins were washed at least 3-5 times with lysis buffer at 4 C.
Protein complexes bound to beads were solubilized in equal amounts (25pl) of sample
buffer 2x plus 10% SDS, boiled for 5 min in water bath, analysed by appropriate
percentage of SDS-PAGE, and the next stages will be discussed in below.
2.6.6. Sodium Dodecyl Sulphate Poly Acrylamide Gel Electrophoresis
(SDS-PAGE)
Proteins were analysed by SDS-PAGE according to the method of Laemmli (Laemmli
1970), using equipment from Bio-Rad. Glass gel plates (12 cm x 10 cm, 12 cm x 9 cm),
spacers, clamp assembly, casting stand and grey silicone gaskets were cleaned with 70%
industrial methyl alcohol (IMS). Glass plate sandwiches were assembled into the clamp
assembly and the unit transferred to the casting stand. A separating gel solution was
prepared of appropriate acrylamide (national diagnostics, UK) percentage (6%, 8%, 10%,
15%) (see Appendix II) for the resolution required. The solution was mixed and poured
into the gap between the glass plates up to the mark using a Pasteur pipette. The solution
was immediately overlaid with distilled water and allowed to polymerise for 45 minutes
in a vertical position at room temperature. The overlaid distilled water was drained off
and the surface of the gel dried with fdter paper. In a sterile bijoux, the 5% stacking gel
solution was prepared and poured over the separating gel to the top of the plates. A ten-
well comb was placed in the sandwich, a mark made 0.5 cm below the edge of the teeth,
and the gel allowed to polymerise at room temperature for 15 minutes. After
polymerisation of the stacking gel, the comb was removed, and wells washed with dH20,
the clamp assemblies removed from the casting stand and attached to the inner cooling
core. T he e lectrode b uffer w as prepared from t en times s tock o f electrode b uffer (see
Appendix II).
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Samples were prepared by mixing 40pg protein extract from whole cell lysate with equal
amount of two times reducing or non-reducing electrophoresis Laemmli sample buffer 2x
(ESB2x)and aliquoted. In non-reducing ESB2x, 10% P-mercaptoethanol (p-ME) was
replaced by distilled water (see Appendix II). To denature the proteins, aliquots were
boiled for 3 minutes and then loaded onto the gel. The inner cooling core was placed into
the cell and electrode buffer poured into the lower chamber so that at least 1 cm of gel
was covered. Then the electrophoresis apparatus was attached to an electric power supply
and the samples were electrophoresed through the gel at a voltage up to 150V and
stopped when the blue line of bromophenol blue had reached the bottom of the separating
gel.
2.6.7. Electrophoretic transfer of proteins to polyvinylidene fluoride
(PVDF) membrane
After running, the gel assembly was r emoved from the gel apparatus, the glass plates
separated and the gel soaked in a jar containing transfer buffer (see Appendix II). For
each gel a piece of PVDF membrane and three pieces of 3MM filter paper (Whatman,
UK) were cut to a size -0.5 cm larger than the gel. The PVDF membrane was first
soaked in methanol for a few seconds (~15 sec) and transferred to a container of distilled
water for two minutes. The PVDF membrane, filter papers and fibre pads were
equilibrated i n t ransfer b uffer for 5 minutes. T he p lastic h older for t he g el membrane
sandwich was opened, a fibre pad was placed onto it followed by a piece of filter paper,
then the gel, the PVDF membrane, the two pieces of filter paper and finally the second
fibre pad. The holder was closed, squeezed gently to exclude air bubbles and then placed
in the transfer apparatus ensuring that the PVDF membrane lies between the cathode and
the gel (Figure 2.3). The tank was filled with transfer buffer sufficient to cover the gel,
membrane sandwich without touching the electrodes and transfer was carried out at 45V
overnight in cold room.
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2.6.8. Immunoblotting and development of blot using enhanced
chemiluminescence (ECL) or ECL plus
Following electrophoretic transfer of proteins to the PVDF membrane, the plastic holder
was removed from the blotting apparatus and opened on a flat surface. The PVDF
membrane was removed and incubated with 20 ml blocking solution for 1 hour shaking
at room temperature. The blocking solution was composed of 2% BSA or 5% dried milk
(Marvel), 0.1% sodium azide in TBST (see Appendix II). Then the blot was washed three
times quick wash with TBST (see appendix II) and incubated with primary antibody
diluted in 5 ml TBST for 1 hour with shaking at room temperature. After three quick
washes and two 10 minutes washes with TBST, the blot was incubated with appropriate
HRP-conjugated secondary antibody (DAKO) (1:2000) for 1 hour with rotation at room
temperature, and then washed as above.
The proteins were then visualised by using enhanced chemiluminescence (ECL) or ECL
plus detection kit (Amersham, UK). When ECL detection system was used, a mixture of
1 ml solution A and 1ml of solution B were poured onto one membrane for 1 minute. A
mixture of solution A: solution B (1:40) was applied for 5 min when ECL plus was
utilised. The fluid was drained off and the membrane wrapped in saran wrap. Any air
bubbles were smoothed out. The blot was placed in autoradiography cassette and
exposed to ECL hyperfilm for 1 minute. The film was developed by hyperprocessor and
the blot re-exposed as required depending on the strength of the signal.
2.6.9. Estimation of protein size
The molecular weight of proteins analysed by SDS-PAGE was determined by
comparison with coloured recombinant molecules of defined size (Rainbow RPN 800,
Amersham) that were electrophoresed on the same gel. Proteins detected, cases studied
and primary antibodies utilised by western blotting are summarised in Tables 2.5 and
2.6.
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Table 2.5. Cases studied by western blotting analysis to detect CD47 and its ligands,















































*, more information was not recorded.
§, All ankle joints were normal.
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Table 2.6. Cases studied by western blotting analysis to detect CD98 and its ligands,
galectin-3 and CD 147 (EMMPRIN) in cultured human articular cartilage (in vitro).
CD98 Galectin-3 CD147
(EMMPRIN)
Antibody/ Goat polyclonal, Mouse mAb 9C4 Mouse mAb 8G6
Dilution 1:500 1:500 1:5000
No. of cases 19 17 17
(sex) (14M/4F)* (11 M/6 F) (11 M/6F)
Knee joint 10 7 7
(Normal/ OA) (3 N/ 7 OA) (3 N/ 4 OA) (3 N/ 2 OA)*
Hip joint 5 5 5
(3 N/ 2 OA) (3 N/ 2 OA) (3 N / 2 OA)
Ankle joint§ 4 5 5
Age range Knee: 62-87 (73) Knee: 62-87 (74) Knee: 62-87 (73)
(Mean) Hip: 70-98 (82) Hip: 70-98 (83) Hip: 70-98 (83)
Ankle: 69-80 (73) Ankle: 62-80 (70) Ankle: 62-80 (70)
*, more information was not recorded.












Figure 2. 3. Assembly of tank transfer apparatus
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2.6.10. Blot stripping
In some cases, immunoblots were stripped of bound antibodies by incubating the blots
with a stripping buffer containing 62.5 mM Tris (PH 6.7), 2% SDS, and 100 mM 2-
mercaptoethanol (ME) (see Appendix II) for 30 minutes at 50°C. Then the blots were
washed twice with TBST for at least 10 minutes each wash. Blocking of non-specific
binding was applied by incubating blots in blocking buffer for one hour. Then blots were




2.7.1. Preparation of microelectrodes
Ten-cm borocilicate glass capillaries GC150F-10, 1.5 mm outer diameter (O.D) x
0.86mm inner diameter (I.D), with inner filament (Harvard apparatus, Edenbridge, Kent,
UK) were pulled to produce two microelectrodes by using Narishege microelectrode
puller (Narishege, Japan). After pulling, a batch of microelectrodes were stored in a clean
container with their tips uppermost.
2.7.2. Filling of microelectrodes
Prior to use, the electrodes were filled with 3M potassium chloride solution (3M KC1). A
glass tissue culture beaker was filled with 3M KC1 and plasticine was pressed firmly
around the rim of the beaker. Electrodes were then pressed onto the plasticine so that
their tips were submerged in the KC1. The tips filled by capillarity and the shafts of the
electrodes were filled using a syringe and lumbar puncture needle. After filling the
electrodes were left for at least 3 minutes to allow the tips to fill by capillary action.






Figure 2.4 - Filling of Microelectrodes with 3M KC1.
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2.7.3. Electrophysiological recording
After 20 minutes pressurisation at 0.33 Hz (2 seconds on, 1 second off), the dishes of
cells were removed from the pressure chamber immediately (about 2 minutes) and post
pressurisation values of membrane potential recorded on the cells over the further 10-12
minutes.
Electrophysiological experiments were performed at room temperature (~ 20°C). Dishes
of cultured chondrocytes were placed on the stage of a wild M40 inverted microscope
(Figure 2.5) and were observed under x200 magnification. A silver/silver chloride
(Ag/AgCl) e arth w ire w as p laced i n the p eriphery o f t he c ulture d ish, m aking c ontact
with the culture medium, to make more stable recording during experiment. The other
end of this wire was connected to the ground terminal of the input headstage of the
Axoclamp Amplifier. The microelectrode was connected to the headstage via a
microelectrode holder, which housed an Ag/AgCl wire. A pre-filled microelectrode was
connected to microelectrode holder so that Ag/AgCl wire of holder passed down the
shaft of the microelectrode making contact with 3M KC1 in shaft of microelectrode.
Microelectrode passed over Ag/AgCl wire into blunt end of microelectrode contacted the
recess and pipette seat. The pipette cap was then turned to firmly hold microelectrode in
place in the holder (Figure 2.6). The central end of microelectrode holder connected to
the input of the headstage. Using a Zeiss micromanipulator (Figure 2.5), the
microelectrode connected to the headstage lowered until its tip was beneath of the
surface of culture medium and focused.
Power to the Axoclamp-2B (Microelectrode Clamp, Axon Instruments) was switched on
(Figure 2.7) and by using the input offset potentiometer any voltage recorded on
microelectrode was offset to the zero line on the oscilloscope (Gould Advance type OS
4000/4001). A command current of 5 nA was set with the step command thumbwheel
switch. A voltage pulse was observed on the oscilloscope. Bridge dial advanced until this
voltage step was eliminated. The bridge was then in balance. The microelectrode tip
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resistance was read from the bridge dial and was usually in the range of 25-50 Mfi,
which was acceptable for experimentation. Lower tip resistances indicated that there was
some damage to the tip or that the electrodes had a large tip diameter. High tip
resistances (> 100 MQ) indicated the probability of air bubbles in the electrode tip, due
to inadequate filling by the capillary. Therefore, electrodes with tip resistances <20 MQ
or >100 MQ were discarded and not used for experimentation. The cells were left at
room temperature for 5 min before the first membrane potential measurement was made.
Each experiment was performed with chondrocytes from at least 3 different donors.
2.7.4. Electrophysiological Procedure
I. An isolated and polygonal human articular chondrocyte (HAC), with no visible contact
with neighbouring cells, was selected for impalement. It has been previously shown that
resting membrane potentials are higher in cells, which are in contact with one or more
neighbouring cells (Bard and Wright 1974).
II. The voltage dependent oscillator was switched on. This produces a tone, which is
dependent on voltage, and changes in accordance with changes in membrane potential.
This piece of equipment provides the advantage that the experimenter can observe the
microelectrode on cell impalement and not have to continually c heck the oscilloscope
monitor, as a change of note alerts the experimenter that the electrode has entered the
cell.
III. The microelectrode tip was positioned over the cell using the micromanipulator.
IV. The electrode tip was then lowered whilst listening to the note of the voltage
dependent oscillator. When the electrode tip entered the cell, the note changed suddenly
from high to a lower frequency.
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V. The digital readout of membrane potential was then observed on the Axoclamp-2B
and this was noted. The electrode tip was then removed from the cell using the
micromanipulator.
The results from individual cells were accepted, if, upon impalement there was a rapid
change in voltage which remained constant for at least 20 seconds. A microelectrode
was changed if there was a dramatic increase or decrease in electrode resistance as this
usually indicated that the electrode had become blocked with debris, or cellular material
or that the electrode had become damaged during cell impalement. Membrane potentials
of a minimum of 5 cells were measured before and after addition of each reagent to be
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Figure 2.6 - Details of the microelectrode holder
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Figure 2.7 - Diagram of Axoclamp-2B system.
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2.8. Chemical reagents
To investigate the role of CD47, CD98 and their ligands in the mechanotransduction
pathway induced by mechanical stimulation at 0.33 Hz in cultured human articular
chondrocytes, a panel of antibodies to CD47, CD98 and their ligands, SIRPa, TSP and
CD 147, were added separately to cell cultures. Membrane potentials of cultured
chondrocytes were measured before (as resting) and 10 minutes after adding Ab. Then
the cells were subjected to standardised mechanical stimulation regime and immediately
after mechanical stimulation, the post-stimulation membrane potentials of chondrocytes
were measured. The Abs and their concentrations utilised are shown in Table 2.8.
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Table 2.8. Chemical reagents
ANTIBODY EFFECT CONCENTRATION SOURCE
Brie 126 Anti-CD47 mAb* 1 pg/ml IBGRL***
C-20 Anti-CD98 pAb** 1.5 pg/ml Sanata Cruz
BU89 Anti-CD98 mAb 1:100 Dr D. Hardie
BU53 Anti-CD98 mAb 1:100 Dr D. Hardie
SE7C2 Anti-SIRPa mAb 1:100 Dr. H.J. Buring,
Tubingen University,
Germany
SE5A5 Anti-SIRPa mAb 1:100 Dr. H.J. Buring,
Tubingen University,
Germany
8G6 Anti-CD 147 mAb 1.5 pi/ml Dr M. Hemler
P10 Anti-TSP mAb 1.5 pg/ml Chemicon
International
-Incubation period of all antibodies: 10 min.
*mAb: Monoclonal antibody
**pAb: Polyclonal antibody
***IBGRL: International Blood Group Reference Laboratory (Bristol, UK)
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2.9. Statistical analysis
The mean, standard deviation (SD) and standard error of the mean (SEM) were
determined in each experiment. For statistical comparisons, when the F-ratio of the two
variances reached significance, the non-parametric Mann-Whitney test was used. When
the ratio did not reach significance, the Student's t test was used.
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CHAPTER THREE
3.0. IN VIVO AND IN VITRO EXPRESSION OF
INTEGRIN-ASSOCIATED PROTEINS IN NORMAL
AND OA HUMAN ARTICULAR CARTILAGE
3.1. IN VIVO AND IN VITRO EVALUATION OF CD47
EXPRESSION IN HUMAN ARTICULAR CARTILAGE
To evaluate in vivo expression of CD47 by normal and OA articular cartilage, a series of
immunohistochemical staining was undertaken on frozen sections of articular cartilage
from femoral head and different anatomical regions of knee joint (femoral condyle, tibial
plateaux or patella). Immunohistochemical assessment of both normal and OA sections
was carried out using mouse mAb anti-CD47 Brie 1 26. The antibody was first tested
over a wide range of concentrations. Preliminary studies showed that this mAb worked
with frozen sections at 1:5000 but not with formalin fixed, paraffin embedded sections.
The positive immunoreactivity in different sections was graded in a range of 1-5. CD47
staining for each zone was scored as: 1, no staining; 2, more cells negative than positive;
3, equal positive and negative; 4, more cells positive than negative; and 5, all cells
positive (see chapter two, 2.3.6, page 90). Each zone of cartilage sections was evaluated
and scored separately.
3.1.1. Expression of CD47/IAP in normal human articular cartilage
Twelve sections of normal articular cartilage were obtained from 6 males (age range 62-
82, mean age 71), 5 females (age range 74-90, mean age 78) and one case whose age and
sex was not recorded. Normal human articular cartilage sections were isolated from 4
femoral heads, 3 females, one male (age range 74-90, mean age 79) (day book numbers
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(DB Nos): 13857, 13867, 13836, 13871); 4 femoral condyles, 2 females, 1 male, 1 case
whose age and sex was not recorded (age range 64-82, mean age 74) (10052, 1 3860,
10070,10051); 3 tibial plateaux, 1 male, 1 female, one case whose age and sex was not
recorded (age range 64-88, mean age 7 3)(10070, 1 3860, 1 3855) and 1 patella (a case
whose age and sex was not recorded)(l 1829).
Normal articular chondrocytes in all zones exhibited a consistent pattern of CD47
expression (Figure 3.1). Chondrocytes in all zones showed very strong expression for
CD47. There was no difference in the pattern of CD47 staining with respect to various
zones (Table 3.1). The median scores for all zones of normal sections were 5. All
chondrocytes in different sections from different donors showed similar staining pattern.
Strong immunoreactivity of CD47 at very high dilution (1:5000) of mAb Brie 126 was
observed, suggesting strong expression o f CD47 in normal articular cartilage. Normal
articular cartilage sections isolated from femoral head and various anatomical regions of
knee joint (femoral condyle, tibial plateaux or patella) showed similar strong
immunostaining pattern. Similarly, there was no difference in immunoreactivity of
different zones in different joints. There was no difference in immunoreactivity of
sections removed from adult donors of different age or sex.
3.1.2. Expression of CD47/IAP in OA human articular cartilage
CD47 expression pattern was assessed in sections from 20 mild OA (7 grade I and 13
grade II) and 12 severe OA (10 grade III and 2 grade IV) of articular cartilage samples.
Samples of OA articular cartilage were obtained from 11 males (age range 62-82, mean
age 73), 9 females (age range 62-90, mean age 78) and 2 cases whose age and sex were
not recorded. Samples of mild OA articular cartilage were obtained from 5 femoral
heads, 1 male, 4 females (age range 74-90, mean 78) (13835, 13873, 13871, 13836,
13857); 8 femoral condyles, 4 males, 2 females, 2 cases whose age and sex were not
recorded (age range 62-88, mean 74) (10071, 13860, 13855, 11045, 11370, 13853,
10051, 13854); 6 tibial plateaux, 3 males, 1 female, 2 cases whose age and sex were not
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recorded (age range 72-88, mean 75) (11045, 13855, 10071, 13853, 13860, 13854) and 1
patella, female (age 67) (10070).
Chondrocytes in all zones showed extensive membrane staining for CD47 (Figure 3.2).
Articular cartilage from mild OA (grades I and II) exhibited a consistent expression of
CD47, which was similar in all zones of cartilage. Strong expression of CD47 was
observed in mild OA sections isolated from femoral head and various anatomical regions
(femoral condyle, tibial plateau or patella) of knee joint (Table 3.1). The median scores
for all zones ofmild OA sections were 5.
Samples of severe OA articular cartilage were obtained from 6 femoral condyles, 3
males, 1 female, 2 cases whose age and sex were not recorded (age range 62-88, mean
76) (11370, 10071, 13855, 13853, 13860, 13854); 5 tibial plateaux, 3 males, 2 females
(age range 62-88) (10052, 10071, 1 3855, 1 0070, 1 0051) and 1 patella, male (age 82)
(10071). In severe OA sections (grades III and IV), chondrocytes in all zones showed
strong immunoreactivity. Strong expression of CD47 was observed in severe OA
sections isolated from femoral head and various anatomical regions (femoral condyle,
tibial plateaux or patella) of knee joint. Clusters and areas of excessive surface
fibrillation showed e xtensive anti-CD47 immunoreactivity (Figure 3.2). There was no
difference in the pattern of CD47 staining with respect to various zones in mild and
severe OA sections. The median scores for all zones of severe OA sections were 5
(Table 3.1). D ifferent grades o f OA articular c artilage d id not s how d ifference i n t he
strong CD47 expression pattern (Table 3.1).
Like normal articular cartilage sections, both mild and severe OA, showed similar strong
immunoreactivity of CD47 at very high dilution (1:5000) of mAb anti-CD47 Bricl26,
suggesting a similar expression pattern of CD47 in both normal and OA articular
cartilage. CD47 positive staining did not show detectable modification in sections
removed from adult donors of different age or sex.
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Table 3.1.CD47 expression in normal, mild OA and severe OA human articular
cartilage. Each zone of articular cartilage from different donors was evaluated and
scored separately. In each zone, the results are shown as mean ± SD. Evaluation was
performed three times. Normal, mild OA and severe OA showed the similar strong
expression pattern in different zones. P value was calculated to compare different zones
in both normal and OA articular cartilage sections. In normal and mild OA surface zone
compared with all zones and P value was >0.05 (not significant). In severe OA clones
grade was compared with the other zones and P value was >0.05 (not significant).
Immunostaining Score
mean ± SEM
Sample n Surface Superficial Clones Middle Deep
Normal 12 4.9 ± 0.08 5
_ 5 5
Mild OA 20 4.7 ±0.1 5
_ 5 5
Severe OA 12 N/A N/A 4.9 ± 0.07 5 5
*N/A, not available.
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Figure 3.1. Immunoreactivity of mAb anti-CD47, Brie 126 in normal adult human
articular cartilage sections. Immunoreactivity was assessed by using mouse anti-CD47
Bricl26 at 1:5000. All sections showed strong expression ofCD47 in different zones.
A, Femoral head, normal, superficial (S)-deep (D), (female, 90 years) (13857), xlOO.
Chondrocytes in all zones showed a similar strong expression pattern of CD47. B,
Femoral condyle normal (FN), mid -deep zone (female, 88 years) (10051), xlOO.
Chondrocytes in middle and deep zones showed extensive membrane staining for CD47.
C, Tibial plateaux normal (TN), mid-zone (M), (male, 64 years) (13855), x400. High
magnification of chondrocytes in mid-zone of TN, with very strong expression ofCD47.
B, Negative control, tibial plateaux normal, mid- zone, (male, 73 years) (11045), x200.
No positive signal at all was observed in TN section as negative control.
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Figure 3.2. Immunoreactivity of mAb anti-CD47, Bricl26, in OA human articular
cartilage. Immunoreactivity was assessed by using mouse anti-CD47 Bricl26 at 1:5000.
All sections showed strong expression of CD47 in different zones. Various Collins
grades of OA showed similar extensive positive expression pattern. A, Femoral head,
OAII surface-deep zone, (female, 90years) (13857), xlOO. From clones towards deep
zone of OA femoral head, all chondrocytes showed a similar strong expression pattern
for CD47. B, Femoral condyle (FA), OA III, superficial-mid zone, (male, 82 years)
(10071), xl OO. No identifiable difference was observed in chondrocytes from superficial
and middle zone for CD47 expression. C, Tibial plateaux, clone in OAII, (male, 64
years) (13855), x400. High magnification of a clone from TAIII showed very strong
expression of CD47. D, Negative control, femoral head, OAII, (female, 74) (13836),
xlOO. No positive signal at all was observed in FA II section as negative control.
126
3.1.3. In vitro evaluation (western blotting analysis) of CD47 expression
in cultured human articular chondrocytes
CD47 is an IgSF member of ~ 50 kD MW, which a number of cell types are recognized
to express this molecule using western blotting and immunoprecipitation (Brown et al
1990; Mawby et al 1994).
In next step of this study, to confirm the in vivo immunohistochemical results, a series of
western blotting experiments was carried out. Chondrocytes were obtained from hip,
knee and ankle joints. Chondrocytes were isolated from normal articular cartilage
obtained from the tibia and talus (ankle joint), femoral head (hip), tibial plateaux and
femoral condyle (knee) of 11 males (age range 69-83, mean 75) and 2 females (age range
71-80, mean 75). OA chondrocytes were isolated from OA articular cartilage obtained
from the femoral head, tibia plateaux, femoral condyle and patella of 4 males (age range
68-87, mean 77) and 2 females (age range 62-87, mean 75). Primary chondrocytes were
seeded at 2xl05 cells/ml concentration. After a period of 10-15 days cultured
chondrocytes were lysed and the proteins extracted.
3.1.3.1. Work of antibodies to CD47
To identify the biochemical characterization of CD47 chondrocytes, a panel of mouse
mAbs anti-CD47, Bricl26, 2B7, miap 400.1, 2E9, I F7, 2E11 and CC2C6, one rat mAb
miap 300.1, and one goat polyclonal Ab (SantaCruz) were applied. Each Ab was tested
with three samples, one normal ankle, one normal and one OA sample, at concentrations
1: 500 and 1:1000. Four mAbs, 2B7, miap 400.1, 2E9 and miap 300.1, showed strong
band at molecular weight approximately 47-55 kD and one polyclonal Ab (Goat
polyclonal, SantaCruz) as well. Four mAbs, Brie 126, 2E11, 1F7 and CC2C6, showed
multiple bands, a very faint band or no binding (Figure 3.3).
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3.1.3.2. Western blotting assessment
Based on the preliminary experiments three Abs, 2 anti-CD47 mouse monoclonal (2B7
and miap 400.1) and one polyclonal antibody (goat polyclonal SantaCruz), were selected
for further assessment. Both mAbs showed single band in normal and OA samples and
the polyclonal Ab showed two bands. Chondrocytes isolated from normal and OA
samples taken from different joints were assessed with these antibodies (Table 3.2).
1. Mouse mAb miap 400.1: Cell extracts obtained from two normal ankles, both talus, 1
male (age 71), and another case, male, whose age was not recorded (13915, 13901); 1
normal femoral head, male (age 70) (13822), 1 normal femoral condyle, male (age not
recorded) (13949); and 1 OA grade II femoral head, male (age 83) (13828); 1 OA grade
III tibia plateaux, male (age 87) (13965), were separated under reducing conditions and
probed with mAb miap 400.1 at 1:500 (Table 3.2). All showed a similar single band at
-50 kD (Figure 3.4. A).
2.Goat polyclonal anti-CD47 (SantaCruz): Cell lysates obtained from two normal ankle,
both talus, 1 male (age 71), and another case, male whose age was not recorded (13915,
13901); 1 normal femoral head (male, age 83) (13828); 1 normal tibial plateaux (male,
age not recorded) (13949); and one OA grade II femoral head (male, age 83) (13828); 1
OA grade III tibia plateaux (male, age 87) (13965), were separated under reducing
conditions and probed with this polyclonal Ab at 1:100 (Table 3.2). Two bands, 47 and
55 kD sizes, were detected (Figure 3.4. B).
3. Mouse mAb 2B7: Normal samples were obtained from ankle (2 talus, 2 tibia), all male
(age range 69-80, mean 73) (13901, 13915, 13920, 13907); 2 femoral condyles, both
male (mean 75) (13919, 13939); 1 tibia plateau, male (age not recorded) (13949); 2
femoral heads, one male and one female (mean 75) (13816, 13822). OA samples were
obtained from 3 femoral condyles, 2 males, 1 female (age range 69-87, mean 78) (13905,
13964, 13939); 2 tibia plateau, both female (mean 75) (13820, 13965); one patella, male
(age 68) (13966). Cell lysates from these samples were analyzed under reducing
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conditions and probed with 2B7 mAb at 1:500 (Table 3.2). All chondrocytes isolated
from normal and OA samples, showed a single band at -50 kD (Figure 3.4. C).
There was no appreciable variation in the intensity of CD47 band between samples from
normal and OA cartilage. There was no difference in results from experiments using
chondrocytes removed from donors of different age and sex or from femoral head and
different areas of knee joint (femoral condyle, tibial plateaux and patella). Compared
with chondrocytes isolated from normal and OA hip and knee joints, slightly stronger
band of CD47 was observed from chondrocytes isolated from different anatomical areas
of ankle (tibia, talus). The intensity ofband in ankle chondrocytes, by using different
mono and polyclonal antibodies was consistently observed (Figure 3.4.A, B).
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2 talus (ankle) (13901, 13915)
2 tibial (ankle) (13920, 13915)
2 femoral condyle (13919,13939)
1 tibial plateaux (13911)
2 femoral head (13822, 13828)
2.OA
2 M, mean 73
2 M, mean 75
2 M, mean 75
1 M, not recorded
1 M, 1 F, mean 75
3 femoral condyle (grades I, II and
III ofOA) (13905, 13964, 13939)
2 M/l F, mean 78
2 tibial plateaux (grades I and III) 2F, mean 75
1 patella (II) (13820, 13965) M,age 68
Miap 400.1 (mouse mAb)
(1:500)
1.Normal
2 talus (ankle) (13901, 13915)
1 femoral condyle (13949)
1 femoral head (13822)
2. OA
2 M, age 71, n/r*
male, n/r
M,age 70
1 tibial plateaux (13965)






2 talus (ankle) (13915, 13901)
2 tibial plateaux (13941, 13911)
1 femoral head (13828)
2. OA
2M, age 71, n/r
2 M, mean 71
M,age 83
1 tibial plateaux (grade III) (13965)
1 femoral head (grade II) (13828)
F, age 87
M, 83
*, n/r: more information not recorded.
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Figure 33. A) Work of antibodies to CD47. Equal amounts (40pg/lane) of total
extracted proteins obtained from the cultured chondrocytes derived from normal ankle
(lanes a), normal (lanes b) and OA (lanes c) knee and femoral head were run in a 10%
SDS-PAGE under reducing conditions. Blocking was applied with 5% dry milk (marvel)
solution overnight at 4°C. CD47 was detected by probing blots with monoclonal CC2C6
(A), 2E11 (B) and 1F7 (C) anti-CD47 antibodies. A) By probing blots with mouse mAb
anti-CD47 CC2C6 (1:500), all samples showed multiple bands in a very broad range of
molecular weight. B) By using anti-CD47 2E11(1:500), all samples showed very faint
multiple bands or no binding. The expression did not show consistency in different
samples. C) By using mouse mAb anti-CD47, 1F7 (1:500), samples showed faint
multiple bands or no binding. The blots shown, are representative a series of
experiments including at least three different donors (normal and OA). Molecular
weights (MW) in kilo Daltons (kD) are indicated on the left.
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(A) (B) (C)
Figure 3.4. A) Detection and comparison of CD47 in normal and OA human
articular chondrocytes. Equal amounts (40pg/lane) of total extracted proteins obtained
from the cultured chondrocytes derived from normal ankle (lanes a), normal (lanes b)
and OA (lanes c) knee and femoral head were run in a 10% SDS-PAGE under reducing
o
conditions. Blocking was applied with 5% dried milk (Marvel) solution overnight at 4 C.
CD47 was detected by probing blots with monoclonal miap400.1 (A), polyclonal goat
(SantaCruz) (B), and monoclonal 2B7 (C) anti-CD47 antibodies. A) By probing blots
with mouse mAb anti-CD47 miap 400.1 (1:500), normal ankle (lane a, tallus, male, age
not recorded) (13901)*, normal (lane b, femoral head, male, age 70) (13822) and OA III
(lane c tibia plateaux, female, age 87) (13965) chondrocytes showed an ~50 kD single
band. B) By using polyclonal goat anti-CD47 (SantaCruz) (1:100), normal ankle (lane a,
tallus, male, age not recorded) (13901), normal (lane b, tibia plateaux, male, age not
recorded) (13949), OA II (lane c, femoral head, male, age 83) (13828), two bands with
different sizes, 47 and 55 kD sizes, were detected. C) By using mouse mAb anti-CD47
2B7 (1:500), normal (lane b, femoral head, male, age 70) (13822) and OA III (lane c,
tibia plateaux, female, age 87) (13965) chondrocytes derived from different joints
expressed an ~50 kD single band. The blots shown, are representative a series of
experiments including at least three different donors (normal and OA). Molecular
weights (MW) in kilo Daltons (kD) are indicated on the left. *,(day book No.)
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3.2. IN VIVO AND IN VITRO EVALUATION OF CD98 IN
HUMAN ARTICULAR CARTILAGE
To evaluate in vivo expression of CD98 in normal articular cartilage, a series of
immunohistochemical staining was undertaken on frozen sections of articular cartilage
from femoral head and different anatomical regions of knee joint (femoral condyle, tibial
plateaux or patella).
CD98 expression on chondrocytes cell membrane was assessed using mouse mAb anti-
CD98 4F2. Preliminary s tudies showed that this mAb worked with frozen sections at
1:50 dilution, but not with formalin fixed, paraffin embedded sections.
The positive immunoreactivity in different sections was graded in a range of 1-5. CD98
staining for each zone was scored as: 1, no staining; 2, more cells negative than positive;
3, equal positive and negative; 4, more cells positive than negative; and 5, all cells
positive (see chapter two, 2.3.6, page 90). Each zone of cartilage sections was evaluated
and scored separately.
3.2.1. Expression of CD98 in normal human articular cartilage
Sixteen sections of normal articular cartilage were obtained from 4 males (age range 39-
73, mean 55) and 7 females (age range 67-83, mean 75). Normal articular cartilage
sections were isolated from 5 femoral heads, all female (age range 73-90, mean 79)
(13857,13835, 13836, 13818, 13867); 6 femoral condyles, 2 males, 3 females, one case
whose age and sex was not recorded (age range 39-74, mean 64) (10070, 10097, 11271,
11045, 11051, 13860); 6 tibial plateaux, 2 males, 3 females, one case whose age and sex
was not recorded (age range 44-73, mean 63) (11417, 10097, 10070, 11045, 11329,
13860) and one patella (male, age 39) (11286).
Immunoreactivity was characterized by a heterogeneous staining pattern (Figure 3.5).
Some cells were positive, others negative. Chondrocytes in all zones of normal articular
cartilage sections isolated from different joints showed positive immunoreactivity with
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an identical expression pattern. The median scores (ranges) for surface, superficial, mid
and deep zones were 4 (2-5), 4 (3-5), 4 (2-4) and 4(2-4), respectively. There was no
statistical difference in immunoreactivity of surface and deep zone (Table 3.3).
The age and sex of donors had no noticeable effect on the pattern ofCD98 expression.
3.2.2. Expression of CD98 in OA human articular cartilage
CD98 expression was assessed in 17 mild (3 grade I and 14 grade II) and 7 severe OA
(6 grade III and 1 grade IV) articular cartilage sections. Samples of OA articular
cartilage were obtained from 8 males (age range 62-85, mean 74), 9 females (age range
67-90, mean 75) and one case whose age and sex was not recorded. Sections of mild OA
articular cartilage were obtained from 5 femoral heads, 1 male, 4 females (age range 73-
90, mean 79) (13857, 13836, 13835, 13818, 13871); 4 femoral condyles, 1 male, 2
females, 1 case whose age and sex was not recorded (age range 67-74; mean 71) (10097,
11271, 11104, 13860); 6 tibial plateau, 2 males, 3 females, one case whose age and sex
was not recorded (age range 67-85, mean 73) (11417, 11271, 10097, 11045, 11104,
13860); and 3 patellae, all male (age range 64-74, mean 67) (11104, 11051, 9907).
Samples o f severe OA articular cartilage were obtained from 4 femoral c ondyles, all
male (age range 62-82, mean 72) (11370, 11045, 9907, 13817); 1 tibial plateaux, male
(age 62) (13817) and 2 patellae, both male (age range 73-82, mean 78) (10071,11045).
Articular cartilage from mild OA (grades I and II) exhibited a heterogeneous staining
pattern in all zones of different joints. The median scores and ranges for surface,
superficial, mid and deep zones were 4 (3-5), 4 (3-5), 4 (2-5) and 4(2-5), respectively. In
severe OA sections (grades III and IV), chondrocytes in clusters and in areas of surface
fibrillation showed the similar heterogeneous expression pattern with other zones
(Figure 3.6). The median scores and ranges for clones, superficial, mid and deep zones
were 4 (3-5), 4 (3-5), 4 (3-5) and 4(3-5), respectively.
There was no detectable difference in the pattern of CD98 expression between normal
and different grades of OA (Table 3.3). The age and sex of donors had no noticeable
effect on the pattern of CD98 expression.
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Table 3.3. Immunoreactivity of CD98 in different normal and OA articular cartilage
sections, isolated from hip (femoral head) and knee (tibia, femoral condyle and patella)
joints, was assessed. The positive staining was scored, as explained in chapter 2 (see
2.3.6, page 90), in a range of 1-5. In each zone, the mean ± SD of CD98 immunostaining
is shown. Each zone of cartilage from different donors was evaluated and scored
separately. Evaluation was performed three times. P value was calculated to compare
different zones in both normal and OA articular cartilage sections. In normal and mild
OA surface zone compared with all zones and P value was >0.05 (not significant). In




Sample n Surface Superficial Clones Middle Deep
Normal 16 3.810.2 410.1 3.510.1 3.5+0.1
Mild OA 17 4.210.1 3.810.1 3.510.12 3.510.2





Figure 3.5. Immunoreactivity of mAb anti-CD98 4F2 in normal adult human
articular cartilage sections. CD98 positive and negative chodrocytes were assessed in
all different zones of normal articular cartilage by using 4F2 mAb at 1:50. A, Femoral
head, superficial-deep zone, (female, 74) (13836), xlOO. In all zones from surface
towards deep zone, chondrocytes showed a heterogeneous pattern for CD98 expression.
B, Tibial plateaux, mid-zone, (female, 72) (11417), x200. Chondrocytes in mid zone
showed a similar heterogenous pattern with the other zones. C, Femoral condyle, normal
(FN), mid-zone, (female, 74) (11271), x400. High magnification of chondrocytes in
mid-zone of TN, with heterogeneous expression of CD98. D, Negative control, femoral
head, mid zone (female, 83) (13835), x200. No positive signal at all was observed in F/H








Figure 3.6. Immunoreactivity of mAb anti-CD98 4F2 in OA human articular
cartilage sections. CD98 positive and negative chodrocytes were assessed in all
different zones ofOA articular cartilage by using 4F2 mAb at 1:50. A, Femoral condyle,
OAIII, (male, age 62) (13817), surface-deep, xlOO. From clones towards deep zone of
OA femoral head, all chondrocytes showed a similar heterogeneous expression pattern
for CD98 .B, Tibial plateaux, OAII, (female, age 67) (10097), mid-zone, x200.
Chondrocyte in mid-zone showed a similar heterogeneous pattern of CD98. C, Femoral
head, OA II, (female, age 74) (13836), surface-mid zone, x400. High magnification of a
clone from FAII showed heterogeneous expression of CD98. D, Negative control,
femoral head, (female, age 83) (13835), mid-zone, x200. No positive signal at all was
observed in F/H section as negative control.
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3.2.3. In vitro evaluation (western blotting analysis) of CD98 in human
articular chondrocytes
CD98 is a heterodimeric cell membrane glycoprotein consisting of an 85 kD heavy chain
(HC) and a 40 kD light chain (LC). CD98 is expressed in various normal cells and
tumour cells (Hemler and Strominger 1982). To confirm the in vivo
immunohistochemical results, a series of western blot experiments was carried out.
Chondrocytes were obtained from hip, knee and ankle joints.
Normal chondrocytes were isolated from 3 talus, 1 tibia (ankle), all male (age range 69-
80, mean 73); 2 femoral condyles, both male (mean age 75) (13901, 13907, 13915,
13920); 1 tibial plateaux, male (age 72) (13941); 3 femoral heads, 2 males and one
female (age range 70-83, mean 78) (13828, 13816, 13822). OA chondrocytes were
isolated from 5 femoral condyles, 1 grade I, 1 grade II, and 3 grade III), 4 males, 1
female (age range 69-87, mean 76) (13964, 13939, 13905, 13918, 13924); 2 tibial
plateaux, both grade II and female (age range 68-74, mean 71) (13820, 13938). Primary
chondrocytes were seeded at 2xl05 cells/ml concentration. After a period of 10-15 days
cultured chondrocytes were lysed and the proteins extracted. Extracts from normal and
OA chondrocytes taken from different joints were analyzed and probed with one
polyclonal goat anti-CD98 (SantaCruz) antibody at 1:500. Cell lysates obtained from
cultured chondrocytes, isolated from normal and OA cartilage, were analyzed under
reducing conditions and probed with goat polyclonal anti-CD98. A similar single band at
-85 kD was expressed by normal and OA chondrocytes (Figure 3.7.A), Cell lysates
from normal and OA chondrocytes were also separated under non-reducing conditions
and probed with the same polyclonal goat anti-CD98. These samples expressed an
approximately 125 kD protein band (Figure 3.7.B), The intensity of the CD98 band in
normal and OA extracts from different donors with different age and sex under reducing
and non-reducing conditions was similar. A stronger band was detected in cell extracts
obtained from ankle chondrocytes when compared with normal and OA of the other
joints in both reducing and non-reducing conditions (Figure 3.7. A, B).
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Figure 3. 7. Recognition and comparison of CD98 in normal and OA human
articular cartilage. Equal amounts (40pg/lane) of total cellular proteins prepared from
the cultured articular chondrocytes derived from normal ankle (lane a), normal (lane b)
and OA (lane c) knee and femoral head were run in a 10% SDS-PAGE under reducing
(A) and non-reducing conditions (B). Goat polyclonal anti-CD98 (1:500) was used in
both conditions. Eleavy chain of CD98, ~85 kD MW, expressed in chondrocytes isolated
from ankle (lane a, (tallus), male, age not recorded) (13901), normal femoral head (lane
b, male, age 70) (13822), and OA (lane c, tibial plateaux, female, age 87) (13965)
cartilage under reducing conditions (A). Total molecule, -125 kD MW, expressed in
chondrocytes isolated from ankle (lane a, talus, male, age 69), normal femoral condyle
(lane b, male, age 80), and OA III femoral condyle (lane c, male, age 87) cartilage under
non-reducing conditions (B). Stronger band was observed in normal ankle in comparison
to normal and OA knee and femoral head. The blots shown are representative a series of
experiments including at least three different donors (normal and OA). Molecular
weights (MW) in kilo Daltons (kD) are indicated on the left.
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3.3.0. IN VIVO AND IN VITRO EVALUATION OF
GALECTIN-3 IN HUMAN ARTICULAR CARTILAGE
To assess the in vivo expression pattern and determine precise immunolocalization of
galectin-3 in normal and OA articular cartilage, paraffin sections isolated from normal
ankle, femoral heads, and different anatomical regions of knee (femoral condyle, tibia
plateaux and patella) were assessed by using immunohistochemical assessment.
Immunohistochemical assessment was performed by using a mouse ani-galectin-3 mAb
(9C4) at 1:400. Preliminary studies showed that this mAb was worked very well with
paraffin embedded sections.
The positive immunoreactivity in different sections was graded in a range of 1-5.
Galectin-3 staining for each zone was scored as: 1, no staining; 2, more cells negative
than positive; 3, equal positive and negative; 4, more cells positive than negative; and 5,
all cells positive (see chapter two, 2.3.6, page 90). Each zone of cartilage sections was
evaluated and scored separately.
3.3.1. Expression of galectin-3 in normal human articular cartilage
Thirty five sections of normal articular cartilage were obtained from 9 males (age range
64-92, mean 76), 6 females (age range 57-90, mean 79) and 2 cases whose age and sex
were not recorded.
Normal articular cartilage sections were isolated from 4 tibia, 3 males, 1 female, 4 talus,
2 males, 2 females, 1 fibula, male and 1 calcaneous, female, from 5 normal ankles, 3
males, 2 females (age range 71-80, mean 77) (13901, 13904, 13906, 13915, 13919); 7
femoral heads, 3 males, 4 females, (age range 72-90, mean 82), (13837, 13876, 13822,
13828, 13893, 13857, 13835); 1 femoral condyle, male (age 80) (13919); 4 tibia
plateaux, 3 males, 1 female (age range 57-87, mean 70) (13888, 13855, 13905, 13904).
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The pattern of expression in all sections showed significant difference between surface
and the other zones (P<0.001) (Table 3.4). The immunoreactivity (cytoplasmic
expression of galectin-3) increased progressively from surface towards the deep zone.
The median scores and ranges for surface, superficial, mid and deep zones were 3 (2-4),
4 (2-5), 4 (2-5) and 4(3-5), respectively. Articular cartilage isolated from different joints
showed a s imilar e xpression p attern (Figure 3.8). The a ge and s ex o f donors h ad n o
noticeable effect on the pattern of galectin-3 expression in different joints.
3.3.2. Expression pattern of galectin-3 in OA human articular cartilage
To assess the expression pattern and determine precise immunolocalization of galectin-3
in OA articular cartilage, 11 mild (2 grade I and 9 grade II), and 6 severe OA (5 grade III
and 1 grade IV), isolated from femoral heads, and different anatomical regions of knee
(femoral condyle, tibia plateaux and patella) were assessed by using
immunohistochemical experiments. Samples of OA articular cartilage were obtained
from 5 males (age range 64-92, mean 79), 9 females (age range 57-90, mean 79) and one
case whose age and sex was not recorded.
Samples of mild OA articular cartilage were obtained from 2 males (age range 64-92,
mean 78) and 5 females (age range 57-90, mean 78). These samples were isolated from
7 femoral heads, 4 males, 3 females (age range 71-92, mean 83) (13893, 13857, 13828,
13822, 13876, 13837, 13835); 1 femoral condyle, male (age 64) (13855); 2 tibial
plateaux, 1 male, 1 female (age range 57-64, mean 60) (13855, 13904) and 1 patella,
male (age 80) (13919). Articular cartilage from mild OA grades I and II exhibited
significant difference between expression pattern of surface and the other zones
(P<0.001). The median scores and ranges for surface, superficial, mid and deep zones
were 2 (2-4), 4 (2-4), 4 (2-4) and 4(3-5), respectively. The pattern of galectin-3
expression in mild OA sections was similar to normal articular cartilage sections. In
normal and mild OA cartilage sections, mid and deep zone chondrocytes in all samples
showed stronger immunoreactivity in comparison to surface zone which fewer cells
were positive.
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Samples of severe OA articular cartilage were obtained from 3 males (age range 73-87,
mean 80), 3 females (age range 71-86, mean 79). These samples were isolated from 4
femoral condyles, all male (age range 73-80, mean 80) (13888, 13919, 13905, 133901);
2 tibial plateaux, both male (age range 64-87, mean 75)(13855, 13905).
Chondrocytes in all zones of severe OA cartilage sections (n= 6) showed a similar strong
expression of galectin-3 (Table 3.4). Clones of degenerated surface zone showed
stronger expression of galectin-3 in comparison to the surface zone of normal and mild
OA. The median scores and ranges for clones, superficial, mid and deep zones were 4
(4), 4 (4), 4 (4-5) and 4.5(4-5), respectively. Galectin-3 expression pattern in various
zones of severe OA sections was similar (P>0.05). In severe OA, chondrocytes of
clusters, showed strong immunoreactivity of galectin-3, as did chondrocyte of various
zones (Figure 3.9).
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Table3.4. Immunoreactivity of galectin-3 in cytoplasm of chondrocytes isolated from
normal, mild and severe OA articular cartilage sections. Significant difference was
observed between surface and the deep zone of normal and mild OA articular cartilage
(P<0.001). In contrast, different zones of severe OA sections did not show significant
difference in galectin-3 expression (P>0.05). Chondrocytes in all zones of severe OA
sections (grades III and IV) showed strong expression of galectin-3. The positive
staining was scored in a range of 1-5. In each zone, the mean ± SEM of galectin-3
immunostaining by chondrocytes is shown. Each zone of cartilage from different donors
was evaluated and scored separately. Evaluation was performed t hree times and then
statistically analysed. In normal sections surface zone compared with the o ther zones
and P value was <0.001 (significant). In mild OA surface zone was compared with the
other zones :surface and superficial P value >0.05 (NS)*, surface and mid-zone >0.05
(NS) and surface and deep zone P value < 0.001 (significant). Severe OA clones grade
was compared with the other zones and P value was >0.05 (not significant). All zones in
severe OA sections showed a similar strong expression of galectin-3.
Immunostaining Score
mean ± SEM
Sample n Surface Superficial Clones Middle Deep
Normal 35 2.810.1 3.510.1 3.710.1 4.410.1
Mild OA 11 2.710.2 3.310.2 3.4 + 0.2 4.310.1
Severe OA 6 N/A** N/A 4 4.3 10.2 4.810.1
*, NS, not significant
**, N/A, not available.
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Figure 3.8. Histochemical localization of cytoplasmic expression of galectin-3 in
normal human articular cartilage sections. Chondrocytes from normal articular
cartilage sections showed positive galectin-3 immunoreactivity in comparison to
negative controls. The sections were immunostained by standard ABC method using
mouse mAb anti-galectin-3 (9C4) (1:400) and DAKO detection kit. A, Femoral
condyle, normal (FN) (male, age 80) (13919), superficial-mid zone, xlOO. Galectin-3
immunoreactivity is increased from surface towards the deep zone. B, Tibial plateaux,
male, (age 73) (13888), Mid-deep zone, xlOO. Chondrocytes in middle zone showed
strong expression of galectin-3. C, Tibia (ankle), (male, 80) (13901), mid-zone, x400.
High magnification of chondrocytes in mid-zone of Tibia, with strong expression of
galectin-3. D, Negative control, talus (ankle) (female, 80) (13908), mid-zone, xlOO. No
positive signal at all was observed in this section as negative control.
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Figure 3.9. Histochemical localization of cytoplasmic expression of galectin-3 in OA
human articular cartilage sections. Chondrocytes from OA articular cartilage sections
showed positive galectin-3 immunoreactivity in comparison to negative controls. The
sections were immunostained by standard method using mouse mAb anti-galectin-3
(9C4)( 1:400) and DAKO detection kit. A, Tibial plateaux, OAIII, (male, age 87)
(13905), surface-deep zone, xlOO. All zones showed a similar strong expression of
galectin-3. B, Femoral condyle OA, FAIII, (male, 80) (13901), mid-zone, x200.
Chondrocytes in middle zone showed strong cytoplasmic staining for galectin-3. C,
Clone in tibial plateaux, OAIII, x400 (male, 87) (13905). Clones in severe OA sections
showed strong expression of galectin-3. D, Negative control, talus (ankle), (female, 80)
(13908), mid-zone, xlOO. No positive signal at all was observed in this section as
negative control.
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3.3.3. In vitro evaluation (western blotting analysis) of galectin-3 in
cultured human articular cartilage
Galectin-3 is a 30 kD carbohydrate-binding protein that plays a role in cell-cell and cell-
ECM interactions. To assess in vitro expression of galectin-3 in human articular
chondrocytes, analysis of the whole cell lysates obtained from normal and OA cultured
human articular chondrocytes was performed.
Normal samples were obtained from ankle (3 talus, 1 tibia), all male (age range 69-80,
mean 73) (13901, 13907, 13915, 13920); 2 femoral condyles, both male (mean 71)
(13939, 13941); 1 tibial plateaux, male (age not recorded) (13949); 3 femoral heads, 2
males and one female (age range 70-83, mean 78) (13828, 13816, 13822). OA samples
were obtained from 1 femoral condyle (grade II), male (age 69) (13939); 3 tibial
plateaux, (1 grade II, 2 grade III), all female (mean age 76) (13965, 13938, 13820); 2
femoral heads, both grade II, 1 male, 1 female (age range 87-95, mean age 91) (13828,
13821). Cultured primary chondrocytes at 2xl05 cells/ml concentration for a period of
10-15 days, were lysed and their proteins extracted. Extracts from normal and OA
cultured chondrocytes taken from different joints were analysed and probed with
monoclonal anti-galectin-3 (9C4) antibody at 1:500.
A similar 30 kD band was expressed by normal and OA chondrocytes obtained from
knee and femoral head, under reducing conditions (Figure 3.10. b, c). The band
expressed from normal and OA chondrocytes did not show identifiable modification. All
extracts obtained from chondrocytes isolated from mild and severe OA, removed from
donors of different age and sex, when separated under reducing conditions and probed
with anti-galectin-3 monoclonal (9C4) antibody, showed a single band at ~30 kD
(Figure 3.10). The intensive of galectin-3 band in normal and OA extracts from
different joints or donors with different age and sex under reducing conditions was
similar. A stronger band of galectin-3 expression in the same amount of whole cell
lysate extracted from normal ankle chondrocytes was detected (Figure 3.10. a), when
compared with the band obtained from normal and OA cultured chondrocytes from knee
and femoral head.
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Figure 3.10. Recognition and comparison of galectin-3 expression in normal and
OA human articular cultured chondrocytes. Equal amounts (40pg/lane) of total
extracted proteins prepared from the cultured chondrocytes derived from normal ankle
(lane a, tibia, male, age 80) (13920)*, normal (lane b, femoral condyle, male, age 69)
(13939) and OAIII (lane c, tibial plateaux, female, age 79) (13938) were run in a 15%
SDS-PAGE under reducing conditions. The detection of galectin-3 was assessed by
probing the blots with mouse mAb anti-gal-3 (9C4) at 1:500. The stronger expression of
galectin-3 in chondrocytes derived from normal ankle in comparison to knee and
femoral head was detected. The blot shown is representative a series of experiments
including three different donors (normal and OA). Molecular weights (MW) in kilo
Daltons (kD) are indicated on the left.
*, (day book No.)
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3.4.0. DISCUSSION
Cell-ECM interactions play a crucial role in cellular functions such as cell adhesion and
mechanotransduction. Integrins, heterodimeric molecules, which are type I
transmembrane glycoproteins, mediate these interactions. Extracellular domains of
integrin subunits constitute the ligand binding domain(s) of these receptors.
Cytoplasmic domains of integrins interact with the actin cytoskeleton and membrane ion
channels and provide a physical connection between the internal and external
environments. Therefore, integrins are signalling receptors that transmit information in
both directions across the plasma membrane and provide an intersection where
mechanical forces, cytoskeletal organization and biochemical signals meet (Hynes 1992;
Aplin et al 1998). It has been previously suggested that a5pi integrin acts as a
mechanoreceptor in human articular cartilage (Wright et al 1997; Salter et al 2001).
Since integrins, such as a5pi integrin have no intrinsic enzymatic activity of their own,
and also are not phosphorylated, they must interact with other proteins to generate
signals (Damsky and Werb 1992).
In order to find a cell surface accessory molecule(s) for a5pi integrin, the first step of
this investigation was focused on the detection and comparison in vivo expression of
three integrin-related proteins, CD47/IAP, CD98 and galectin-3, in normal and OA
human articular cartilage. One of the objectives of this study was to determine whether
integrin-related proteins CD47, CD98 and galectin-3, are expressed in human articular
cartilage and to compare the topographical and zonal distribution of these proteins in
normal and OA cartilage. It was noted that alterations in the expression or activity of one
or more of the molecules involved in the signal transduction pathway could conceivably
modify the response of diseased chondrocytes.
Human articular cartilage is an inhomogeneous tissue, with variation in matrix
composition, chondrocyte morphology, and metabolism occurring with depth from the
articular surface. Previous studies have demonstrated that cells isolated from different
zones of articular cartilage retain their morphological and metabolic characteristics when
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maintained in homogeneous cell culture conditions such as monolayer (Aydelotte et al
1988; Lee et al 1993) and agarose culture (Lee and Bader 1995,1997). Variation in the
behavior of subpopulations of chondrocytes can be maintained in culture for as long as 3
weeks, demonstrating that intrinsic differences between subpopulations do exist (Lee et
al 1998).
3.4.1. In vivo and in vitro expression of CD47 in human articular
cartilage
This study showed the presence of IAP/CD47 in normal and OA articular cartilage.
CD47 strongly expressed on the plasma membrane of chondrocytes in all zones by
human chondrocytes in both normal and OA human articular cartilage. There was no
topographical variation in the expression of CD47 in either normal or OA articular
cartilage. Different grades ofOA did not show any modification in strong expression of
CD47 in all zones of articular cartilage. There was no significant alteration in staining
pattern between different cases.
Biochemical analysis of both normal and OA cultured chondrocytes obtained from
different joints expressed a band at nearly 50 kD as CD47. In vitro results were
consistent with in vivo immunohistochemical studies. In addition, in vitro results
showed two bands, which could be due to glycosylation of CD47, which is discussed in
previous studies (Mawby et al 1994, see below). This supports the extensive expression
of CD47 and this cell surface protein might be important in chondrocyte function
potentially mechanotransduction.
CD47 is a multiple membrane-spanning IgSF member of ~50 kD molecular weight
(MW), and a number of cell types are recognized to express this molecule. Brown et al
(1990) have initially demonstrated that CD47 is expressed on the plasma membrane of
all hematopoietic cells, such as T cells (Reinhold et al 1997), neutrophils (Parkos et al
1996), mast cells (Ghannadan et al 1998), bone marrow stromal cells and spleen
(Furusawa et al 1998) and erythrocytes, which express no known integrins (Brown et al
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1990). Non-haematopoietic cells such as mesenchymal cells (Wang et al 1998),
epithelial and endothelial cells (Parkos et al 1996), fibroblasts and brain (Mawby et al
1994; Jiang et al 1999) express CD47 as well. Campbell et al (1992) have also shown
that the tissue distribution of CD47/IAP is ubiquitous, by examining mRNA (Northern
blot studies) from a variety of tissues including heart, skeletal muscle and lung. Mawby
et al (1994) have reported a strong expression pattern of CD47 in brain in comparison to
variable expression in different layers of epithelia such as skin by using
immunohistochemical studies. This is the first study detailing the topographical and
zonal distribution of IAP/CD47 in normal and OA human articular cartilage.
IAP is expressed in essentially all tissues, but the four alternatively spliced forms of IAP
mRNA have distinct tissue distribution such as forms 1 and 2 in human keratinocytes,
only form 2 in human umbilical vein endothelial cells, and form 4 in a nasal epithelial
carcinoma cell line (2650). Much of the form 2 found in many tissues arises from
endothelium, interstitial fibroblasts, or resident lymphocytes and macrophages. Form 4
is expressed predominantly by neural tissue (Reinhold et al 1995). The two most
common CD47 are the isoforms 2 and 4. Variation in the function of CD47 may be due
to alternative splicing of mRNA and the production of four isoforms of different
molecular weights. The pattern of CD47 expression on cultured chondrocytes, following
biochemical analysis, shown in the present study suggests that the molecule may exist in
more than one form, possibly due to differential glycosylation or to the variation in
existence of four isoforms on different cell types. CD47 has six potential N-
glycosylation sites, five of which are in an Ig superfamily domain (Campbell et al 1992;
Mawby et al 1994). Mawby et al (1994) have shown that three of these sites carry N-
glycans in erythrocytes and deglycosylation of erythrocyte CD47 generated components
of 26-26.5 kD, together with a defined band of approximately 30 kD and a mature
protein band at 50 kD as well. These studies suggest that the pattern of CD47
glycosylation is varied in different cell types and may change under cellular certain
conditions.
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Another possible explanation for expression of two different bands with differential
molecular weight in a range of 47-55 kD was the presence of two isoforms of CD47 for
this protein in chondrocytes. As shown previously, both by RT-PCR and
immunohistochemistry, there is cell-type specificity of expression of the different IAP
isoforms.
Eight mAbs and one polyclonal Ab were tested to evaluate the biochemical
characterization of CD47 molecule on chondrocytes and find out which one works with
western blotting. Four antibodies were not suitable for western blotting, which may be
because of denaturation or modification of epitopes during the procedure. The presence
of specific conformational epitopes on the CD47 molecule may have different functions
in antigen presentation and this could be due to the certain conditions of chondrocytes.
Since CD47 and P3 integrin were physically and functionally associated, CD47 was
initially called integrin-associated protein (IAP) (Brown et al 1990; Lindberg et al 1994).
CD47 has been shown to associate with integrins in multiple cell types (Porter and
Hogg 1998) in different cellular functions such as integrin-mediated calcium influx in
endothelial cells (Schwartz, 1993), cell adhesion (Lindberg et al 1996) and cell
migration (Wang et al 1998). Thus, it is possible that the functions of IAP extend beyond
integrin signal transduction. In addition, it has been shown that in human bone cells
(HBC), anti-CD47 Brie 126 antibody inhibits the integrin-mediated hyperpolarization
response induced by 0.33 Hz mechanical stimulation (Salter et al 1997). Furthermore,
recently Graf et al (2003) have demonstrated a common role of CD47/integrin complex
in multiple mechanical stimuli and different cell types.
A variety of data suggests that CD47 functions as a signalling molecule. The strong
expression of CD47 in normal and OA articular cartilage and the known ability of CD47
to act as an integrin accessory protein suggest that chondrocyte CD47 would have a
signalling function. Similarly, strong expression of aipi, a5pi and
aVp5 integrins (Woods et al 1 994), and especially a5pi integrin in vivo (Salter et al
1992) and in vitro (Loeser et al 1995) in articular cartilage have been previously
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reported. In addition, the critical role of a5pi integrin in integrin-mediated response of
articular chondrocytes to mechanical stimulation and acting as a mechanoreceptor
(Wright et al 1997; Salter et al 2001, 2002) suggests a parallel function of CD47 and
a5pl integrin. CD47 showed an expression pattern similar to a5pi integrin on
chondrocytes, and also has a potential to act as an accessory molecule for a5pi integrin
in articular cartilage. These suggest a functional role for CD47 in integrin-mediated cell
matrix interactions in human articular cartilage.
It has been previously shown that CD47 is involved in integrin-independent functions in
multiple cell types (Cooper et al 1995; Frazier et al 1999; Ticchioni et al 1997; Reinhold
et al 1997; Waclavicek et al 1997; Wu et al 1999; Liu et al 2001). CD47 has integrin-
dependent and integrin-independent functions. Since IAP/CD47 is expressed on cells
independent of integrin expression (e.g., on erythrocytes), it may represent a molecule
involved in signal transduction for other receptors as well (Brown et al 1990). Studies of
the distribution of possible ligands such as thrombospondin-1 and SIRP-a would
suggest potential interaction. It has been previously reported that TSP-1 is expressed in
human articular cartilage (Miller and McDevitt 1988; DiCesar et al 1994; Pfander et al
2000). The interaction between TSP and CD47 induces the activation of autoreactive T
lymphocytes (Vallejo et al 2000), the spreading of platelets (Chung et al 1999) and
melanoma cells on fibrinogen (Gao et al 1996). These data raise the possibility that
chondrocyte CD47 recognizes a ligand present in the ECM of articular cartilage. It will
be important to establish CD47 ligand (s) in ECM of cartilage and to identify possible
functions of this molecule in cell signalling and regulation of chondrocyte activity both
in normal cartilage and in diseases such as OA. Thus, possible association between
TSP-1 and CD47, suggests a route by which CD47 may influence chondrocyte-matrix
interactions and mechanotransduction.
In summary, CD47 is strongly expressed on chondrocytes in normal and OA cartilage,
and its expression does not appear to be altered by age, site, or grade/progression of
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disease. This suggests that CD47 plays an important role in chondrocyte metabolic
functions, such as mechanotransduction.
3.4.2. In vivo and in vitro expression pattern of CD98 in human
articular cartilage
This study showed the presence of CD98 in normal and OA articular cartilage. CD98 is
expressed on the plasma membrane of chondrocytes in heterogeneous immunoreactivity
in both normal and OA adult human articular cartilage. There was no topographical
variation in the expression of CD98 in either normal or OA articular cartilage. Different
grades of OA did not show any modification in expression pattern of CD98 in all zones
of articular cartilage. The staining pattern in different cases did not show significant
alterations. Biochemical analysis showed that both normal and OA cultured
chondrocytes obtained from differentjoints expressed CD98. Consistent within vivo
immunohistochemical results, CD98 is expressed by cultured normal and OA articular
chondrocytes.
CD98 is a 125 kD disulphide-linked heterodimeric membrane glycoprotein, consisting
of an 85 kD glycosylated heavy chain and a 40 kD non-glycosylated light chain (Haynes
et al 1981). CD98 (4F2 antigen) was originally detected by a murine mAb raised against
the human T cell tumor line HSB-2 (Eisebarth et al 1980; Haynes et al 1981). This
antigen is expressed on all human tissue lines, the majority of malignant human cells,
and peripheral blood cells (Eisebarth et al 1980; Haynes et al 1981). This antigen has
also been detected in breast (Chandrasekaran et al 1999), keratinocytes (skin and hair
follicles) (Patterson et al 1984), and embryonic but not adult fibroblasts (Azzarone et al
1984).
The present study for the first time showed the expression of CD98 by human
chondrocytes in both normal and OA articular cartilage in a similar heterogeneous
pattern. The possible mechanisms for the heterogeneous expression pattern of CD98 in
either normal or OA articular cartilage are suggested by the other data. Initial reports on
CD98 showed expression to be predominantly restricted to activating T cells. CD98 is
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only expressed at low levels on resting T and B lymphocytes, a high level of expression
can be induced following stimulation of resting T cells. Thus, CD98 appears to be a
marker for cell activation and is found as well on monocytes (Haynes et al 1981;
Suomalainen 1986). In this study, variation of CD98 expression in articular chondrocyte
may reflect the following possibilities:
1. Chondrocyte heterogeneity
The recognized heterogeneity of chondrocytes is reflected in differences of metabolism
and cell shape (Aydelotte et al 1988; Siczowski and Watt 1990). It is also extended to
expression of cell receptor molecules, enabling chondrocytes to regulate their
interactions with the pericellular environment under certain conditions. Salter et al
(1995), using immunohistochemistry technique showed variation of integrin expression
by chondrocytes at different sites (articular, epiphyseal, growth plate, and meniscal
cartilage) in human fetal knees. Cells from the epiphyseal area showed findings
consistent with those obtained by Durr et al (1993). There was no expression of
|33, p4, p6, and the a3 subunit by chondrocytes (Durr et al 1993; Salter et al 1995).
Salter et al (1992, 1995) also demonstrated that fetal articular chondrocytes expressed
a2 and a6 integrin, whereas adult articular chondrocytes did not. This heterogeneity
may r eflect t he v ariation i n m orphology and m acromolecular c ontent d uring c artilage
development and maturation.
Previous studies have also demonstrated that the expression of cell surface molecules,
such as integrins, is preferentially related to their ligand molecule(s) that are
appropriately present in the pericellular matrix of human articular cartilage. Studies have
shown that annexin V, a receptor for type II collagen (Reid et al 2000), as well as CD44,
a receptor for hyaluronan (Aguiar et al 1999), are expressed by chondrocytes and
mediate interactions with cartilage matrix components. However, in a study using the
same adhesion assays, these molecules did not appear to play a major role in the
adhesion of bovine chondrocytes to bovine cartilage (Kurtis et al 2001). Integrin or non-
integrin receptors, may also mediate chondrocyte adhesion to cartilage. Nevertheless,
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under the certain conditions (Kurtis et al 2003), several integrins were implicated in
adhesion of chondrocytes to cartilage, whereas others were not. In addition, Woods et al
(1994) have demonstrated that mAbs to integrins, readily detected their target subunits
once chondrocyte integrins were freed from interactions with matrix components or
ligands. In this respect, this study focused on galectin-3, as a potential ligand for CD98,
but was unable to find a parallel pattern of expression of the two molecules in human
articular cartilage. The expression of galectin-3 was limited to intracellular in
chondrocytes. The zonal variation of galectin-3 immunoreactivity in normal articular
cartilage and significant difference between normal and OA cartilage in the expression
pattern of galectin-3 were the other dimensions of difference between CD98 and
galectin-3 expression. This is the first study that has shown the expression of CD98 and
its potential ligand, galectin-3, by chondrocytes and there is no more about the function
of this glycoprotein in cartilage.
2. Differential masking ofaccessibility of the anti-CD98 antibodies to chondrocyte
It is possible that because of CD98 interaction with ECM ligands epitopes recognized by
the antibody 4F2 used in this study could be masked. To look at this, It would be
possible to pretreat sections with proteases such as chondroitinase which will remove
ECM molecules. Alternatively, we could use a panel of antibodies against epitopes or
look at expression pattern other subpopulations of chondrocytes from cartilage. Cho et al
(2001) have reported that CD98 antibodies are highly heterogeneous both in function
and in the ability to bind to CD98 on the U937 cell surface. They have also
demonstrated that it seems unlikely that this heterogeneity simply reflects concentration
or affinity of the antibodies used, since each antibody was tested over a wide range of
concentrations. Thus CD98 molecule has heterogeneous biological characteristics.
In this respect, several groups have focused on the variation of the other cell surface
molecules such as integrin expression under some specific circumstances. Salter et al
(1995) have shown that a2 integrin immunoreactivity was similar to the distribution of
types I and III collagen in human fetal articular chondrocytes (Treilleux et al 1992).
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This suggested the possibility that expression of adhesive molecules is dependent in part
on the environment in which a chondrocyte finds itself. Both tenascin (Mackie et al
1987) and fibronectin (Dessau et al 1980) are variably expressed in developing limb
cartilage. In later stages of limb and joint development, it appears that molecules such as
fibronectin isoforms and tenascin may show differential expression in articular cartilage
and immature cartilages that will undergo maturation and be replaced by bone (Pacifici
et al 1 993). Evidence shows that integrins on a number o f c ells must b e activated to
function as adhesive receptors (Kieffer and Philips 1990; Philips et al 1991). Examples
exist of continued expression of inactive forms of some integrins, such as a5(31 and
a6|31, after differentiation of keratinocytes and retinal neurons (Neugebauer and
Reichardt 1991; Adams and Watt 1990). Studies have shown poor adherence in vitro of
freshly extracted adult articular chondrocytes to a variety of adhesion proteins, including
fibronectin and collagen, despite expression of appropriate receptors (Loeser 1993;
Salter et al 1995). However, adherence to these substrates was identified after a period in
monolayer culture. These findings suggested that mature chondrocytes may express low-
affinity receptors which are activated in culture conditions. Similarly, high affinity
receptors may be expressed by chondrocytes in vivo only when the appropriate stimuli
are present (Salter et al 1995; Loeser et al 1993).
The diversity of responses in which the 85 kD membrane protein, as CD98, has been
implicated, in multiple cell types, supports the notion that this molecule probably plays a
key role in cell signalling. The functional (Fenczik et al 1997; Warren et al 2000) and
physical (Miyamoto et al 2003) association between CD98 and CD29 ((31 integrin) in
the cell membrane are well documented and has led to the suggestion that CD98
signalling into the cell is in fact mediated via integrin activation. Several lines of
evidence suggest that CD98 may modulate the integrin-mediated functions such as T
cell co-stimulation (Warren et al 2000), integrin-dependent adhesion in two separate
studies (Fenczik et al 1997; Chandrasekaran et al 1999), cell fusion (Ohta et al 1994),
cell-cell fusion and aggregation (Tabata et al 1994) and amino acid transport (Pineda et
al 1999).
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A genetic screen revealed that CD98 might indirectly influence integrin affinity for
ligand. In particular, CD98 has been shown to stimulate pi integrin-mediated cell
adhesion to ECM (Fenczik et al 1997). Kolesnikova et al (2001) by using co-
immunoprecipitation have recently demonstrated that CD98 constitutively and
specifically associates with pi integrins (a2pi, oc3pi, a5pi, a6pi), but minimally with
a4pi. Recently, Rintoul et al (2003) have reported that cross-linking CD98 induced the
clustering of pi integrins to form high density complexes and proposed that CD98 acted
as a 'molecular facilitator' in the plasma membrane. This results in integrin activation,
integrin-like signalling, and anchorage-independent growth.
These findings reveal that CD98 can regulate different types of adhesion molecules
including integrins through distinct mechanism, reinforcing the notion that CD98 acts as
a critical protein in articular cartilage metabolism and mechanotransduction. Based on
these data so far, showing the functional and physical association between CD98 and
pi intgerins, it would be reasonable to test the idea that CD98 in articular cartilage
might form a physical or functional complex on the chondrocyte cell membrane that
potentially coordinates and regulates integrin-dependent functions and signalling in
articular cartilage. However, it is equally possible that CD98 has a dynamic role in
chondrocytes metabolic activity such as matrix receptor in cell-matrix interactions and
protein transport.
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3.4.3. Comparison of the expression pattern of CD98 and Galectin-3 in
human articular cartilage sections
Galectin-3 binds to CD98 heavy chain in both a human T cell line (Jurkat) and in murine
macrophage (WEHI-3) (Dong and Hughes 1997), but a direct link between galectin-3
binding to this surface antigen and its biological effect has not been demonstrated. This
suggested comparing the pattern of expression of CD98 and Galectin-3 in normal and
OA cartilage.
An objective of this project was to ascertain and compare the pattern of CD98 and
galectin-3 expression in normal and different grades of OA by using
immunohistochemical studies. Both CD98 and galectin-3 were expressed in human
articular cartilage. CD98 was expressed on cell membrane and galectin-3 expressed in
cytosol.
Compared with CD98 expression pattern, galectin-3 immunoreactivity observed in
human articular cartilage sections was strikingly different. There was no positive
relationship between the immunohistochemical staining score of CD98 and galectin-3.
Indeed, CD98 scores in all zones were moderate, and this pattern was similar
(consistent) in different grades of normal and OA cartilage sections. In contrast, a
statistical trend was observed for galectin-3 scores in various zones of normal and mild
OA sections. In addition, an upregulation pattern of staining in severe OA was observed.
Analysis of the data according to immunohistochemistry results revealed that the
expression of galectin-3 in human articular cartilage was significantly associated with
the zone of cartilage and the grade of OA disease. Whereas, CD98 expression
approximately in all zones of normal and OA articular cartilage sections showed a
similar heterogeneous pattern.
Thus, no detectable correlation was found between CD98 and galectin-3 expression
pattern in normal and OA human articular cartilage.
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In summary, although this study was unable to show an association between CD98 and
galectin-3 expression pattern in human articular cartilage, it seems that CD98 and
galectin-3 have the other roles in chondrocyte physiology.
3.4.4. Role for galectin-3 in human articular cartilage
This study has demonstrated that galectin-3 is expressed by human articular
chondrocytes. Galectin-3 is expressed in the cytoplasm of chondrocytes in both normal
and OA human articular cartilage. There was topographical variation in the expression
of galectin-3 in normal and mild OA articular cartilage. In both normal and mild OA
sections the immunoreactivity was increased progressively from surface towards the
deep zone. Severe OA did not show any modification in strong expression of galectin-3
in all zones of articular cartilage. The immunohistochemistry results from different cases
were consistent. Biochemical analysis showed that galectin-3 is expressed by cultured
normal and OA articular chondrocytes obtained from different joints.
Galectin-3 is a 30 kD galactoside-binding protein belonging to the galectin family. This
protein is composed of carboxyl-terminal carbohydrate recognition domain (CRD) and
amino-terminal tandem repeats. Galectin-3 normally distributes in epithelia of many
organs and various inflammatory cells, including macrophages, as well as dendritic cells
and kupffer cells (Flotte et al 1983). The expression of this lectin is up-regulated during
inflammation (Flotte et al 1983), cell proliferation (Moutsatsos et al 1987), and cell
differentiation (Liu et al 1995; Nangia-Makker et al 1993). Its expression is also affected
by neoplastic transformation, up-regulated in certain types of lymphomas (Hsu et al
1996; Konstantinov et al 1996) and thyroid carcinoma (Fernandez et al 1997; Xu et al
1995), while down-regulated in other types of malignancies, such as colon (Lotz et al
1993; Castronovo et al 1992), breast (Castronovo et al 1996), ovarian (vanden Brule et
al 1994), and uterine (vanden Brule et al 1996) carcinomas. It has been reported that the
expression of this lectin has a strong correlation with the grade and malignant potential
of primary brain tumors (Bresalier et al 1997), although there are conflicting reports on
the role of galectin-3 in cell adhesion and tumor metastasis. Increased galectin-3
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expression has also been noted in human atherosclerotic lesions (Nachtigal et al 1998).
These findings suggest that galectin-3 expression is affected during these physiological
and pathological responses.
Galectin-3 is mainly localized in the cytoplasm, although, depending on cell types and
differentiation stage, this protein can also be detected in nucleus, on cell membrane, or
extracellularly (Barondes et al 1994). Therefore, it has been reported to function through
both intracellular and extracellular actions.
1. Intracellular functions: Galectin-3 has been identified as a component of
heterogeneous nuclear ribonuclear protein (hn RNP) (Laing and Wang 1988), a factor in
pre-mRNA splicing (Dagher et al 1995), and prevent leukemia T cell apoptosis, that is
probably mediated through interaction with the Bcl-2 family members (Yang et al
1996).
2. Extracellular (Exogenous) functions: Galectin-3 has long been suspected of
modulating cell to ECM interaction in a novel fashion (Barondes et al 1994; Ochieng et
al 1998). In vitro studies have suggested that galectin-3 is involved in a variety of
processes, such as cell-cell or cell-ECM interactions, and it could be act as a signalling
molecule (Hughes et al 1992, 1994; Mehul et al 1995).
It has been reported that this protein is secreted from monocytes/macrophages (Cherayil
et al 1989; Sato and Hughes 1994) and epithelial cells (Sato et al 1993; Lindstedit et al
1993), and demonstrated to function as an extracellular molecule in activating various
types of cells, including monocytes/macrophages (Liu et al 1995), lymphocytes (Hsu et
al 1996; Dong and Hughes 1996), neutrophil (Yamaoka et al 1995) and mast cells
(Frigeri et al 1993; Zuberi et al 1994). Sano et al (2000) have reported that extracellular
(exogenously added) galectin-3 acts as a novel chemokinetic for monocytes and
macrophages in inflammation process.
Dong and Hughes (1996) have initially shown that galectin-3 stimulated uptake of
2_|_extracellular Ca in human Jurkat T cells. They have also shown that exogenous
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galectin-3 binds to surface glycoproteins, including CD98, in the human lymphoblastoid
Jurkat T cell line (Dong and Hughes 1995, 1996). It has been recently shown that
galectin-3 has a role in recirculation and shuttling of important molecules such as
pi integrin that results in limiting their expression on the cell surface, remodelling the
cytoskeleton and modulating cell spreading and adhesion (Furtak et al 2001).
Galectin-3 treated human monocytes upregulate production of IL-1 (Jeng et al 1994). A
number o f c ytokines h ave b een i mplicated i n t he p athogenesis o f OA, predominantly
through regulation of matrix metalloproteinase (MMP) production (see 1.2.3, page 24).
Evidence from work in other fields has indicated that galectin-3 may also regulate
cytokines production and function (Sano et al 2000). The ability of galectin-3 to enhance
the production of IL-1 is of significance, as this cytokine is recognized as mediator of
joint destmction.
The data from other studies and the present study suggest the following possible
functions of galectin-3 in articular chondrocytes:
1. Anti-apoptotic molecule
Matarrese et al (2000) have shown that galectin-3 overexpression in human breast
cancer cells leads to a series of modifications, including cytoskeleton rearrangement of
cell spreading as well as surface expression of a4 and P7 integrins, which resulted in
increased cell adhesion and prolongs the survival of the cells and confers resistance to
cell death by apoptosis. The antiapoptotic effect of galectin-3 appears to result from the
ability of this molecule to heterodimerize with Bcl-2 protein, a well known suppressor of
apoptosis (Yang et al 1996). Galectin-3 immunoreactivity has never been detected in the
extracellular cartilage or bone matrices, suggesting that the protein is not s ecreted in
cartilage and bone (Colnot et al 1999). The present study confirmed that galectin-3 is
expressed as a cytoplasmic protein in articular chondrocytes from different joints.
Several lines of evidence have previously indicated that galectin-3 is i nvolved in the
cascade of cellular events, occurring in chondrocytes, as they enter programmed cell
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death in the zone of calcification (Bronckers et al 1996; Ohyama et al 1997; Roach
1997). Galectin-3 is an anti-apoptotic molecule in breast carcinoma cell line BT549
(Akahani et al 1997) and its over production confers resistance to programmed cell death
induced by anti-Fas antibody and staurosporine in human leukemia T-cells (Yang et al
1996) and human breast epithelial cells (Matarrese et al 2000). The effect of galectin-3
seems to be mediated via binding to Bcl-2, a proto-oncogen protein suppressor of
apoptosis. Bcl-2 is present in chondrocytes of epiphyseal plate cartilage (Wang et al
1997) whereas it may be involved in the survival of early maturing chondrocytes. The
spatio-temporal distribution ofBcl-2 and galectin-3 in the plate cartilage are very similar
(Colnot et al 1998, 1999).
Colnot et al (2001) have also reported that the g alectin-3 null mutation in mouse has
several effects on chondrocyte differentiation, most notably premature cell death of
chondrocytes without concomitant vascular invasion in the metaphysis during
endochondral bone formation. This suggested that there is intracellular regulation of
chondrocyte apoptosis by molecules implicated in programmed cell death, like the
proto-oncogene Bcl-2 (Aiming et al 1997; Wang et al 1997).
2. Chondrocyte differentiation and endochondral ossification
Studies have demonstrated a role for galectin-3 in chondrocyte differentiation (Fowlis et
al 1995; Colnot et al 1999, 2001) and endochondral ossification (Colnot et al 1998,
1999, 2001). Fowlis et al (1995) have shown that in the midgestation mouse embryo, the
major site of galectin-3 expression is the cartilage. Colnot et al (1999) have shown that
subcellular distribution of the protein in growth plate chondrocytes of fetal and neonatal
mice is mainly cytoplasmic, with high amounts detectable in mature and early
hypertrophic cells. These results suggested an intracellular function for galectin-3 in
terminal differentiation of chondrocytes and galectin-3, considered to be a general
cytoplasmic marker of the differentiation chondrocytes.
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It also could possibly result from a role of galectin-3 as an adhesion or a signalling
molecule promoting vascular invasion since it has been shown to induce endothelial cell
morphogenesis and angiogenesis in vivo (Nangia-Makker et al 2000). An increase in
expression of galectin-3 in advanced stages of OA may occur as a result of the
imbalance in chondrocyte homeostasis that occurs in OA cartilage and provides a
condition to modify normal chondrocyte to an OA chondrocyte.
Because galectin-3 influences cell growth and repair in peripheral nerve injury in
nervous system (Pesheva et al 1998), it may also be important for the growth and injury
protection of the cartilage tissue in grades III and IV OA that are advanced stages ofOA
degradation. Thus, it may contribute to the protection of the surface cartilage against
inflammatory attacks.
In order to d etermine the possible functional significance of the zonal distribution of
galectin-3 in normal and OA cartilage, potential ligands of galectin-3 in cartilage must
be established and appropriate in vitro studies must be undertaken. A correlation of the
zonal distribution of potential ligands of galectin-3 in articular cartilage with the
distribution of galectin-3 could indicate a functional relationship. In this study, the main
aim of galectin-3 immunohistochemical studies was to determine of one ligand, which in
distribution match CD98. It appears that CD98 is unlikely to act as a ligand for galectin-
3 in human articular chondrocyte.
Although, this work was unable to disclose a relation between CD98 and galectin-3
expression pattern in human articular cartilage, but the expression pattern of these two
molecules in human articular cartilage may clarify more details about the cartilage
biology. Further studies are needed to elucidate the precise functional role of this
molecule in the healthy and diseased chondrocyte metabolism and possibly in
mechanotransduction pathway and progression ofOA.
Western blotting analysis did not show difference between normal and OA cartilage in
galectin-3 expression pattern. Despite the differential expression of galectin-3 in normal
and severe OA cartilage, no identifiable difference was found between normal and OA
163
cultures chondrocytes. For a precise c omparison of the immunohistochemistry results
and western blotting analysis, further studies are needed to analyse galectin-3 expression
of numerous cultured chondrocytes from different grades of OA cartilage. In addition, it
has been shown that in vivo and in vitro conditions affect the expression pattern of
different molecules (Salter et al 1995; Loeser et al 1993).
Thus, the picture that has emerged is that intracellular galectin-3 contributes to the
essential functions such as terminal differentiation (Colnot et al 1999) and cell survival
(Colnot et al 2001) in chondrocytes. In summary, galectin-3 association with some types
of integrins in the other cells such as aipi in adenocarcinoma cells (Ochieng et al 1998)
and aMp2 in macrophage (Dong et al 1997) and ECM glycoproteins like fibronectin
(Probstmier et al 1995), laminin (Ochieng et al 1995) and tenascin (Rosenberg et al
1991), anti-apoptotic effect (Colnot et al 2001), cell differentiation (Colnot et al 1998,
1999, 2001), effect on IL-1 production (Jeng et al 1994) and also its effect on [Ca2+]i in
Jurkat cells ( Dong and Hughes 1996), suggest different roles for galectin-3 in human
articular cartilage. Further work is needed to determine which proteins interact with
galectin-3 in normal and OA articular cartilage, to control chondrocyte metabolism
during development and in disease processes such as osteoarthritis.
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3.4.5. Comparison of the in vitro expression of various proteins in
chondrocytes isolated from different joints
The proteins, CD47, CD98 and galectin-3, studied in this project, appear to be present at
greater levels in normal ankle cartilage than in normal and OA cartilage from knee and
hip joints. These data, in part, show the biochemical heterogeneity of different joints.
Since the results in several samples obtained from different donors were consistent, the
results of this study were not because of artefact or any other technical variation. In
addition, blot stripping and reprobing has confirmed the results obtained. The present
study would be consistent with published literature confirming cartilage heterogeneity.
Finding out more details of differences between chondrocytes in various joints would
provide an insight in the mechanism of articular cartilage disease and elucidate the
molecular alterations of primary OA. The goal in OA research is to identify the early
stages of disease, develop means of blocking the progression of the disease process, and
reversing its effects. A v ariety of reports have shown biochemical and biomechanical
differences of ankle with other joints (Cole and Kuettner 2002). It has been shown that
human knee and ankle joint differ in their prevalence of OA or chondrodegeneratoin in
vivo (Koepp et al 1999). Approximately 6% of the adult population are affected by
symptomatic OA of the knee, this percentage increases to almost 10% in individuals
over 65 years of age (Felson et al 1987). Symptomatic OA does develop in the ankle,
although rarely (<_1%), and the prevalence does not increase with age (Muehleman et al
1997).
Studies have shown that synthesis of proteoglycans (PGs) (Eger et al 2002) and PG
content (Treppo et al 2000) of the ankle are higher than that of the knee. It has also been
shown that t here are differences in the sensitivity of knee and ankle chondrocytes to
their response to catabolic mediators such as IL-ip. Knee chondrocytes responded to
lower doses of IL-ip than did ankle chondrocytes. With IL-lp stimulation, there is also
an increase in proteolytic activity in both the knee and ankle, as evidenced by increased
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neopeptides for both aggrecanase and matrix metalloproteinases (MMPs), the levels of
neopeptides were higher in the knee than ankle. Ankle is also able to rebound faster with
increased PG synthesis than the knee, when IL-1 p is removed (Eger et al 2002). Studies
have also shown significant differences between knee and ankle chondrocyte response to
proteoglycan loss in the presence of second catabolic mediator, fibronectin-fragment
(Fn-fs). The 29 kD Fn-fs causes a greater degree of PG loss (30-50%) from knee
cartilage than from ankle cartilage in explant culture (Kang et al 1998).
Chondrocytes within each joint cartilage build a matrix around themselves that confer
different properties to their tissues, with the ankle tissue being tougher, more elastic, and
more resistant to damage. Even when isolated from that matrix, the cells maintain
differences in their responses to stimulation (Cole and Kuettner 2002). In vivo studies
(Teppo et al 1998) on cartilage from human knee and ankle pairs have supported the
concept that a combination of biochemical and biomechanical factors affects the
chondrocytes and their matrix, thus making the ankle tissue more resistant to enzyme
damage and disease progression than that of the knee. These works demonstrated that
the ankle cartilage appeared denser, with a higher GAG content, lower water content,
higher equilibrium modulus and dynamic stiffness and lower hydraulic permeability
(Cole and Kuettner 2002).
These differences may provide insight into the pathogenesis of OA and may help in the
design of therapeutic strategies for detection and treatment (Huch et al 1997). Additional
studies are needed to characterize potential differences between chondrocytes in knee
and ankle cartilage in their gene expression and matrix biosynthesis.
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CHAPTER FOUR
4.0. ROLE FOR CD47 AND ITS LIGANDS IN
CHONDROCYTE MECHANOTRANSDUCTION
4.1. CD47 AND ct5(31 INTEGRIN INTERACTIONS
The present study showed strong expression pattern of CD47 by chondrocytes in human
articular cartilage. The strong expression of a5(31 integrin in human articular cartilage
has been previously demonstrated (Salter et al 1992; Loeser et al 1995). In addition,
anti-a5 and anti-pl antibodies can inhibit chondrocyte electrophysiological responses
after 0.33 Hz cyclical mechanical stimulation (Wright et al 1997). It has been suggested
that a5pl integrin may act as a mechanoreceptor in chondrocyte mechanotransduction
(Salter et al 2001). Since CD47 has been described to be linked to and to modulate
functions of integrins on different cell types, the possibility exists that CD47 may act
through a5pi integrin modulation in chondrocye mechanotransduction. Thus, in this
chapter, the physical association of CD47 with a5pi integrin and ligands in
chondrocytes, its effect on electrophysiological response after mechanical stimulation,
and its potential role/s in chondrocyte mechanotransduction are investigated.
The physical association of CD47 with a5pi integrin and recognized CD47 ligands,
TSP1 and SIRPoc, was investigated by using immunoprecipitation and western blotting.
In these experiments primary chondrocytes, isolated from femoral condyle, normal,
whose age and sex was not recorded (14013); tibial plateaux, normal, male (age 62)
(14016), and cell line C20A4, P8 and PI 1 were used. Primary chondrocytes were seeded
at 2xl05 cells/ml concentration. After a period of 10-15 days cultured chondrocytes were
lysed and the proteins were extracted. In all experiments whole cell 1 ysates from the
same sample were used as positive control.
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4.1.1. Assessment the physical association of CD47 with
a5 and pi integrin in resting human articular chondrocytes
Studies have shown that CD47 is functionally associated with a5pi integrin in the
erythroleukemia cell line K562 (Blystone et al 1995) and physically associated with a4
integrin in Jurkat T cells (Barazi et al 2002) and a2 integrin in melanoma cells (Chung
et al 1997). Different studies have also shown physical association between CD47 and p
integrins including pi integrin (Gao et al 1996; Chung et al 1 997; Wang et al 1 998,
1999; Barazi et al 2002).
To analyze potential cross talk between CD47 and a5pi integrin in articular
chondrocytes, in the physical association between CD47 and a5 integrin was assessed.
One mg pre-cleared whole cell lysates were immunoprecipitated with mouse mAb anti-
CD47 CC2C6 and protein A/G resin. Immunoprecipitated proteins were analyzed by
running onto 8% SDS-PAGE under reducing conditions. Separated proteins were
immunoblotted with rabbit polyclonal anti-a5 integrin at 1:2000. In both control and
immunoprecipitated (IP) samples, a band at -150-160 kD (Figure 4.1) was identified,
which is consistent with the known molecular weight of a5 integrin.
Subsequently, immunoprecipitated CD47 and associated proteins were analysed under
the same condition and immunoblotted with mouse monoclonal anti-pi integrin, JB1A,
at 1:1000. The immunoprecipitated sample did not show a band at -125 kD size, the
molecular weight of pi integrin, when compared with control (Figure 4.2.A).
To assess the possibility of epitope denaturing and antibody interactions during
immunoprecipitation and western blotting, the same whole cell lysate was
immunoprecipitated with 2 pg/ml mouse mAb anti-pi integrin, JB1A, and protein A/G
resin. The immunoprecipitated proteins were analysed under reducing conditions and
immunoblotted with anti-CD47, 2B7 at 1:500. Immunoprecipitated samples did not







Figure 4.1. Assessment the physical association of CD47 and a.5 integrin in resting
human articular chondrocytes. One mg cell lysate obtained from normal femoral
condyle (14013)* was pre-cleared and then incubated with 25 pi /ml primary mouse
mAb anti-CD47, CC2C6, and protein AJG resin overnight. The immunoprecipitated (IP)
sample (lane a) was suspended in electrophoresis sample buffer 2x plus 10% SDS and
run onto 8% reducing gel and blotted with rabbit polyclonal anti-a5 integrin at 1:2000.
Total cell lysates were electrophoresed and blotted with anti-a5 integrin as control (lane
b). As shown above, CD47 is coimmunoprecipitated with a.5 integrin in resting primary
chondrocytes. The results shown are representative of cultured chondrocytes from three
different experiments. Molecular weights (MW) in kilo Daltons (kD) are indicated on
the left.
*, day book number.
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Figure 4.2.A. Assessment of physical association of CD47 and piintegrin in resting
articular chondrocytes. One mg normal cell lysate obtained from normal chondrocytes
(14013) was pre-cleared and then incubated with 25 pi/ml primary mouse mAb anti-
CD47, CC2C6, and protein A/G resin overnight. The immunoprecipitated (IP) sample
(lane a) was suspended in electrophoresis sample buffer 2x plus 10% SDS and run onto
8% reducing gel and blotted with mouse monoclonal antibody anti-piintegrin JB1A at
1:1000. Total cell lysates (lane b) were electrophoresed as control. In IP sample
piintegrin is not expressed at -125 kD and there is no physical association between
CD47 and piintegrin in resting chondrocytes. The results shown are representative of
cultured chondrocytes from three different experiments. Molecular weights (MW) in
kilo Daltons (kD) are indicated on the left.
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Figure 4.2.B. Assessment of physical association of pi integrin and CD47 in resting
articular chondrocytes. One mg cell lysates obtained from normal chondrocytes
(14013) (lane a) and cell line, P8, (lane b) were pre-cleared and immunoprecipitated
with 2 pg/ml mouse monoclonal antibody anti-pl integrin, JB1A, and protein A/G resin
overnight. The IP samples were suspended in electrophoresis sample buffer 2x plus 10%
SDS and run onto 8% reducing gel and immunoblotted with mouse monoclonal anti-
CD47 (2B7) at 1:500. Total cell lysates (lane c) were used as control. As shown above,
CD47 did not coimmunoprecipitate with pi integrin in resting chondrocytes. The results
shown are representative of cultured chondrocytes from three different experiments.
Molecular weights (MW) in kilo Daltons (kD) are indicated on the left.
171
4.1.2. Assessment the physical association of CD47 and pi integrin in
the presence of anti-CD47 mAb Bricl26 and in stimulated human
articular chondrocytes
CD47 was initially identified as an associated protein with P integrins including
P3 integrin (Brown et al 1990) and pi (Gao et al 1996; Chung et al 1997; Wang et al
1998, 1999; Barazi et al 2002). In platelets, CD47 has been described to be physically
linked to pi (Chung et al 1999) and P3 (Chung et al 1997; Brown et al 1990) integrins
and to form a signal-transducing complex, allowing their activation to a higher
affinity/avidity state after its ligation with the CBD domain of TSP1 in static conditions.
Many intracellular proteins have been demonstrated that interact directly with the
integrin P subunits including signal transduction proteins such as FAK (Dedhar and
Flannigan 1996). To determine whether CD47 is physically associated with pi integrin
in chondrocytes under certain conditions, the interaction either in the presence of anti-
CD47 Bricl26 or after 0.33 Hz cyclical mechanical stimulation was assessed.
In first experiment, normal cultured chondrocytes were pretreated with anti-CD47
Brie 126 for 1 min, 5 min and 10 min. Extracts from these samples were
immunprecipitated with anti-CD47 (CC2C6) and analysed by western blotting.
Separated proteins immunoblotted with mouse mAb anti-pi integrin, JB1A, at 1:1000.
In comparison to the band obtained from whole cell lysate at -125 kD, anti-CD47
pretreated chondrocytes did not show a detectable band (Figure 4.3. A). Thus, the
presence of Brie 126 had no effect on physical association between pi integrin and
CD47. In the second experiment, normal cultured chondrocytes were subjected to 0.33
Hz cyclical mechanical stimulation for lmin and 5 min. Extracts from different resting
and stimulated chondrocytes were immunprecipitated with anti-CD47 (CC2C6).
Immunoprecipitated CD47 and associated proteins were analysed by western blotting
and immunoblotted with mouse mAb anti-pi integrin, JB1A, at 1:1000. As shown in
Figure 4.3. B stimulated chondrocytes did not show any modification in the physical
association of CD47 and pi integrin, when compared with unstimulated chondrocytes.
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Figure 4.3.A. Assessment of physical association between CD47 and plintegrin in
the presence of anti-CD47, Bricl26, in cell line C20A4. Non-treated (lane a) and
pretreated cultured cell line C20A4, PI 1, with anti-CD47 Brie 126 for 1 min (lane b), 5
min (lane c) and 10 min (lane d) were lysed and whole cell lysates were extracted. The
lysates pre-cleared and incubated with primary mouse mAb anti-CD47, CC2C6 (IgG),
and protein A/G resin overnight. The IP samples were suspended in electrophoresis
sample buffer 2x plus 10% SDS, run onto 8% reducing gel, and immunoblotted with
mouse monoclonal antibody anti-(31integrin, JB1A, at 1:1000. As shown above,
untreated (lane a) and treated lanes (b-d) did not show modification in the CD47 and
pi integrin coimmunoprecipitation. Total cell lysates (whole extract, lane e) were
electrophoresed and immunoblotted with anti-pi integrin as control. Molecular weights
(MW) in kilo Daltons (kD) are indicated on the left.
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Figure 4.3.B. Assessment of physical association between CD47 and pi integrin
following 033 Hz cyclical mechanical stimulation. Normal chondrocytes (14013) and
cell line C20A4, P8, were seeded and after 10-15 days were subjected to 0.33 Hz
cyclical mechanical stimulation (MS). Resting chondrocytes (lanes al and a2) and
stimulated chondrocytes at 1 min (lanes bl and b2), and 5 min (lanes cl and c2) were
lysed. Extracts were immunoprecipitated with anti-CD47 (CC2C6) and immunoblotted
with anti-pl integrin, JB1A, at 1:1000. The whole cell lysates obtained from normal
primary chondrocytes (14013)(lane dl) and cell line C20A4, P8 (lane d2) were used as
positive control. Resting and stimulated chondrocytes did not show noticeable difference
in the CD47 and pi integrin coimmunoprecipitation. a, Resting; b, 1 min MS; c, 5 min
MS; d, whole cell lysate/ control. Molecular weights (MW) in kilo Daltons (kD) are
indicated on the left.
174
4.2. EXPRESSION AND INTERACTIONS OF CD47
LIGANDS, TSP1 AND SIRPa
4.2.1. Expression and interactions of TSP1 in human articular
chondrocytes
4.2.1.1. Expression of TSP in human articular chondrocytes
TSP1 is ~ 450 kD multifunctional ECM glycoprotein, with three identical subunits and
multiple domains, which mediates different cell-matrix interactions. The presence of
TSP1 in articular cartilage has been previously reported (Miller and McDevitt 1988;
DiCesar et al 1994; Pfander et al 2000). In this study, in vitro expression pattern of TSP-
1 by normal and OA articular cartilage was studied.
Normal chondrocytes were isolated from 4 talus (ankle), 3 males, 1 female (age range
62-72, mean age 68)(13901, 13907, 13915, 12820); 1 tibial plateaux, male (age 72)
(13941); 2 femoral head, 1 male and 1 female (age range 70-83, mean 78) (13828,
13822). OA chondrocytes were isolated from 1 femoral head (grade II, male, age
83)( 13828); and 2 tibial plateaux, grade II and III, both female (age range 62-87 mean
75) (13820, 13965).
Extracts from normal and OA chondrocytes were analyzed using western blotting under
reducing conditions and immunoblotted with a mouse monoclonal anti-TSP, P10,
(Chemicon) antibody at 1:100. Cell lysates from normal and OA chondrocytes obtained
from ankle, knee and femoral head showed similar band of ~160-170 kD which is
consistent with the known molecular weight of one subunit of this glycoprotein (Figure
4.4).
One normal tibial plateaux, male (age 72), and two OA, both tibial plateaux, grades II
and III, both female (age range 62-87 mean 75) showed a faint band. The other samples
from different donors showed strong consistent band. The intensity of TSP band in
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normal ankle, normal and OA extracts from different donors of different age and sex
under reducing conditions was approximately similar (Figure 4.4).
4.2.1.2. Interactions between CD47 and TSP1 in articular chondrocytes
Functional and physical interactions between CD47 and C-terminal cell binding domain
of TSP1 in a number of cellular activities have been demonstrated (Gao et al 1996;
Chung et al 1997; Wang et al 1999; Dorahy et al 1997; Frazier et al 1999; Tulasne et al
2001).
To test the possibility of CD47 and TSP interactions in chondrocyte, one mg pre-cleared
whole c ell 1 yastes w ere immunoprecipitated w ith mouse mAb anti-CD47 CC2C6and
protein A/G resin. Immunoprecipitated CD47 protein and its associated p roteins were
separated by running onto 8% SDS-PAGE under reducing conditions. Separated proteins
were immunoblotted with mouse mAb anti-TSP antibody, P10, at 1:100. As shown in
Figure 4.5 the control and immunoprecipitated (IP) lysates showed a similar size band
of-160-170 kD which is consistent with known molecular size of one subunit of TSP 1.
CD47 showed physical association with TSP in human articular chondrocytes.
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Figure 4.4. Detection and comparison of TSP1 expression in normal and OA
human articular cartilage. Equal amounts (80 pg/lane) of total extracted proteins
prepared from the cultured chondrocytes derived from normal ankle (lane a, talus, male,
age 72) (13915), normal (lane b, femoral head, male, age 83) (13828) and OA (lane c,
tibial plateaux, grade III OA, female, age 87) (13965) samples were run onto 6% SDS-
PAGE under reducing conditions. The detection of TSP1, was assessed by
immunoblotting with mouse mAb anti-TSP, P10, (Chemicon) at 1:100. Normal and OA
chondrocytes isolated from different joints, expressed nearly a similar band. The blot
shown is representative of three different donors. Molecular weights (MW) in kilo
Daltons (kD) are indicated on the left.
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Figure 4.5. Assessment of physical association between CD47 and TSP1 in primary
chondrocytes. One mg normal cell lysate obtained from femoral condyle normal
(14013) was pre-cleared and then incubated with 25 pl/ml primary mouse mAb anti-
CD47, CC2C6 (IgG), and protein A/G resin overnight. The immunoprecipitated proteins
were suspended in electrophoresis sample buffer 2x plus 10% SDS and run onto 8%
reducing gel and blotted with mouse mAb anti-TSP, P10, at 1:100. As shown above, IP
sample (lane a) and total cell lysates, as control (lane b) expressed TSP at -160-170 kD.
CD47 is coimmunoprecipitated with TSP1 in human articular chondrocyte (lane a).
Results shown are representative of cultured chondrocytes from three different
experiments. Molecular weights (MW) in kilo Daltons (kD) are indicated on the left.
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4.2.1.3. Physical association between TSP and pi integrin in primary chondrocytes
and C20/A4 cell line
It has been shown that integrins are important signalling receptors for TSP1 in multiple
cell types including T cells (Wilson et al 1999) and platelets (Chung et al 1997). To
investigate the physical association between TSP and pi integrin in human articular
chondrocytes, cultured chondrocytes were lysed and the proteins extracted. One mg cell
lysate was pre-cleared and incubated with 2 pg/ml primary mouse mAb anti-pi integrin,
JB1A, and protein A/G resin. Immunoprecipitated proteins were separated by running
onto 8% reducing gel and immunoblotted with anti-TSP antibody, P10, at 1:100.
In the first experiment, TSP1 was seen to be expressed in both primary chondrocytes
(14013) and cell line C20A4 (P8) (Figure 4.6. A). To confirm the results, extracts from
another primary chondrocytes (14016) and cell line C20A4 (P11) were similarly
immunoprecipitated and immunoblotted. These samples did not show band at consistent
molecular weight (—160-170 kD), when compared with the whole cell lysates as positive
control (Figure 4.6. B).
These results suggest a weak, transient physical association between pi integrin and
TSP in human articular chondrocytes.
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Figure 4.6. Assessment of physical association between pi integrin and TSP1 in
primary human articular chondrocytes (A) and cell line C20A4 (B). A) One mg cell
lysate obtained from femoral condyle normal (14013) (lane a) and cell line C20A4, P8
(lane b) were pre-cleared and then incubated with 2 pg/ml primary mouse mAb anti-
(31 integrin, JB1A, (Chemicon), and protein A/G resin overnight. The IP samples were
suspended in electrophoresis sample buffer 2x plus 10% SDS and run onto 8% reducing
gel and blotted with mouse monoclonal anti-TSP at 1:100. As shown above IP samples,
(lanes a and b), pi integrin is coimmunoprecipitated with TSP. B) The same experiment
with another primary normal chondrocytes (14016), (lane a) and cell line C20A4, Pll
(lane b) did not show the physical association between TSP and CD47. Total cell lysates
(lane c) were electrophoresed and blotted with anti-TSP as control. Molecular weights
(MW) in kilo Daltons (kD) are indicated on the left.
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4.2.2. Expression and interactions of SIRPa in human articular
chondrocytes
SIRPa is a second natural ligand of CD47. It has been shown that SIRPa is expressed in
a variety of cells including myeloid cells and neurons (Adams et al 1998; Oshima et al
2002). In the present study using a panel of anti- SIRPa Abs, immunohistochemistry
and western blotting methods, the expression of this IgSF member in articular
chondrocytes was investigated.
4.2.2.1. Work of antibodies to SIRPa
To identify whether or not chondrocytes express SIRPa, a panel of mouse mAbs anti-
SIRPa antibodies, SE12B6, SE7C2 and SE5A5 and one rabbit polyclonal anti-SIRPa
(ABR) were applied. In preliminary studies all antibodies were tested by
immunohistochemistry on frozen and paraffin sections. The antibodies did not show
positive signal at all on either paraffin or frozen sections at a range of concentrations. To
assess the expression of SIRPa molecule by human articular chondrocytes, cell lysates
obtained from cultured chondrocytes isolated from normal ankle, normal and OA knee
and femoral head, were studied. In vitro expression of SIRPa was assessed by using the
same Abs. Each Ab was tested with three samples, one normal ankle, one normal and
one OA knee sample, at concentrations of 1:500 and 1:1000 under both reducing and
non-reducing conditions. Anti-SIRPa mAbs, SE5A5 and SE7C, showed no binding at
all at different concentrations and conditions (Figure 4.7). Anti-SIRPa mAb SE12B6
showed a very faint band or no binding under non-reducing conditions (Figure 4.7. C).
Polyclonal rabbit anti-SIRPa (ABR) showed strong band at molecular weight
approximately 70-80 kD, that it was consistent with the range of the molecular weight of
this molecule (Figure 4.8).
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Figure 4.7. Work of mAbs anti-SIRPa, SE12B6 and SE7C2, to SIRPa. Cultured
chondrocytes isolated from normal ankle (lane a), normal (lane b) and OA (lane c)
articular cartilage were lysed. Extracts were analysed by running onto 8% reducing (A
and B) and non-reducing (C) gels. Blot A immunoblotted with mAb anti-SIRPa SE7C2
at 1:500, and both blot B and C immunoblotted with anti-SIRPa ,SE12B6, at 1:500. As
shown above, blots A and B did not show a consistent main single band but blot C, anti-
SIRPa SE12B6 showed very faint single band at 70-80 kD under non-reducing
conditions in some samples and no binding in the other samples. Molecular weights
(MW) in kilo Daltons (kD) are indicated on the left.
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4.2.2.2. Expression of SIRPa in human articular chondrocytes
Based on the above preliminary studies rabbit polyclonal anti-SIRPa (ABR) at 1:1000
was selected for further biochemical assessment.
Normal chondrocytes were isolated from 3 talus (ankle), all male (age range 69-71,
mean age 70) (13901, 13915, 13907); 1 tibial plateaux, female (age 71) (13911); 3
femoral heads, 2 males and 1 female (age range 70-83, mean 78) (13828, 13822, 13816).
OA chondrocytes were isolated from 1 femoral head, grade II, male (age 83) (13828); 2
tibial plateaux, grades II and III, both female (age range 62-87 mean 75) (13820, 13965).
Extracts from normal and OA chondrocytes taken from different joints were analyzed by
running onto 8% SDS-PAGE under reducing conditions. Analyzed proteins were
immunoblotted w ith rabbit polyclonal (ABR) anti-SIRPa at 1:1000. Both normal and
OA chondrocytes showed a similar band at -70-80 kD, which is consistent with the
known range molecular weight of this receptor. Chondrocytes i solated from different
donors did not show detectable difference in the expression pattern of SIRPa in the
several experiments (Figure 4.8). A slightly stronger band was detected from
chondrocytes isolated from normal ankle in comparison to the band visualized from
normal and OA chondrocytes isolated from knee and femoral head (Figure 4. 8). In cell
line C20A4 (P11), SIRPa was expressed at a similar size and similar to expression
pattern by primary normal chondrocytes (Figure 4.8).
4.2.2.3. Assessment the physical association between CD47 and SIRPa
Recent reports have shown CD47-SIRPa interactions in a number of cellular functions
in multiple cell types including fibroblast NIH3T3 (Kharitonenkov et al 1997), rat
alveolar macrophage (Adams et al 1998) and T cells (Seiffert et al 2001).
In next step of this part, the physical association between CD47 and SIRPa in resting
articular chondrocytes was assessed using immunoprecipitation and western blotting.
Cell lysates were pre-cleared and incubated with primary mAb anti-CD47 CC2C6 and
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protein A/G resin. Immunoprecipitated proteins were separated by running onto 8%
reducing gel and immunoblotted with rabbit polyclonal anti- SIRPa antibody at 1:1000.
Immunoprecipitated proteins did not express a band at the determined molecular weight
by positive control. As shown in Figure 4.9, in -70-80 kD molecular weight that SIRPa
is expressed in the positive control, this molecule is not expressed in electrophoresed
immunoprecipitated sample isolated from primary normal chondrocytes. Human
articular chondrocytes do not appear to show physical association between CD47 and
SIRPa.
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Figure 4.8. Detection and comparison of SIRPa in normal and OA human
articular cartilage. Equal amounts (40p.g/lane) of total extracted proteins prepared
from cultured human articular chondrocytes derived from ankle (lane a), normal (lanes
b, I), OA (lane c) chondrocytes and cell line C20A4 (lane II) were run onto 8% SDS-
PAGE under reducing conditions. The detection of SIRPa was assessed by probing the
blots with rabbit polyclonal anti-SIRPa (ABR) at 1:1000. A) Normal ankle (lane a,
talus, male, age not recorded) (13901) exhibited stronger band of SIRPa in comparison
to normal (lane b, femoral head, male, age 70) (13822) and OA (lane c, tibia OA grade
III, female, age 87) (13965) chondrocytes. Both normal and OA chondrocytes did not
show detectable difference in the pattern of SIRPa expression. B) Both cell lysates
from normal primary chondrocytes from knee (lane I, femoral condyle, age and sex were
not recorded) (14013) and cell line C20A4, Pll (lane II,) expressed SIRPa. All
chondrocytes isolated from different joints expressed SIRPa. No detectable difference
was observed between normal and OA chondrocytes in the expression of
SIRPa. Stronger band of ankle chondrocytes in comparison to femoral head and knee
chondrocytes was observed. The blots shown are representative of three different donors




Figure 4.9. Assessment of physical association between CD47 and SIRPa in
primary normal chondrocytes. One mg normal cell lysate obtained from femoral
condyle normal (age and sex were not recorded)(14013) was pre-cleared and
immunoprecipitated with primary mouse mAb anti-CD47, CC2C6 (IgG), and protein
A/G resin overnight. The IP sample (lane a) was suspended in electrophoresis sample
buffer 2x and 10% SDS and run onto 8% reducing gel and immunoblotted with rabbit
polyclonal anti-SIRPa at 1:1000. As shown above, CD47 did not coimmunoprecipitate
with SIRPa in resting chondrocytes. Total cell lysates (lane b) were electrophoresed and
immunoblotted with anti-SIRPa as control. The results shown are representative of
cultured chondrocytes from three different experiments. Molecular weights (MW) in
kilo Daltons (kD) are indicated on the left.
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4.3.0. ROLE FOR CD47 AND ITS LIGANDS IN THE
ELECTROPHYSIOLOGICAL RESPONSE OF HUMAN
ARTICULAR CHONDROCYTES TO 0.33 Hz
MECHANICAL STIMULATION
The full numerical results of individual electrophysiological experiments from which the
values given in the Tables in this part are derived are given in Appendix III. The total
cases used in this section of the experimental work include 7 females (age range 57-88,
mean age 75) and 6 males (age range 66-92 mean 75) (Table 4.1). Non-confluent
cultures grown in vitro for 10-12 days were used for all experiments. Cells were
mechanically stimulated at 0.33 Hz for defined periods. Results shown in this part are
from a single representative experiment. Experiments were repeated from human
articular chondrocytes derived from at least 3 adult donors and were reproducible
between donors.
4.3.1. Effect of function-blocking mAb anti-CD47 Brie 126 on the
response of cultured chondrocytes to 0.33 Hz cyclical mechanical
stimulation
A series of experiments was undertaken to establish whether CD47 is involved in the
chondrocyte electrophysiological response to 0.33 Hz (2 sec on, 1 sec off) cyclical
mechanical stimulation (MS). Cultured n ormal chondrocytes were used to investigate
the role of CD47 in the hyperpolarisation response of normal chondrocytes to 0.33 Hz
cyclical mechanical stimulation. Function-blocking mAb anti-CD47 Brie 126 at
concentration of lpg/ml was incubated with monolayer cultured normal chondrocytes at
o
37 C for 10 minutes prior to 0.33 Hz cyclical mechanical stimulation for 20 minutes.
The membrane potentials of 5 cells were recorded prior to and after the addition of
Brie 126 and also after the standard regime of 0.33 Hz cyclical mechanical stimulation.
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In nil dish (as control), chondrocytes were subjected to 0.33 Hz cyclical mechanical
stimulation for 20 minutes. Membrane potential of 5 chondrocytes were measured and
showed a h yperpolarisation r esponse (Table 4.2.a). In test dish, the exposure of the
cells to Brie 126 alone produced no significant change in membrane potential. When the
normal cells were subjected to cyclical mechanical stimulation in the presence of Brie
126, there was no change in membrane potential (Table 4.2.a).
A similar experiment was carried out with OA cultured chondrocytes to investigate
whether there was a role for CD47 in the depolarisation response ofOA chondrocytes to
0.33 Hz cyclical mechanical stimulation. The membrane potential of OA chondrocytes
with antibody only did not show any alteration whereas there was no change in
membrane potential which is induced by 0.33 Hz cyclical mechanical stimulation (Table
4.2.b).
Brie 126 was found to inhibit the electrophysiological response of both normal and
osteoarthritic chondrocytes at 0.33 Hz mechanical stimulation (Table 4.2.a and b). The
modification response following mechanical stimulation in both normal and OA cultured
chondrocytes significantly abrogated. This suggests the involvement of CD47 in
articular chondrocytes mechanotransduction.
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Table 4.1. Normal and OA samples used in electrophysiology experiments.
Normal samples OA samples
A. Femoral head : sex/age (DB No.) A. Femoral head
1. M/79 (13873) l.OAIII, F/88 (13902)
2. M/ 92 (13876D)
3. F/82 (13878)
A. Knee joint: Region, sex/age (DB B. Knee joint: Region, sex/age (DB
No.) No.)
1. TN, F/57 (13904) 1. FA II, F/79 (13938C)
2. FN, M/69 (13939) 2. FA II, M/66 (13943)
3. FN, M/72 (13941) 3. FA III, M/- (13949)
4. FN, M/- (13949) 4. FA II, F/64 (13959)
5. FA II, F/76 (13962)
6. FA I, N/R (13964)
7. TAII, MI- (13983)
M, male; F, female; DB No., day book number. TN, tibial plateaux normal; FN, femoral
condyle normal; TA, tibial plateaux OA; FA, femoral condyle OA.
189
Table 4.2.a. Effect of 1 pg/ml anti-CD47 Brie 126 on the membrane hyperpolarisation
response of normal cultured chondrocytes to 0.33 Hz cyclical mechanical stimulation
Membrane potential (-mV)
(mean ± SEM)
Reagent n Resting Brie 126 Bricl26+ % change P value
alone 0.33 Hz MS
Nil 5 14.8±1.1 - 24±1.9 +62 0.001
Brie 126 5 18.6±1 19.4+1 19.4+0.87 +0 NS*
*NS: not significant. Compared with antibody alone
Table 4.2.b. Effect of 1 pg/ml anti-CD47 Brie 126 on the depolarisation response ofOA
cultured chondrocytes to 0.33 Hz cyclical mechanical stimulation
Membrane potential (-mV)
(mean ± SEM)
Reagent n Resting Brie 126 Brie126+ % change P value
alone 0.33 Hz MS
Nil 5 46+2.3 - 22.2+2.2 -52 * 0.001
Brie 126 5 40.8+2.6 40.8+1.9 42.2+2 -3 NS*
*NS: not significant. Compared with antibody alone
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4.3.2. Effect of mAb anti-TSP, P10, on the depolarisation response of
OA chondrocyte to 0.33 Hz cyclical mechanical stimulation
A series of experiments was undertaken to establish whether TSP-1 is involved in the
chondrocyte electrophysiological response following 0.33 Hz cyclical mechanical
stimulation.
OA chondrocytes were seeded in complete media at a density of lxlO4 cells/ml. mAb
anti-TSP, P10, at concentration of 1.5 pg /ml was incubated with non-confluent
chondrocytes at 37° C for 10 min prior to 0.33 Hz cyclical mechanical stimulation. The
membrane potential of suitable chondrocytes were measured at rest, 10 min after
incubating with antibody alone and after 0.33 Hz cyclical mechanical stimulation.
The antibody itself was found to have no effect on the membrane potential of
chondrocytes. The depolarisation response, seen in osteoarthritic articular chondrocytes
subjected to 0.33 Hz cyclical mechanical stimulation, was assessed. This
electrophysiological response was significantly inhibited in the presence of anti-
thrombospondin at concentration of 1.5pg/ml (Table 4.3).
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Table 4.3. Effect of 1.5 pg/ml anti-TSP mAb (Chemicon) on the depolarisation response
of OA cultured chondrocytes to 0.33 Hz cyclical mechanical stimulation
Membrane potential (-mV)
(mean ± SEM)
Reagent n Resting Anti-TSP Anti-TSP + % change P value
alone 0.33 Hz MS
Nil 5 30±1.9 - 17.411.3 -42 0.0001
Anti-TSP 5 29.611.2 2910.8 29.81 1.6 6 NS*
*NS: not significant. Compared with antibody alone
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4.3.3. Effect of anti- SIRPcc Abs, SE5A5 and SE7C2, on the OA
chondrocyte depolarisation response to 0.33 Hz cyclical mechanical
stimulation
A series of experiments was undertaken to establish whether SIRP-a is involved in the
chondrocyte electrophysiological response to 0.33 Hz cyclical mechanical stimulation.
Two function-blocking mAbs against SIRPa, SE5A5 and SE7C2, at 1:100, were
applied. The monoclonal Abs were incubated with OA cultured chondrocytes in separate
experiments for 10 min at 37 C prior to 0.33 Hz cyclical mechanical stimulation for 20
minutes.
In the presence of anti-SIRPa mAb SE7C2, the electrophysiological response of
cultured OA human chondrocytes to 0.33 Hz cyclical mechanical stimulation was
inhibited, indicating that this protein has a role in chondrocyte mechanotransduction.
Another anti-SIRPa mAb, SE5A5, which is known to block the binding of SIRPa to
CD47 (Lagadec et al 2003), did not show significant inhibitory effect on depolarisation
response of osteoarthritic chondrocytes following 0.33 Hz mechanical stimulation
(Table 4.4).
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Table 4.4. Effect of function blocking anti-SIRPa antibodies, SE5A5 and SE7C2, at




Reagent n Resting Anti-SIRPa Anti-SIRP + % change Pvalue
alone 0.33 Hz MS
Nil 5 24.8±0.8 - 16.4±0.9 -33 0.0002
SE5A5 5 29.2±1 29+1.1 23.2±0.8 -20 0.002
SE7C2 5 26.2±0.8 27.4±0.9 28.211.3 7 NS*
*NS: not significant. Compared with antibody alone
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4.4. CD47 AND INTRACELLULAR SIGNALLING
Previous studies have shown that at least two signals are required for the formation of
intracellular integrin-mediated signalling cascades, one involving protein kinase C
(PKC) and the other involving tyrosine kinase activation (Burridge et al 1992). Protein
tyrosine kinases play a central role in integrin-mediated signalling cascades (Parsons
1996; Komberg et al 1992; Burridge et al 1992; Schmidt et al 1998). Tyrosine
phosphorylation of several cellular proteins appears to play an essential role in integrin-
mediated signal transduction (Lin et al 1995). It has been shown that CD47 has a role in
protein tyrosine phosphorylation (Gao et al 1996; Chung et al 1997; Frazier et al 1999;
Green et al 1999).
Protein kinase C (PKC) appears to be one of the key intermediates in integrin-mediated
signalling in many cell types (Clark and Brugge 1 995; Juliano and Haskill 1993). In
certain cell types, inhibition of PKC activity results in the inhibition of cell attachment
and spreading as well as FAK phosphorylation (Woods and Couchman 1992; Vuori and
Ruoslahti 1993; Haimovich and Kaneshiki 1996). Activation of PKC can promote the
cellular changes mediated by integrin/matrix interactions (Vuori and Ruoslahti 1993;
Chen et al 1994; Short et al 1998).
4.4.1. Effect of anti-CD47 Bricl26 on protein tyrosine phosphorylation
and PKCa activation in resting articular chondrocytes
To assess CD47 signalling pathway in chondrocyte mechanotransduction, intracellular
events, the phosphorylation tyrosine residues of signalling molecules and PKCa
activation following cyclical mechanical stimulation in the presence of anti-CD47
Brie 126 were assessed. Because studies have shown the effect of some antibodies alone
such as CD47 antibodies (Ticchioni et al 1997) on tyrosine phosphorylation, the
possibility of the influence anti-CD47 Brie 126 alone on tyrosine phosphorylation and
PKCa activation was investigated. Cultured cells were incubated with Brie 126 at
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appropriate time courses and tyrosine phosphorylation and PKCa translocation were
assessed.
Cultured primary chondrocytes or cell line C20A4 were preincubated with anti-CD47
Brie 126 at lmin, 5 min and 10 min. Extracts were immunoprecipitated with anti-
phosphotyrosine, analysed by running onto 8% SDS-PAGE under reducing conditions
and immunoblotted with mouse mAb anti-phosphotyrosine-HRP, PY-20, at 1:1000. As
shown in Figure 4.10. A, the cultured chondrocytes did not show detectable alteration in
tyrosine phosphorylation in comparison to the resting cells. In the presence of anti-CD47
Brie 126, no modification in tyrosine phosphorylation was observed, compared with the
basal amount in resting cells.
To investigate the possibility of the influence of anti-CD47 Brie 126 on the PKCa
translocation, mAb anti-CD47 Brie 126 was incubated with primary chondrocytes at 30
sec, 1 min, 5 min and 10 min. Extracts were fractionated to cytosolic and particulate
compartments. Both cytosolic and particulate compartments were analyzed by running
onto 10% SDS-PAGE under reducing conditions. Separated proteins were
immunoblotted with mouse mAb anti-PKCa, M4 at 1:1000. The presence of anti-CD47
Brie 126 only had no effect on translocation of PKCa from cytosolic compartment to the
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C20A4
Figure 4.10.A. Effect of anti-CD47, Brie 126 alone on the integrin-mediated
ppl25FAK tyrosine phosphorylation in primary chondrocytes and cell line C20A4.
Cultured chondrocytes preincubated with lpg/ml anti-CD47 Brie 126 for 1 min (lane a);
5 min (lane b); and 10 min (lane c). Resting cells (nil) (lane d) were used as control. Cell
lysates obtained from primary chondrocytes (top) (14016) and cell line C20A4, Pll
(bottom) were immunoprecipitated with anti-phosphotyrosine, electrophoresed by
running onto 8% gel under reducing conditions and immunoblotted with mouse mAb
anti-phosphotyrosine-HRP, PY-20 at 1:1000. The presence of antibody alone, at
different time courses (a-c), did not appear to play a role in the FAK tyrosine







Figure 4.10.B. Effect of anti-CD47, Brie 126 alone on the integrin-mediated PKCa
translocation in primary chondrocytes. Cultured chondrocytes were incubated with
lpg/ml anti-CD47 Brie 126 for 30 sec (lane a); 1 min (lane b); 5 min (lane c); and 10
min (lane d). Resting (nil) cells dish (lane e) was used as control. Whole cell lysates
from cultured normal chondrocytes (tibial plateaux, normal, male, age 54 years) (13973)
were fractionated to cytosolic and particulate compartments. PKCa expression was
assessed by running both compartments onto 10% SDS-PAGE reducing gel and
immunoblotted with mouse mAb anti-PKCa, M4, at 1:1000. In the presence of anti-
CD47 Brie 126 at different time courses, no alterations observed in PKCa translocation
from cytosolic to particulate compartment. Molecular weights (MW) in kilo Daltons
(kD) are indicated on the left.
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4.4.2. Effect of anti-CD47 on tyrosine phosphorylation and PKCa
activation following cyclical mechanical stimulation in articular
chondrocytes
Protein tyrosine phosphorylation after mechanical stimulation has now been clearly
identified in a number of systems as an important occurrence both early in
mechanotransduction and in downstream s ignalling events that result in regulation of
gene expression (Berk et al 1995).
It has been previously revealed that lmin 0.33 Hz cyclical mechanical stimulation
results in increased tyrosine phosphorylation of signalling molecules, FAK, P-catenin
and paxillin, in both primary and C20A4 cell line cultured chondrocytes (Lee et al
2000). To determine if CD47 is involved in this tyrosine phosphorylation following
mechanical stimulation, in the presence of 1 pg/ml anti-CD47 (Brie 126), the extent of
tyrosine phosphorylation of signalling molecules was assessed.
In primary chondrocytes increased tyrosine phosphorylation of FAK within 1 min
mechanical stimulation was significantly abolished in the presence of mAb anti-CD47
Brie 126 (Figure 4.11. A). Similarly, increased tyrosine phosphorylation of different
size molecules i ncluding 65, 90 and 125 kD after 1 min mechanical stimulation was
observed in cultured cell line C20/A4. This response, in the presence of anti-CD47 Brie
126, was completely blocked. Both primary chondrocytes and C20/A4 cell line showed
an increase of FAK tyrosine phosphorylation that in the presence of anti-CD47 was
markedly decreased (Figure 4.11. A).
It has been shown recently that 0.33 Hz cyclical mechanical stimulation within 30
seconds results in PKCa translocation from cytosolic to particulate compartment (Lee
et al 2002). In the present study, the effect of anti-CD47, Brie 126, on this translocation
was investigated. The results showed that this translocation of PKCa is significantly







Figure 4.11.A. Effect of anti-CD47, Brie 126, on the ppl25FAK tyrosine
phosphorylation after 0.33 Hz cyclical mechanical stimulation in primary articular
chondrocytes and cell line C20A4. Cell lysates obtained from primary chondrocytes
(top) (14016) and cell line C20A4, Pll (bottom) were immunoprecipitated with anti-
phosphotyrosine, electrophoresed by running onto 8% gel under reducing conditions and
immunoblotted with mouse mAb anti-phosphotyrosine-HRP, PY-20 at 1:1000.
Tyrosinre phosphorylation of ppl25FAK is increased after lmin mechanical stimulation
(lane b). This tyrosine phosphorylation in the presence of anti-CD47 was markedly
decreased (lane c). In 5 min mechanical stimulation alone (lane d) and in the presence of
anti-CD47 (lane e), no significant alteration was observed. In cultured cell line C20/A4,
in addition to FAK, the stronger bands of different size molecules including 65 and 90
kD were observed (lane b). All bands were considerably blocked in the presence of anti-
CD47 (lane c). Resting cells (lane a); 1 min mechanical stimulation (lane b); lmin
mechanical stimulation in the presence of anti-CD47 (lane c); 5min mechanical
stimulation and (lane d); and 5 min mechanical stimulation in the presence of anti-CD47





Figure 4.11.B. Effect of anti-CD47, Brie 126, on PKCa translocation after 0.33 Hz
cyclical mechanical stimulation in primary articular chondrocytes. Whole cell
lysates from cultured normal chondrocytes (tibial plateaux, normal, male, age 54 years)
(13973) were fractionated to cytosolic and particulate compartments. PKCa expression
was assessed by running both compartments onto 10% SDS-PAGE reducing gel and
immunoblotted with mouse mAb anti-PKCa, M4, at 1:1000. PKCa translocation was
observed in particulate compartment that subjected to 30 sec 0.33 Hz cyclical
mechanical stimulation (lane b, particulate). This response was inhibited in the presence
of lpg/ml anti-CD47 Brie 126 (lane c, particulate). Resting cells (lane a) were used as
control. PKCa translocation was assessed in three more donors, but there was technical
problems in sonicator and separation of cytosolic and particulate did not occur properly.
Molecular weights (MW) in kilo Daltons (kD) are indicated on the left.
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4.5.0. DISCUSSION
4.5.1. CD47 and natural ligands expression and interactions
Integrin receptors for ECM molecules play central and complex roles in cell interactions.
A complex series of steps leads from initial integrin interactions with an extracellular
ligand to transmembrane effects on the localization of cytoskeletal molecules or
signalling molecules, to the activation of signalling pathways, and to eventual regulation
of gene expression. Identifying distinct mechanisms of integrin responses to
extracellular stimuli and patterns in the classes of responding molecules will be crucial
for understanding how integrins function. It is becoming increasingly apparent that full
understanding of integrin functional activities may require understanding of integrin
associations with other cell-surface molecules (Miyamoto et al 1995).
It is well established that ligand binding and cell-surface clustering of integrins can lead
to the assembly of large multi-component intracellular signalling complexes (Turner et
al 1991; Hynes 1992). As integrins including a5pi have no intrinsic enzymatic activity
of their own, they must interact with o ther p roteins to generate signals (Damsky and
Werb 1992).
It has been shown that several kinds of proteins, including immunoglobulin superfamily
(IgSF) proteins that bind to integrins, may generally function in concert to mediate both
cell-cell and cell-ECM interactions, which in turn stimulate cytoskeletal reorganization,
migration and a cascade of intracellular signalling pathways.
4.5.1.1. CD47 -integrin associations
The present study showed a physical association between CD47 and a5 integrin in
human articular chondrocytes. In vitro binding studies have also demonstrated no
physical association between CD47 and pi integrin in unstimulated and stimulated
articular chondrocytes. These suggest a role for CD47 in modulation the function of
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a5(31 integrin in chondrocyte mechanortransduction. Integrin cytoplasmic domains are a
key nexus of interaction between the extracellular environment and intracellular
structures and signaling cascades. Both the a and p subunit cytoplasmic domains make
important contributions to various aspects of overall integrin function including
cytoskeletal organization, cell motility, signal transduction, and modulation of integrin
affinity for ligands and activation.
Studies have shown that three regions are implicated in integrin ligand binding: the N-
terminal portions of both the a and p subunit and the A (or I) domain in the integrins
that contain it (Loftus et al 1994; Cao et al 1998). The ligand binding sites on the
P1 and P3 subunits are the best understood. RGD-containing peptides cross-link to the
N-terminal portion of the P3 subunit (Loftus et al 1990; Takada et al 1994). For integrin
a subunits that do not possess an A domain, ligand binding localizes to the N-terminal
portion. This region corresponds roughly to the amino-terminal 400 amino acids on
several a subunits including a4, a5 and anb( Loftus et al 1994). It contains the metal
ion-dependent adhesion site (MIDAS) binding sites and is composed of seven
homologous, repeated domains, although there are conflicting reports on the role of
divalent cations in ligand binding by switching the integrin into an active conformation
(Cao et al 1998).
CD47 was initially identified as an associated protein with P integrins including
P3 integrin (Brown et al 1990; Lindberg et al 1993; Wu et al 1999) and pi (Gao et al
1996; Chung et al 1997; Wang et al 1998, 1999; Barazi et al 2002). In platelets, CD47
has been described to be physically linked to pi (Chung et al 1999) and P3 (Chung et al
1997; Brown et al 1990) integrins and to form a signal-transducing complex, allowing
their activation to a higher affinity/avidity state after its ligation with the CBD domain of
TSP1 in static conditions. Many intracellular proteins have been demonstrated that
interact directly with the integrin p subunits including signal transduction proteins such
as FAK (Dedhar and Hannigan 1996). Studies have shown physical associations
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between CD47 and the a2 integrin subunit in melanoma cells (Chung et al 1997) and
a4 integrin subunit in Jurkat T cells (Barazi et al 2002).
This is the first study that has shown the physical association between CD47 and subunit
a5 integrin. There are several reports that have specifically focused on the role of a5
subunit and its importance as a part of an integrin in a variety of cellular functions. Cao
et al (1998) have demonstrated that there are domains on the integrin a5 subunit that
mediate cell signaling on fibronectin. These include cell adhesion, cell spreading, cell
migration, focal adhesion formation, modulation of interactions of focal adhesion
components and P subunit cytoplasmic domain, and tyrosine phosphorylation. In
addition, it has been previously reported (Loftus et al 1994) that the N-terminal one-third
of integrin a and p subunits mediate integrin-ligand recognition. This region is also
involved in the interactions between a and P subunits.
Dalton et al (1995) have previously shown that ligand binding of a5pl integrin alters the
integrin life cycle and permits a longer retention of these proteins at the cell surface.
Studies h ave s hown t hat i ntegrin i nteraction w ith a 1 igand i s a c ritical step for s ignal
transduction such as tyrosine phosphorylation (Palecek et al 1997; Koyoma et al 1996;
Miyamoto et al 1995; Schmidt et al 1998). Taken together, it is more likely that spatial
redistribution of pi integrin, due to interaction of a5pl integrin with accessory proteins
such as CD47, plays an important role in early signaling events such as tyrosine
phosphorylation and cytoskeletal reorganization.
O'Toole et al (1994) have demonstrated previously that affinity modulation and ligand
binding of a5pi integrin are cell type specific, the cell type specific signals that
modulate integrin affinity are transmitted through the cytoplasmic domains and both
a and P cytoplasmic domains are involved in affinity modulation. They also have
shown that the regulation of integrin affinity by the a subunit cytoplasmic domain is a
subunit specific. In those studies anb and a5 specify different affinity states in CHO
cells, anb the low and a5 the high affinity state. They concluded that the a subunit
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cytoplasmic domain designate integrin-specific affinity differences, whereas (3 subunit
may be permissive for the high affinity state.
It has been shown previously (Blystone et al 1995) that CD47 can regulate the function
of a5pi integrin in erythroleukemia cell line K562. The modulatory effect of CD47 in
a5pi-mediated phagocytosis required P3 integrin. Barazi et al (2002) have shown that
anti-CD47 B6H12 is physically associated with a4pi integrin and also has an inhibitory
effect on a5pi integrin in integrin-mediated adhesion in Jurkat T cells. Therefore, they
reclassified B6H12 as a function-modifying Ab for CD47.
Disatnik and Rando (1999) have shown that outside-in signalling pathways are initiated
when muscle cells attach to fibronectin via a5 integrins. It has been shown previously
that a5 -deficient cells survive poorly and undergo apoptotic cell death when plated on
fibronectin as the sole substrate (Tavema et al 1998). The poor survival of a5 -deficient
cells is reflected by the absence of spreading on fibronectin, whereas cells that express
a5 integrin attach and spread readily on fibronectin. In many cell types, the process of
attachment and spreading is coincident with the formation of focal adhesions and
phosphorylation of FAK as well as other proteins that localize to focal adhesions
(Schaller et al 1992; Hanks et al 1992). Indeed, a5 expressing cells demonstrate robust
FAK phosphorylation when plated on fibronectin. Consistent with their ability to attach
and spread, a5 -deficient cells do not manifest any FAK phosphorylation on fibronectin
(Disatnik and Rando 1999).
It has been shown previously that integrins play an important role in mediating
mechanical stress-induced signals. Specifically, integrins like a5(31 and aV(33 are
essential for the mechanotransduction of hemodynamic forces into biochemical signals
(Muller et al 1997; Dimmelers et al 1998; Takahashi and Berk 1996; Traub and Berk
1998; Jalali et al 2001; Urbich et al 2002). A series of studies on a5pi integrin response
to mechanical stimulation in human umbilical vein endothelial cells (HUVEC) has
shown that the a5 subunit acts as a mechanoreceptor (Yano et al 1997). They have
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demonstrated that a5 subunit acts by sensing and responding to cyclic strain with
subsequent transduction of the signal inside the cell through the cytoplasmic domain of
pi subunit. It has been also shown previously that in chondrosarcoma cells mechanical
strain was found to increase a5 expression when the cells were adherent to plastic (most
likely via fibronectin and vitronectin), while cells adherent to collagen type II increased
expression of a2 (Holmvall et al 1995). A recent study has shown that mechanical
loading induced an increase in the amount of integrin subunit a5 in immature and
mature cartilage but not in the integrin subunit pi content (Lucchnetti et al 2003). In
addition, it has been shown that stretching at 0.33 Hz cyclical mechanical stimulation
produces hyperpolarisation of cultured chondrocytes, which was found to be inhibited
by RGD peptides and antibodies to the a5 and pi integrin subunits (Wright et al 1997).
There are a number of possible explanations for the lack of association between CD47
and pi integrin in human articular cartilage. Although, chondrocyte CD47 may function
as a pi integrin binding molecule only under certain transient circumstances.
Miyamoto et al (1995) have demonstrated that extracellular triggering of an integrin
response involves a series of specific stages of hierarchies of protein interactions. A
substantial number of potential intermolecular interactions are already known, including
evidence for the binding of talin (Horwitz et al 1986), a-actinin (Otey et al 1990), and
FAK (Schaller and Parsons 1994) to the p 1 integrin cytoplasmic domain (Lewis and
Schwartz 1995). In addition, there is accumulating evidence to suggest the existence of
protein-protein interactions among cytoskeletal proteins and a variety of signalling
molecules (Clark and Brugge 1995). Because so many proteins can potentially interact
with each other based on in vitro studies, it is important to determine whether there are
specific patterns or hierarchies of interactions induced by pi integrins within
cytoplasmic milieu (Miyamoto et al 1995).
Although the results from the present study suggest that there is no physical association
between CD47 and pi integrin, it can not rule out the possibility that the presence of pi
integrin and CD47 interactions. This could be due to several reasons:
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1) The biochemical manipulations in the coimmunoprecipitation and western blotting
experiments affect the epitope recognized by applied mAbs
2) CD47 ligation by applied mAb affects the interaction between CD47 and pi integrin
3) CD47-p1 integrin interaction is either weak or that there is no consistent direct
association.
In addition t o the direct interactions with i ntegrin cytoplasmic domains, a number of
cytoskeletal and signalling molecules have been shown to become spatially associated
with integrins upon integrin engagement and clustering (Dedhar and Hannigan 1996).
Miyamoto et al (1995) have proposed a model of hierarchical association of cytoskeletal
and signalling molecules with integrins on the basis both of experiments carried out with
immunoprecipitation and immunofluorescence. Some of the interactions have been
demonstrated by immunoflurescence alone and showed a spatially localized interaction
(spatial colocalization), upon integrin occupation or clustering (Dedhar and Hanningan
1995). It is possible to demonstrate a spatial association of CD47 with pi integrin that
can play a role in integrin-mediate chondrocyte mechanotransduction.
Studies have shown that both a and P subunits are involved in FAK tyrosine
phosphorylation. For example, Leong et al (1995) have shown that both dub and P3
cytoplasmic domains are involved in FAK tyrosine phosphorylation. Evidence shows
that both a and P subunit cytoplasmic domains make important contributions to various
aspects of overall integrin function including cytoskeletal organization, cell motility,
signal tranduction, and modulation of integrin affinity for ligands (Aplin et al 1998).
In summary, the data from this study and other studies suggest that a5-CD47 interaction
may play an important role in modulation of a5pi integrin-mediated signaling pathway
in articular chondrocyte. The physical association of CD47 and a.5 subunit may
influence the pi subunit and the conformation and activation of total heterodimer
molecule a5pi integrin and produce an important effect on integrin-mediated
intracellular signalling.
207
4.5.1.2. Expression and interactions of TSP1 with CD47 in human articular
chondrocytes
The results of this study showed TSP1 is expressed by normal and OA chondrocytes and
has physical association with chondrocyte CD47.
4.5.1.2.1. In vitro expression of TSP-1
TSP1, as an important ligand for CD47, possesses a variety of critical structural and
functional characteristics. TSP1 is a 450 kD trimeric multifunctional matrix protein
composed of several binding sites and differential affinity for a number of cellular and
extracellular molecules.
TSP-1 is synthesized by a variety of cells including smooth muscle cells (Wang and
Frazier 1998), endothelial cells (Sheibani and Frazier 1995), fibroblasts (Tsao and
Mousa 1995) and melanoma cells (Gao et al 1996a, b). TSP-1 has also been shown to be
present in human articular cartilage (Miller and McDevitt 1988, 1995; DiCesar et al
1994; Pfander et al 2000). Different studies demonstrated TSP-1 expression and its
potential role in the development of embryonic and epiphyseal cartilage (Tucker et al
1997; Iruela-Arispe et al 1993). Miller and McDevitt (1995) proposed that TSP-1 binds
to chondrocyte surface receptors by an RGD dependent mechanism.
Pfander et al (2000), using immunohistochemistry and mRNA expression have reported
the differential pattern of TSP-1 expression in normal, mild OA and severe OA articular
cartilage. They demonstrated TSP-1 expression mainly over mid and deep zone,
although TSP-1 mRNA expression was seen mainly in mid-zone chondrocytes. They
also reported a slight increase in TSP-1 mRNA expression by middle zone chondrocytes
in mild OA cartilage. In their studies, OA cartilage with moderate changes showed an
interterritorial reduction in TSP-1 staining. Severe OA cartilage showed a major
decrease in TSP-1 protein, and displayed a significant reduction in TSP-1 mRNA
expression compared with mild OA cartilage. They concluded that TSP-1 is
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predominantly expressed in middle zone chondrocytes in normal and mild/moderate OA
cartilage and significantly reduced in severe OA.
In the present study, western blotting analysis both normal and OA cultured
chondrocytes from donors showed a little variation in TSP-1 expression. It seems that
the biological variance (i.e. age and sex of donor) and/ or cartilage pathology and
technical artefact may be the most likely explanations for these differences.
4.5.1.2.2. Physical associations of TSP1 with CD47
This study showed that TSP is physically associated with CD47 in human articular
chondrocyte.
Multiple distinct receptors acting together to mediate cell-ECM interactions is a
common theme that is likely to be critical in providing various levels by which the
strength of the interactions can be regulated. Cartilage homeostasis is regulated, in part,
by the interaction of chondrocytes with ECM such as a5pi integrin with the
multidomain ECM protein fibronectin.
TSP1 is a known CD47 ligand, and also it has been shown that TSP1 can regulate,
through CD47, the functions of anbp3 integrin in platelets and aVp3 integrin in
melanoma cells. A number of cells that have their critical functions regulated by TSP1-
CD47 interactions have been reported (see Table 1.4, page 67). CD47 and TSP1
physical and functional interactions are involved in a variety of integrin-mediated
critical functions including calcium mobilization in fibroblast (Tsao and Mousa 1995),
spreading and tyrosine phosphorylation in melanoma cells (Gao et al 1996), platelet
aggregation (Chung et al 1997; Dorahy et al 1997; Frazier et al 1999; Tulasne et al
2001), spreading of vascular smooth muscle cells (Wang et al 1998). In addition, recent
studies by Graf et al (2002, 2003) have shown that CD47/TSP1 complex with an integrin
can act as a common mechanosensitive system in different cell types in response to
different mechanical stimuli. They have shown that both endothelial cells and fibroblasts
are able to sense both shear stress and mechanical stretch through a common
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mechanosensitive molecular mechanism. The decisive proteins involved in this general
mechanosensitive regulation are the avp3 integrin, IAP/CD47 and TSP1.
These reports and data from the present study, reinforce the hypothesis that TSP1 is
involved in integrin-mediated chondrocyte mechanotransduction through binding to
CD47. In the present study, the physical and functional association between CD47 and
TSP1 in chondrocyte is shown. Like CD47 and a5pi integrin, TSP is involved in
electrophysiological response of chondrocyte following 0.33 Hz cyclical mechanical
stimulation. The data suggest that, the CD47/TSP1 complex may modulate
a5pi integrin-mediated signal transduction.
4.5.1.2.3. Physical association of TSP1 and pi integrin
The present study has shown that TSP1 is coimmunoprecipitated with pi integrin in
human articular chondrocyte.
TSP-1 is a ligand for several integrins, including aVp3 and anbP3 on platelets (Chung et
al 1997), a3pi on neurons (DeFreitas etal 1995), a4pl anda5pi onT lymphocytes
(Yabkowitz et al 1993a), a3piand a4pl on breast carcinoma cells (Chandrasekaran et al
1999; Krutzsch et al 1999). TSP-1-integrin interactions appear to mediate numerous
TSP-1 functions (see Table 1.4, page 67). It has been shown that TSP1 can mediate T
cell adhesion to fibronectin through binding to a4pl and a5pi integrins (Yabkowitz et
al 1993).
This is the first study that has shown the strong indirect interaction of TSP, an ECM
multidomain protein, with a5pl integrin by binding with CD47 and a direct interaction
by binding withpi integrin in resting chondrocytes. It is possible that under certain
conditions such as mechanical stimulation and/or alteration of integrin affinity/avidity,
this interaction may modulate intracellular signalling. Further studies are needed to
determine the precise mechanism of this interaction.
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4.5.1.3. SIRPa expression and interaction
4.5.1.3.1. In vitro expression of SIRPa
A panel of antibodies was used to investigate the expression of SIRPa in vivo by using
immunohistochemistry. All antibodies didn't show any positive signal. The western blot
studies showed that SIRPa is expressed by both normal and OA cultured chondrocytes.
No identifiable difference was observed between normal and OA chondrocytes.
This molecule shows heterogeneity in molecular weight (~ 65-120 kD) in various tissues
due to differential glycosylation (Kharitonenkov et al 1997) and existence of alternative
SIRPa transcripts coding for this molecule (Veillette et al 1998). SIRPa is ubiquitously
expressed in all tissues examined (heart, brain, spleen, lung, liver, muscles, kidney, and
testis), being most abundant in the brain and the spleen (Kharitonenkov et al 1 997).
Using immunohistochemistry with a specific anti- SIRPa antibody, it has been shown
that SIRPa is strongly expressed in myeloid cells (macrophages, monocytes,
granulocytes, dendritic cells) and neurons (Adams et al 1998).
These observations and a similar structure of SIRPa and cell adhesion molecules
suggest a role for SIRPa as a signal transducer molecule in various cell types. It has
been shown previously t hat adhesion of cultured fibroblasts to various E CM proteins
induces the tyrosine phosphorylation of SIRPa and its association with SHP-2 in a
manner dependent on Src family kinases and FAK (Tsuda et al 1998; Oh et al 1999).
This is the first study that showed the expression of SIRPa by both normal and OA
cultured articular chondrocytes. No detectable difference was found between the
expression of SIRPa by normal and diseased chondrocytes. Like other molecules that
were assessed in this study such as CD47, CD98, and galectin-3, ankle chondrocytes
showed stronger band of this molecule in comparison to the other normal and OA
articular chondrocytes isolated from the other joints.
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4.5.1.3.2. Interaction of SIRPa and CD47 in human articular chondrocytes
The present study demonstrated that SIRPa is not physically associated with CD47 in
cultured chondrocytes.
Seiffert et al (1999) reported that extracellular domain of SIRPa cannot bind to the
CD47-deficient human ovarian carcinoma cell line OVIO, but to human CD47-
transfected OVIO. Yoshida et al (2002) have demonstrated the interaction between Ig
domain of CD47 and SIRPa in B lymphocytes. Interestingly, they have noticed that the
binding capacity of soluble SIRPa Ig domain varied between B cell lines: pre-B cell
lines and myeloma cell lines bound larger amounts of SIRPa Ig than mature B cell
lines. They suggested that the affinity/avidity state of CD47 for SIRPa may change
during B cell maturation. Thus, the affinity/avidity of CD47 could be modified under
certain transient conditions. Latour et al (2001) have demonstrated that CD47/SIRPa in
resting state of T cells, is disrupted after an environmental condition, and rapidly
restored to down regulate inflammatory response and maintain homeostasis. This group
have also proposed theoretically, SIRPa and TSP1 might compete for CD47 on T cells,
assuming they would be expressed simultaneously during the immune response. Based
on these data, some of the certain transient conditions in the present study such as the
presence of physical association of TSP (as counterreceptor) and a5 with CD47,
stimulated and unstimulated states and normal and OA chondrocytes may have role in
the CD47 and SIRPa physical association.
It has been shown that SIRPa and CD47 are coexpressed by monocytes, immature
dendritic cells (iDC) and mature dendritic cells (mDC), and the cross talk between the
two molecules on the same cell is under current investigation (Latour et al 2001). In
several studies it has been shown that CD47/ SIRPa interaction plays important roles in
cell-cell interaction such as B lymphocytes adhesion to endothelial cells (Yoshida et al
2002) and T cell activation (Seiffert et al 2001). Oldenborg et al (2000, 2001) have
demonstrated that under normal circumstances, CD47 on RBCs prevents their
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elimination by ligating the macrophage receptor SIRPa. Thus, the histological and
biomechanical characteristics of cartilage suggest that chondrocyte CD47 interacts with
an important extracelluar matrix protein, TSP1. This interaction (ECM-cell interaction)
can play a central role in transduction the mechanical stimulation into the intracellular
space.
Different studies have shown that SIRPa involves in to function in a variety of cellular
signalling systems i ncluding integrin-mediated pathways (Inagaki et al 2000) such as
MAPK activation and FAK tyrosine phosphorylation (Oh et al 1999).
However, SIRPa is not expressed by chondrocytes in vivo, its consistent expression in
vitro and its role in electrophysiological response of cultured chondrocytes are
confirmed the presence of SIRPa in articular chondrocyte. Thus biochemical results are
not artefact and it seems that the mAbs used in the present study did not work with
immunohistochemical experiments.
In conclusion, based on the present results, it appears that SIRPa is involved in
chondrocyte mechanotransduction in a CD47-independent pathway, or may be mediated,
at least in part, through CD47-dependent under certain conditions. Furthermore,
SIRPa may involve in the chondrocyte metabolism functions in an integrin-mediated
signalling pathway. Further studies might address this question and provide insight into
the role of SIRPa in the chondrocyte mechanotransduction.
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4.5.2. The role of CD47 and its iigands, TSP and SIRPa, in the
electrophysiological response of chondrocytes to 0.33 Hz cyclical
mechanical stimulation
4.5.2.1. Electrophysiological response of normal and OA chondrocytes to 0.33 Hz
cyclical mechanical stimulation
Normal and OA chondrocytes showed a consistent and reproducible membrane
hyperpolarisation and depolarisation response respectively, following 0.33 Hz cyclical
mechanical stimulation.
Biomechanic forces can be transmitted into the cell by a variety of structures:
deformation of the cell membrane, stress and strain on the cytoskeleton, deformation of
the nucleus, and direct signalling pathways via receptors of the ECM such as integrins
(Mollenhauer and Erdmann 2002). Because physical forces are generally applied
directly or indirectly to the plasma membrane of cells, it has been noted that mechanical
forces can affect the permeability of the cellular membrane to various ions (Sachs 1991;
Liu et al 1999). The changes in cell membrane potential have been used as a sensitive
bioassay of human articular chondrocyte response to mechanical stimulation and have
allowed identification of chondrocyte mechanoreceptors and pathways activated in
normal human articular chondrocytes after cyclical mechanical stimulation (Salter et al
2001). Salter et al (Wright et al, 1992; Wright et al, 1996; Salter et al 1997, Wright et al,
1997; Salter et al, 2000; Lee et al, 2000, 2002; Salter et al 2001, 2002) analysed
mechanotransduction pathways in chondrocytes from humans by using a technique that
allows the application of controlled pressure to cultured cells. The standard regime of
cyclical mechanical stimulation used consists of 0.33 Hz (2 seconds on, 1 second off) for
20 minutes at 37 C. In this system that used in the present study as well, cyclical
mechanical stimulation has been shown to induce deformation on the base of the plastic
tissue culture dish and its adherent cells. A pressure pulse of 50 kPa results in 4000
pstrain on the base of the dish, which is equivalent to 0.40% deformation (Wright et al
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1992; Salter etal 2002). Stimulation of human chondrocytes at this regime results in
membrane hyperpolarisation, which is attributable to the passage of positive ions
potassium from the cell to the exterior through ion channels. In contrast, low frequency
stimulation, at 0.104 Hz and continuous stimulation result in membrane depolarisation.
This depolarisation is attributable to the entry of positive ions (sodium into the cell)
through ion channels, from interstitial fluid. Reagents that block membrane ion channel
activation and activity can be used to identify which channels are involved in the
production of these membrane responses (Salter et al 2001). It has been shown that
cyclical mechanical stimulation at 0.33 Hz cyclical mechanical stimulation, results in
membrane hyperpolarisation of normal human articular chondrocytes as a result of small
conductance (SK) calcium-dependent K+ channels (Wright et al 1992).
Previously it has been demonstrated that the apamin-sensitive ion channel is the channel
involved in hyperpolarisation response of normal articular chondrocytes (Wright et al
1996), whereas, the depolarisation response is associated with activation of a
tetrodotoxin-sensitive Na+ channel (Millward-Sadler et al 2000a; Salter et al 2002).
Although, it has been shown that both normal and OA chondrocytes express small
conductance (SK) calcium-dependent K+ channels (Millward-Sadler et al 2000a), it is
likely that the differential electrophysiological response is a result of activation of
different signalling pathways, as suggested by the results observed using the chemical
inhibitors of intracellular signalling molecules. SK channels play important roles in
excitable cells, and generation of long-lasting hyperpolarisation, slow after-polarization
is essential for normal neurotransmission (Bond et al 1999).
Chondrocytes in osteoarthritis are known to show significant phenotypic differences
from those of normal cartilage (Aigner and Dudhia 1997). These differences in
phenotype, including altered expression of integrins, cytokines, and growth factors, as
well as production of ECM, are believed to represent a reparative or remodelling
response of chondrocytes following damage to cartilage (Ostergaard and Salter 1998).
The range of integrin and other adhesion molecules expressed by chondrocytes is
modified in OA, increasing the potential for altered cell-matrix interaction (Ostergaard
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and Salter 1998; Ostergaard et al 1998; Lapadula et al 1998). There are also changes in
the expression of a number of ECM molecules, such as fibronectin (Jones et al 1987),
tenascin (Salter et al 1993) and thrombospondin (Pfander et al 2000) which function as
potential integrin ligands, and these may also influence integrin-mediated signalling
(Probstimer and Pesheva 1999). These differences are reflected in the differences in
matrix production and expression of surface receptors for ECM molecules and cytokines
(Ostergaard and Salter 1998). The difference in responses to 0.33 Hz cyclical
mechanical stimulation is a further example of difference between normal and OA
chondrocytes. Such differences may have significant effects on cartilage structure and
functions if anabolic mechanical stimuli fail to be recognised or elicit inappropriate
response (Salter et al 2002). The mechanotransduction pathway that identified in
chondrocytes involves recognition of the mechanical stimulus by integrins and
activation of integrin signalling pathway with the generation of a cytokine loop resulting
in a second cascade of intracellular signalling events. Normal and OA chondrocytes
show differences at multiple stages of the mechanotransduction cascade. Early events
are similar, involve cx5(31 integrin and stretch activated ion channels and are associated
with similar rapid tyrosine phosphorylation events. The actin cytoskeleton and PKC, are
required for the integrin-dependent mechanotransduction in normal but not OA
chondroccytes. Autocrine/paracrine signalling cascades generated following mechanical
stimulation also differ in respect of cytokines and the effect of these cytokines on cell
responses. Modified responses of chondrocytes in OA cartilage to mechanical
stimulation may be an appropriate, adaptive response to the altered mechanical
environment to which the cell is exposed.
The seeding of chondrocytes at very low concentrations (lxlO4 cells/ml) and impalement
at non-confluent gives the possibility to record the membrane potential of each cell
separately. It was noted whilst performing electrophysiological experiments that there
was a degree of variation between the baseline resting membrane potential when
comparing articular chondrocytes obtained from different donors, although the degree of
hyperpolarisation observed following cyclical mechanical stimulation did not differ
significantly between donors. Cell confluency is thought to contribute to this, and
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although cells were plated at the same density (1 xlO4 cells/ml) for every
electrophysiological experiment performed, after the 10-12 days incubation period there
were noticeable variations in cell confluency between donors. Biological variance (i.e.
age and sex of donor) is the most likely explanation for these differences. It has been
previously reported that resting membrane potential increases as the density of the
culture increases (Bard and Wright 1974) (Figure 4.12), and it has been suggested that,
as cell confluency increases, there may be alterations in the permeability of the cell
membrane to sodium, chloride or potassium, the three ions principally responsible for
maintaining and altering membrane potential levels. It has also been shown that the
substrate on which cells are cultured can have effects on resting membrane potential
level (Bard et al 1974), with fibroblastic cells cultured on collagen having higher resting
membrane potentials than the same cells cultured on plastic. Thus, confluent cells may
have higher resting membrane potentials, as they are likely to have produced a
considerable amount of extracellular matrix which they will have forged strong
attachments to.
Cell Density (confluence)
Figure 4.12. Effect of cell confluency on resting membrane potential (Bard and Wright
1974).
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4.5.2.2. The role of CD47 in chondrocyte electrophysiological response
This study showed that the electrophysiological response of both normal and OA human
articular chondrocytes to 0.33 Hz cyclical mechanical stimulation is inhibited in the
presence of anti-CD47, Brie 126.
Integrins act as transmembrane link among the ECM, c ytoskeletal proteins, and actin
filaments. Mechanical stimuli may activate intracellular signalling as a result of
deformation of the ECM and induce changes in the conformation or clustering of
integrins following mechanical stimulation (Ingber 1991; Aplin et al 1998). Roles for
integrins and integrin-associated signalling molecules in the mechanotransduction
pathway activated after 0.33 Hz mechanical stimulation, leading to membrane
hyperpolarisation, were shown by the use of function blocking monoclonal antibodies
and pharmacologic inhibitors (Wright et al 1996). Exposure of chondrocytes in primary
monolayer culture to GRGDSP peptide, which competes for integrin-matrix ligand
binding sites, resulted in inhibition of the hyperpolarisation response whereas the control
peptide GRADSP had no effect. The hyperpolarisation response was reduced
considerably when cells were preincubated with P4C10 (pi) and BIIG2 (a5) anti-
integrin antibodies. These data with the other studies have demonstrated that
a5pi integrin functions as a chondrocyte mechanoreceptor and activates a signal
cascade involving the tyrosine protein kinases, the actin cytoskeleton, PLC-associated
inositol triphosphate pathway and PKC (Wright et al 1997; Salter et al 2001).
It has been previously shown that a5pi integrin is strongly expressed by articular
cartilage in several studies ( Salter et al 1992; Woods et al 1994; Loeser et al 1995) and
acts as a mechanoreceptor in mechanotransduction pathway of both normal and
osteoarthritic cartilage (Wright et al 1997). Like other types of integrins, a5pi integrin
has no intrinsic enzymatic activity and also is not phosphorylated. Therefore it must
interact with other proteins to generate signals (Damsky and Werb 1992; Ishibashi et al
2002). The regulated specific interaction of several individual proteins to form a
complex with new functions is a well established principle of signal transduction
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(Brown and Frazier, 2001). Thus, to better understand how a5pi integrin is involved in
mechano-induced response of chondrocyte following mechanical stimulation, it is
necessary to know which molecule/s in cell membrane or ECM can physically and
functionally associate with this integrin.
CD47, integrin-associated protein (IAP), a member of IgSF, ubiquitously 50 kD protein,
is a transmembrane glycoprotein that can modulate a range of cellular functions
including, cell adhesion (Lindberg et al 1996), cell spreading (Gao et al 1996), and
calcium influx (Schwartz et al. 1993). Salter et al (1997) have previously shown that in
human bone cells (HBC), anti-CD47 Brie 126 antibody inhibited the hyperpolarisation
response induced by 0.33 Hz mechanical stimulation, but had no effect on the
depolarisation response induced by 0.104 Hz mechanical stimulation. Interestingly, Graf
et al (2003) have recently shown, when fibroblasts are subjected to both laminar flow
and pulsatile loading mechanical stimuli, they used a similar mechanosensitive
regulation pathway that was composed of CD47/ integrin and TSP. Similarly, when
endothelial cells are subjected to the same loading mechanical stimuli, they showed the
same mechanosensitive regulation pathway as well. They concluded that a
CD47/integrin complex-dependent common mechanism acts as a receptor for TSP1 in
the mechanosensitive regulation in different cell types for different mechanical stimuli.
To explain the mechanism of CD47 function in the electrophysiological response after
0.33 Hz cyclical mechanical stimulation the possibilities include 1) modulation of
a5piintegrin signalling, 2) integrin-regulated calcium entry, 3) regulation the function
of stretch-activated ion channels including Ca2T -activated K+ channels and 4) integrin-
independent modulation function of CD47.
1. Several reports support the modulation effect of CD47 on integrins in a variety of
cells including ocnbP3 on platelets (Brown et al 1990; Chung et al 1997) , a2pi on
vascular smooth muscle cells (VSMC) (Wang and Frazier, 1999) and aVp3 on
melanoma cells (Gao et al 1996) and may regulate the functions of integrins and act as a
transducer element in activation mediated via integrins (Zho and Brown 1993) in various
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cell types. Moreover, it has been shown that CD47 can modulate a5pl integrin
functions by affecting other integrins including avP3 and a4pi signaling transduction
(Blystone et al 1995; Barazi et al 2002). Evidence suggests that signal transduction
through integrins depends on integrins and integrin-associated proteins (Shattil et al
1998; Wright et al 1996; Hogg and Porter 1998). It has been shown that a number of
proteins, including IgSF proteins, that bind to integrins, may generally function in
concert to mediate both cell-cell and cell-matrix interactions, which in turn stimulate
intracellular processes (Oshima et al 2002). Regarding the similar effect of CD47 and
a5piintegrin, as mechanoreceptor of chondrocyte, on electrophysiological response of
normal and OA chondrocytes, it seems reasonable to suggest the modulation effect of
CD47 on a5pi integrin.
2. Wright et al (1992, 1996) have demonstrated that stretch of the base of the culture
plate and the attached chondrocytes results in the changes in membrane potential. They
have also shown that these changes are mediated by stretch-activated ion channels in
chondrocyte plasma membrane. The blockade by quinidine of the hyperpolarisation
response to cyclical 0.33 Hz mechanical stimulation (Wright et al 1992), suggested
• 2+ -f-involvement of Ca -activated K channels. There is also substantial evidence to suggest
that the hyperpolarisation response is dependent on intracellular Ca2+ concentrations.
The role of calcium influx from outside the cell previously suggested by the L-type
calcium channel blocker, verapamil (Wright et al 1992), and confirmed by the use of
somatostatin and cadmium ions, which also block the L-type calcium channel
(Narahashi et al 1987; Tsunoo et al 1990).
3. Preliminary studies also have shown that CD47 acts as a calcium channel and has a
critical function in integrin-mediated calcium influx in endothelial cells (Schwartz et al.
1993). Taken together, suggests that it is likely that CD47 exerts its effect on mechanical
stimulation in part by regulation the calcium influx by modulation of the Ca2+ -activated
K+channels.
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4. Studies have reported the integrin-independent role of CD47 in some cellular
functions (Reinhold et al 1997; Ticchioni et al 1997). Therefore, it is possible that CD47
plays a role in both integrin-dependent and independent of chondrocyte
mechanotransduction.
In summary, similar immunohistochemical expression pattern and electrophysiological
role of CD47 in both normal and OA cartilage suggest that CD47 plays role/s in early
events of mechanical stimulation that is/are similar in both normal and OA cartilage
such as integrin-mediated rapid tyrosine phosphorylation events (Salter et al 2002).
4.5.2.3. The role of TSP-1 in OA chondrocytes electrophysiological response
This study showed that antibody to TSP completely inhibited the electrophysiological
response of chondrocytes following 0.33 Hz cyclical mechanical stimulation.
TSP-1 is a multifunctional protein, which mediates different cell-matrix interactions.
Peptide sequences within the C-terminal domain bind to the CD47 (Gao et al 1 996),
which has been shown to modulate the integrin function in a variety of cells (Gao et al
1996; Reinhold et al 1997; Ticchioni et al 1997). It is involved in multiple cellular
processes including formation of multi-protein complexes on the cell surface and the
clustering of receptors that initiate signal transduction. TSP1 dictates the composition of
these multiprotein complexes through specific interactions with growth factors,
cytokines, other matrix components, and membrane proteins (Chen et al 2000).
TSP1, through association with CD47, influences the integrin functions in a number of
cells. For example the interactions of CD47-TSP1 affect the function of avp3 on
melanoma cells in integrin-dependent cell spreading (Gao et al 1 996a; Frazier et al
1999), a2pi on vascular smooth muscle cells (VSMC) in chemotactic response and
aVp3 (Wang and Frazier, 1 998;Wang et al 1 999; Chung et al 1 999), and otnbP3 on
platelets (Chung et al 1997). Graf et al (2003) have recently shown that the expression
and function of TSP1 is similar with CD47 in a common mechanism for the
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mechanosensitive regulation of apoptosis in different cell types and for different
mechanical stimuli. In this mechanism TSP1 functions as a ligand and an integrin/ CD47
complex as receptor.
In addition to CD47, several surface receptors, including pi and P3 integrins (Defrietas
et al 1995; Frazier et al 1991; Lawler et al 1993; Yabkowitz et al 1993; Gao et al 1996,
Chandrasekaran et al 1 999), heparan sulfate proteoglycans (Vischer et al 1 997), Ca2+
ions (Lawler et al 1982; Miller et al 1995), CD36 (Dawson et al 1997), and Low-density
lipoprotein receptor-related protein (Godyna et al 1995) can transduce signal following
interaction with TSP1 or specific TSP1 peptides. For example Ca2+ ions might be
involved in activation of ion channel/s that is shown play important role in chondrocyte
mechanotransduction such as SK channels.
Moreover, TSP1 peptides can induce the tyrosine phosphorylation of several proteins,
including 70 and 120 kD species (Gao et al 1996; Wilson et al 1999; Chung et al 1999;
Ticchioni et al 1997; Tulasne et al 2001). There is also interaction between CD47 and
TSP1, via an integrin-independent pathway, that provides costimulatory signals to T
lymphocytes (Reinhold et al 1997; Ticchioni et al 1997). Studies have shown the
involvement of TSP in cellular functions through a CD47-independent manner (Tulasne
et al 2001).
In summary, it is more likely that chondrocytes CD47/TSP1 complex may associate with
a5pi integrin to modulate its function following mechanical stimulation. It has been
shown in several settings, the binding agonist peptide 4N1K, or CBD, of TSP 1 to CD47
stimulate the activity of integrins to a higher affinity / avidity state (Hughes and Pfaff
1998). Taken together, it appears that CD47-TSP complex affects the affinity / avidity
state of a5pi integrin following mechanical stimulation of human articular
chondrocytes.
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4.5.2.4. The role of SIRPa in OA chondrocytes electrophysiological response
SIRPa is involved in electrophysiological response following 0.33 Hz cyclical
mechanical stimulation.
To establish role/s for SIRPa in chondrocyte mechanotransduction, two recognized
function blocking Abs against SIRPa, SE5A5 and SE7C2, in electrophysiology system
were tested. The electrophysiological response of chondrocytes in the presence of
SE7C2 mAb was significantly inhibited whereas, SE5A5 did not show any modification
in this response.
SIRPa is recently known as another important ligand for CD47. Both CD47 and SIRPa
belong to Ig superfamily. Like other members of the SIRP family, SIRPa consists of
three domains: the extracellular domain, the transmembrane domain and the intracellular
domain. The extracellular domain is composed of an amino-terminal Ig variable (IgV)
region and two Ig constant (C) regions. In several reports, it has been shown that Ig
domain of CD47 and the amino terminal Ig domain of SIRPa can interact directly to
each other (Jiang et al 1999; Seiffert et al 1999, Han et al 2000, Vemon-Wilson et al
2000).
Different SIRPa epitopes may have different functional roles, and this could be due to
their relative ability to cluster and induce a signalling cascade in chondrocytes. SE5A5
and SE7C2 mAbs were recognized different epitopes on the same antigen (Seiffert et al
1999, 2001) and one of which is involved in chondrocyte mechanotransduction at least
in this system. Therefore, both SE7C2 and SE5A5 characterized as function-blocking
mAb but have different noncompetitive epitopes. SE7C2 recognizes a site on the SIRPa
molecule necessary for chondrocyte response to mechanical stimulation, whereas
SE5A5 does not.
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It is possible that the EC Ig domain of SIRPa influences the conformation of the
integrin/s, CD47 and/or ion channels to promote binding to them and modulate their
functions.
Tsuda et al (1998) have shown indirectly the interaction between integrins engagement
by ECM proteins and induction tyrosine phosphorylation of SIRPa and suggested that
SIRPa might be a member of the group of proteins that are at focal adhesion contacts
and undergo tyrosine phosphorylation in response to the interaction of integrins with the
ECM. Thus, it seems likely that SIRPa, under specific conditions (circumstances),
undergoes a transient state, including interaction with integrins or/and phosphorylation
on tyrosine residues and in part participates in mechanical-induced response of articular
chondrocytes mechanotransduction. Alternatively, SIRPa could be associated with other
proteins, which contribute to the electrophysiological response of chondrocytes such as
ion channels. In any case, this study has provided a specific functional role for SIRPa in
chondrocyte mechanotransduction. This study demonstrated that SIRPa, a 1 igand for
CD47, is expressed by human articular chondrocytes. Although the results of the
present study was unable to show a physical association between CD47 and SIRPa, but
indicated that SIRPa is involved in chondrocyte mechanotransduction by inhibiting
electrophysiological response following cyclical mechanical stimulation.
The electrophysiology observations, which are obtained from the present study, give
evidence that the CD47 and its potential ligands, TSP1 and SIRPa, as components of the
mechanotranduction pathway, are also responsive for the regulation of intracellular
signalling after mechanical stimulation. In conclusion the results of the present study
indicated that both ligands of CD47, TSP1 and SIRPa, are involved in chondrocyte
mechanotransduction.
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4.5.3. CD47 and intracellular signalling after 0.33 Hz cyclical
mechanical stimulation
4.5.3.1. The role of CD47 in chondrocyte protein tyrosine phosphorylation
following 0.33 Hz cyclical mechanical stimulation
The present study has demonstrated that CD47 is involved in rapid tyrosine
phosphorylation of ppl2FAK following 1 minute 0.33 Hz cyclical mechanical
stimulation in chondrocyte. Both primary chondrocyte and cell line C20A4 showed the
same response.
The intracellular signalling cascades that are activated when integrins bind to their
extracellular ligands are varied (Clark and Brugge 1995). Signalling molecules,
transmitting information from the extracellular compartment into the cell, so-called
outside-in signalling (Hynes 1992; Juliano and Haskill 1993). The specific pathways
appear to differ depending on the specific integrin/ligand interaction and the type of cell
(Disatnik and Rando 1999). One of the earliest changes initiated by integrin engagement
is clustering of integrins at focal adhesions and tyrosine phosphorylation of proteins
such as paxillin, talin, and the cytosolic enzyme focal adhesion kinase (FAK) (Schaller
et al 1992; Hanks etal 1992; Kornberg et al 1992; Rozengurt and Fernandez 1997).
Tyrosine phosphorylation of several cellular proteins appears to play an essential role in
integrin-mediated signal transductoin because its inhibition blocks gene expression (Lin
et al 1995). The phosphorylation state of cellular proteins, which reflects a balance
between protein kinases and protein phosphatases activities, could switch on or switch
off the biochemical pathways in the cells. FAK phosphorylation is considered to be a
critical step in the downstream signalling that promotes a number of cellular functions
(Burridge et al 1992).
It has been previously shown that tyrosine phosphorylation in chondrocyte is integrin
and stretch-activated ion channels dependent (Lee et al 2000). The mechanism by which
integrins activate tyrosine phosphorylation of focal adhesion proteins is poorly
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understood. This process may involve engagement of integrins with their ECM ligands
leading to conformational change, clustering of integrins and the formation of organized
complexes between integrins and cytoskeletal proteins (Howe et al 1998). For example,
integrin clustering m ay lead to the oligomerization of different FAK molecules, F AK
then undergoes trans-autophosphorylation and activation (Hotchin and Hall 1995). FAK
may also be recruited to nascent focal adhesions because it interacts, either directly or
through the cytoskeletal proteins talin and paxillin, with the cytoplasmic tail of integrin
P subunit (Giancotti and Ruoslahti 1999). These could be possible mechanisms by which
integrins stimulation resulting from mechanical stress leads to tyrosine phosphorylation
(Hemg-Sheng Lee 2000, PhD Thesis).
As an index of chondrocyte integrin-mediated intracellular signalling, in the present
study, the tyrosine phosphorylation status of chondrocytes following 0.33 Hz c yclical
mechanical stimulation has been monitored. This process evaluated in the pretreated
chondrocytes with function-modifying anti-CD47 Brie 126.
Previous studies have shown an association between CD47 and FAK tyrosine
phosphorylation in different cell types. Gao et al (1996) have shown that the presence of
TSP or its CD47 agonist peptide in medium of cultured C32 melanoma cells causes
rapid and intensive tyrosine phosphorylation (Gao et al 1996; Frazier et al 1999; Green
et al 1999). Chung et al (1997) have demonstrated that in platelets, small amounts of
FAK are associated with the integrin-IAP complex extracted from resting platelets. FAK
association with this complex is rapidly increased upon agonist (4N1K peptide of TSP 1)
activation. Ticchioni et al (1997) have reported that in T cells, CD47 cross-linking with
mAb B6H12, function-modifying mAb, induces the phosphorylation on tyrosine of
several proteins. Liu et al (2002) have demonstrated that in neutrophil, tyrosine
phosphorylation is a key event occurring down stream of antibody-mediated CD47
ligation. They have particularly shown that involvement of tyrosine kinase linked
signalling events in the mechanism of CD47-mediated regulation of PMN migration.
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Although ligation of CD47 with its antibody B6H12 is reported to induce tyrosine
phosphorylation (Ticchioni et al 1997), but other studies have also shown that the same
antibody has opposing effects and can selectively enhance and inhibit the function of
different integrins (Barazi et al 2002). Based on these data, B6H12 mAb is recognized as
a function-modifying antibody for CD47. In addition, since different antibodies
recognize different epitopes on the same protein, the ligation of each antibody with its
antigen shows differential effect on the antigen affinity/avidity, and this response is
varied in multiple cell types (is cell type specific) (Reinhold et al 1997). In the present
study, the presence of antibody alone had no effect on protein tyrosine phosphorylation
in chondrocytes. In addition, in electrophysiology experiments and PKCa activation
assessment, the presence of antibody only did not show modification in the resting
condition of chondrocytes.
The transphosphorylation model has been previously proposed to explain the mechanism
of intgerin-mediated FAK phosphorylation (Rodriguez-Fernandes 1999). This model
suggests that the aggregation of FAK molecules, which are either directly associated
with the P integrin cytoplasmic domain (Otey 1996; Giraultetal 1999) or indirectly
associated with P integrin through other intermediate molecules would favour the
transphosphorylation and activation of FAK in focal contacts (Zheng et al 1998). A
similar mechanism of FAK activation could operate in the case of other non-integrin
adhesion receptors (Otey 1996). Based on this model CD47 can act as an associated
protein in a5pi integrin-mediated and also non-integrin FAK tyrosine phosphorylation.
It has been shown that ppl25FAK is associated with cytoplasmic domain of the
integrin pisubunit and this interaction plays a critical role in ppl25FAK activation
(Richardson and Parsons 1995). Studies have also demonstrated that although
ppl25FAK can associate in vitro with P integrins (pi, p2, p3), the precise mechanism
may differ among integrins and /or cell types (Kornberg et al 1992; Richardson and
Parsons 1994). Thus ppl25FAK activation in chondrocyte may result from a change in
its c onformation, p erhaps i nduced b y modulation o f a ffinity/avidity o f a 5P1 integrin.
Affinity/avidity modulation of a5pl integrin may result in effects of CD47/TSP1
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complex on a5pi integrin due to 0.33 Hz mechanical stimulation. Within lmin 0.33 Hz
cyclical mechanical stimulation, CD47/TSP1 complex that is associated with a5pi
integrin through a5 subunit may cause conformational change in a5pi integrin and
result in ppl25FAK tyrosine phosphorylation.
In summary, inhibition of the mechanically induced tyrosine phosphorylation of FAK by
anti-CD47, coimmunoprecipitation of CD47 with both a5 integrin and TSP1 in
chondrocytes as well as coimmunoprecipitation of pi integrin and TSP1, would suggest
a role for CD47/TSP1 complex in integrin-mediated mechanotransduction. As
mentioned by Graf et al (2000, 2003), a similar complex in endothelial cells and
fibroblasts is shown that responded to different mechanical stimuli.
4.5.3.2. The role of CD47 in PKCa activation following 0.33 Hz cyclical mechanical
stimulation in articular chondrocyte
In the present study, PKCa translocation within 30 sec cyclical mechanical stimulation
in chondrocytes is inhibited in the presence anti-CD47 mAb Brie 126. This suggests that
CD47 is involved in PKCa translocation following 0.33 Hz cyclical mechanical
stimulation.
PKC isoforms play an important role in intracellular signalling (Nishizuka 1986;
Rasmussen 1986). Since the isoforms are expressed on different genes, have strictly
regulated tissue expression, and display biochemical differences, they seem to exert
different biological functions (Mischak et al 1993; Ozawa et al 1993;Haller et al 1998).
One of the earliest changes initiated by integrin engagement is clustering of integrins at
focal adhesions and tyrosine phosphorylation of proteins such as FAK and paxillin
(Disatnik and Rando 1999). It has been also demonstrated that PKC is involved in focal
adhesion and stress fibre formation in fibroblasts plated on fibronectin (Woods and
Couchman 1992). Numerous reports have described the association between integrin
signalling and protein kinase C (PKC) isoforms activation (Richardson and Parsons
1995; Gao et al 1996; Woods and Couchman 1992). PKC appears to be one of the key
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intermediates in integrin-mediated signalling in many cell types (Clark and Brugge
1995; Juliano and Haskill 1993). In certain cell types inhibition of PKC activity results
in the inhibition of cell attachment and spreading as well as FAK phosphorylation
(Woods and Couchman 1992; Vuori and Ruoslahti 1993; Haimovich and Kaneshiki
1996). Activation of PKC can promote the cellular changes mediated by integrin/matrix
interactions (Vuori and Ruoslahti 1993; Chen et al 1994; Short et al 1998). Using
specific PKC inhibitors, Haimovich et al (1996) showed that PKC plays a critical role in
integrin signalling and FAK phosphorylation in platelets. Haller et al (1998) showed that
PKCa and PKCs translocate to nuclear structures and focal adhesions upon the binding
of vascular smooth muscle cells to fibronectin. Disatnik and Rando (1999) have shown
that PKC is necessary for outside-in signalling mediated by a5 integrin in muscle cells
as a result of cell spreading on fibronectin. These results together demonstrate a specific
role ofPKC in integrn-mediated signal transductioin.
Previous studies by using PKC inhibitors have shown that PKC activity is important in
the signaling pathways activated in human and bovine chondrocytes by mechanical
stimulation (Wright et al 1997; Millward-Sadler et al 2000; Han et al 2001), which
results in increased proteoglycan production. It has been shown that PKCa is the major
isozyme present in human articular cartilage (Zhang et al 1999) and there is no clear
difference in PKC isozyme expression in primary cultures of normal and OA
chondrocytes (Lee et al 2002). The latter study has also demonstrated increased
association of PKCa with RACK1 and pi integrin in primary human articular
chondrocytes. These findings suggested that mechanotranduction via integrins is
necessary for association between RACK1/ PKCa and pi integrin following cyclical
mechanical stimulation.
Lee et al (2002) have also reported that within 30 seconds 0.33 Hz cyclical mechanical
stimulation, PKCa translocated to particulate compartment. In the present study, this
integrin-mediated PKCa translocation is used to indicate the potential role of CD47 in
this intra-cellular signalling process. In the presence of function-modifying anti-CD47
Brie 126, translocation of PKCa is inhibited.
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The data from this study and other studies suggest that the function of a5pi integrin and
PKCa activation are modified by CD47 function. It appears that CD47-TSP1 complex
bound and modified the affinity/avidity of a5pl integrin and caused rapid activation of
PKCa that this in turn activated FAK tyrosine phosphorylation and intracellular cascade.
PKCa is a member of cPKC isoforms that have been found to be activated by a calcium-
dependent manner. Maasch et al (2000) have demonstrated that the temporal changes in
[Ca2+]j and the velocity of PKCa translocation in vascular smooth muscle cells are
closely correlated. They demonstrated that translocation of PKCa is dependent on a
threshold Ca2+ concentration (Cannell et al 1994; Maasch et al 2000). Maasch et al
(2000) have also demonstrated that in living cells the mode of [Ca2+]j entry into the
cytosol and localization of the [Ca2+]j rise influence PKCa targeting. The targeting of
the enzyme to different sites (nucleus, cytoskeleton, microtubules, contractile fibers and
cell membrane) may be regulated by specific binding of PKC to so-called receptors of
activated protein kinase C (RACKS). Transmembranous Ca2+ influx has previously been
suggested to lead to localized PKC activation. These data demonstrate the local increase
• 7+
in [Ca ]j increases the affinity of binding sites for PKC at plasma membrane (Maasch et
al 2000).
Previous studies in both endothelial cells (Schwartz et al 1993) and fibroblasts (Tsao and
Mousa 1995) have shown that IAP inhibition blocks a Calcium transient which may
augment PKC activation (Gao et al 1996). A transient increase in intracellular Ca2+
concentration as a result of its passage through gadolinium-sensitive ion channels
appears to be one of the earliest events involved in the response of chondrocytes to
mechanical stimulation and may be necessary for integrin-dependent tyrosine
phosphorylation of focal adhesion associated molecules and PKC activation (Guilak et al
1999). These data suggest that CD47 may modulate Ca2+ influx and the local
fluctuations in Ca2+ in turn regulate PKCa activation.
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Protein kinase C-a (PKC a) has been detected in focal adhesions (Jaken et al 1989).
Preliminary studies have shown that activation of PKC by phorbol ester enhances
tyrosine phosphorylation of ppl25FAK in CHO cells, while a PKC inhibitor blocks this
tyrosine phosphorylation (Vuori and Ruoslahti 1993; Richardson and Parsons 1994).
Since PKC may induce integrin clustering, it is possible that a potential mechanism by
which P KC may induce FAK phosphorylation i s the promotion o f integrin c lustering
(Rodriguez-Fernandes 1999). Vuori and Ruoslahti (1993) have shown that PKC
regulates a5piintegrin-mediated ppl25FAK phosphorylation and the spreading of
Chinese hamster cells on fibronectin.
In summary, the mechanism of CD47 modulation of PKCa translocation could be
exerted by its association with a5pi integrin and /or its role in Ca2+ ion influx.
231
CHAPTER FIVE
5.0. ROLE OF CD98 AND ITS LIGAND, CD147, IN
CHONDROCYTE MECHANOTRANSDUCTION
5.1. ROLE FOR CD98 IN ELECTROPHYSIOLOGICAL
RESPONSE OF HUMAN ARTICULAR CHONDROCYTES
5.1.1. Effect of a panel of anti-CD98 antibodies on the cultured
chondrocytes response to 0.33 Hz cyclical mechanical stimulation
The results of the present thesis in chapter 3 showed that normal and OA chondrocytes
expressed CD98 and its ligands, galectin-3 and CD147. Since studies have shown the
interaction between CD98 and integrins in different cell types, a series of experiments
were undertaken to investigate the role of CD98 and its ligand, CD 147, in chondrocyte
mechanotransduction.
In first step, electrophysiological experiments were carried out to establish whether
CD98 is involved in chondrocyte response to 0.33 Hz (2 sec on, 1 sec off) cyclical
mechanical stimulation. N ormal chondrocytes w ere isolated from 2 femoral condyles,
one male (age 72) (13941) and another one, male, whose age was not recorded (13949).
OA chondrocytes were isolated from 3 femoral condyles, two grade II and one grade III,
2 females, 1 male (age range 64-79, mean 70) (13938, 13943, 13959) and one tibial
plateaux, grade II, male (age not recorded) (13983). Primary chondrocytes, seeded in
complete media at a density of lxlO4 cells/ml, were used to investigate the role of CD98
in the electrophysiological response of chondrocytes to 0.33 Hz cyclical mechanical
stimulation.
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To investigate the role of CD98 in chondrocyte mechanotransduction, a panel of anti-
CD98 antibodies, polyclonal goat anti-CD98 Ab (Santa Cruz), mouse mAbs, BU89 and
BU53, were applied
Polyclonal goat anti-CD98 Ab (Santa Cruz) at 1.5 pg/ml was incubated with normal
cultured chondrocytes at 37° C for 10 min prior to 0.33 Hz cyclical mechanical
stimulation. The membrane potentials of 5 cells were recorded prior to and after the
addition of Ab and also after the period of 0.33 Hz cyclical mechanical stimulation. The
exposure of cultured chondrocytes to anti-CD98 polyclonal alone produced no
significant c hange i n m embrane p otential. The A b h ad n o e ffect o n h yperpolarisation
response of normal chondrocytes after 0.33 Hz cyclical mechanical stimulation (Table
5.1.a).
A similar experiment was carried out with OA cultured chondrocytes in the presence of
polyclonal goat anti-CD98 (Santa Cruz) and two function-blocking mouse mAbs anti-
CD98, BU53 and BU89. The membrane potential ofOA chondrocytes with antibody
only did not show any alteration. The depolarisation response of OA chondrocytes did
not show alteration in the presence of polyclonal Ab at 1.5 pg/ml after 0.33 Hz cyclical
mechanical stimulation (Table 5.1.b). OA chondrocytes in the presence of each
monoclonal antibody alone, either BU53 or BU89, at 1:100 did not show alteration in
membrane potential. OA cultured chondrocytes were subjected to 0.33 Hz cyclical
mechanical stimulation in the presence of each mAb separately. The depolarisation
response of OA cultured chondrocytes did not show alteration in the presence of either
mAb BU89 or mAb BU53, after 0.33 Hz cyclical mechanical stimulation (Table 5.1c).
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Table 5.1.a. Effect of polyclonal anti-CD98 antibody (Santa Cruz), at 1.5 pg/ml on the




Reagent n Resting Anti-CD98 Anti-CD98 + % change P value
alone 0.33 Hz MS
Nil 5 23.6±0.92 - 33.6+1.6 +42 0.0001
Anti-CD98 5 23.4±1.5 23.6±1.3 3411.3 145 0.0001
Table 5.1.b. Effect ofpolyclonal anti-CD98 antibody (SantaCruz), at 1.5 pg/ml on the




Reagent n Resting Anti-CD98 Anti-CD981 % change P value
alone 0.33 Hz MS
Nil 5 3311.4 - 23+1.5 -30 0.005
Anti-CD98 5 33.211.5 31.611.5 2411.7 -27 0.002
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Table 5.1.c. Effect of function blocking anti-CD98 antibodies, BU89 and BU53 at




Reagent n Resting Anti-CD98 Anti-CD98 1 % change P value
alone 0.33 Hz MS
Nil 5 30.6±2.2 - 2011.5 -35 0.001
BU89 5 35±1.9 31.2±3 24.811.5 -29 0.02
BU53 5 26.8±1.2 25.8±1.4 18.610.01 -30 0.001
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5.2. Expression and function of CD147 (EMMPRIN) in human
articular chondrocyte mechanotransduction
5.2.1. In vivo expression of CD147 (EMMPRIN) in normal and OA
human articular cartilage
CD 147 (EMMPRIN) is a highly glycosylated, ~57 kD, transmembrane glycoprotein that
is a member of Ig superfamily (IgSF) located on the surface of human tumor cells and
some other cells including normal keratinocytes (Biswas et al 1995). Cho et al (2001)
have demonstrated that CD 147 acts as a member of CD98 functional unit.
To evaluate in vivo expression of CD147 in normal and OA articular cartilage, a series
of immunohistochemical staining was undertaken on frozen sections of articular
cartilage from femoral head and different anatomical regions of knee joints (femoral
condyle and tibial plateaux). Four sections of normal articular cartilage were obtained
from 2 males and 2 females (age range 63-90, mean 75) and one case whose age and sex
was not recorded. Normal human articular cartilage sections were isolated from 2
femoral heads, one female, one male (age range 76-90, mean age 83) (13857A,
13871G); 1 femoral condyle, female (age 63) (13867J); 1 tibial plateaux (a case whose
age and sex was not recorded) (13860A); and one talus, male (age 69) (13940).
Seven sections of OA articular cartilage were obtained from 1 male (age 76), 3 females
(age range 74-90, mean age 81) and one case whose age and sex was not recorded. OA
human articular sections were isolated from 3 femoral heads, two females, grades I and
II, one male, grade II (age range 74-90, mean age 80) (13857B, 13871G, 13867B); 2
femoral condyles, both grade II, one female (age 78) (13853L) and one whose age and
sex not recorded (13860); 2 tibial plateaux, one grade III, female (age 78) (13853J) and
one case whose age and sex was not recorded (13860).
CD147 expression was assessed using mouse mAb anti-CD147, 8G6, at 1:5000. This
mAb was worked very well with frozen sections. Both normal and OA cartilage showed
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a similar strong expression pattern of CD147 (Figure 5.1). All chondrocytes in sections
from different donors showed a similar strong staining pattern. Chondrocytes in all
zones showed a similar expression pattern of CD147 (Figure 5.1). Strong
immunoreactivity of CD147 at very high dilution (1:5000) of mAb 8G6 was observed,
suggesting strong expression of CD 147 in normal and OA articular cartilage.
5.2.2. In v itro expression o f C D147 (EMMPRIN) i n n ormal and OA
human articular chondrocytes
To assess the biochemical characteristics of CD147 in articular cartilage, a series of
western blotting experiments was performed. Normal chondrocytes were isolated from 4
talus, 1 tibia (ankle), 4 males, 1 female (age range 69-80, mean age 70) (13920, 13901,
13907, 13915, 13820); 2 tibial plateaux, 1 male (age 72), 1 not recoded (13941, 13949);
1 femoral condyle, male (age 69) (13939); 3 femoral heads, 2 males and 1 female (age
range 70-83, mean 78) (13816, 13822, 13828). OA chondrocytes were isolated from 2
femoral heads, both grade II, 1 male, 1 female (age range 83-98, mean 90) (13828,
13821); 3 tibial plateaux, 1 grade II and 2 grade III, all female (age range 62-87 mean
76) (13820, 13865, 13938) and one femoral condyle, grade II, male (age 69) (13939).
In preliminary studies, cell lysates extracted from cultured human articular chondrocytes
were run under both reducing (Figure 5.2. A) and non-reducing (Figure 5.2. B)
conditions and probed with mouse anti-CD147, 8G6, mAb at a range of dilutions. Under
reducing conditions, some samples showed a band ~50 kD size, but the other samples
did not express the same band as a main band and expressed multiple faint bands. The
expression pattern in several samples was not consistent. Under non-reducing
conditions, all samples showed a broad protein staining band between 35 and 50 kD and
this was consistent in all samples (Figure 5.2.B), Normal chondrocytes in comparison to
OA chondrocytes did not show detectable difference in the expression pattern of CD147.
Compared with normal and OA chondrocytes isolated from knee and femoral head, a
stronger band of this molecule in chondrocytes obtained from normal ankle (Figure 5.2.









Figure 5.1. Immunoreactivity of mAb anti-CD147, 8G6, in normal and OA human
articular cartilage sections. Immunoreactivity was assessed by using mouse anti-
C1D47, 8G6, at 1:5000. All sections showed strong expression of C1D47 (EMMPRIN)
in different zones. A, Tibial plateaux, normal (TN), superficial-deep, (age, sex not
recorded), xlOO (13860A). Chondrocytes in all zones showed strong expression pattern
of CD147. B, Femoral head, normal, mid-zone (male, 76 years), x 200 (13871G). Mid-
zone chondrocytes showed strong expression pattern for CD 147. C, Femoral condyle
(FA), OA II, mid zone (female, 78 years), x400 (13853J). OA chondrocytes in mid-zone
of FAII showed strong expression of CD147. D, Femoral condyle, norma! (FN), mid
zone (female, 63 years), x200 (13967J). In comparison to negative control (D),
chondrocytes in all zones ofnormal and OA sections showed a similar strong expression
pattern ofCD 147 immunostaining.
238
MW a b c MW a b c
(A) (B)
Figure 5.2. Detection and comparison of CD147 (EMMPRIN) in normal and OA
human articular cartilage. Equal amounts (40pg/lane) of total extracted proteins
prepared from the cultured human articular chondrocytes derived from normal ankle
(lane a, talus, male, age not recorded) (13901) normal (lane b, femoral head, male, age
70) (13822) and OA (lane c, tibia plateaux, OAIII, female, age 87) (13965) samples
were run in a 10% SDS-PAGE under reducing (A) and non-reducing (B) conditions.
Detection of CD147 was assessed by probing the blots with mouse mAb anti-CD147
8G6 at 1:5000. Under reducing conditions, the samples did not show a consistent
expression pattern. Multiple faint bands were observed in some samples and others
showed a ~50 kD single band (A). All samples, under non-reducing conditions, showed
a consistent broad protein staining band between 35 and 50 kD (B). No detectable
difference was seen in normal and OA cartilage in the expression of CD147. The
stronger band of CD147 was detected from normal ankle chondrocytes in comparison to
knee and femoral head. The blots shown are representative of three different donors
(normal and OA). Molecular weights (MW) in kilo Daltons (kD) are indicated on the
left.
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5.2.3. Effect of anti- CD147 mAb on the OA chondrocyte depolarisation
response to 0.33 Hz cyclical mechanical stimulation
To establish whether CD 147 would affect the articular chondrocytes
electrophysiological response, a series of electrophysiological experiments was carried
out. OA chondrocytes were isolated from tibial plateaux, OA grade II, male (whose age
was not recorded) (13983). OA chondrocytes were seeded in complete media at a
density of lxlO4 cells/ml. A function-blocking mAb anti-CD147, 8G6, at 1.5 pl/ml was
incubated with OA cultured chondrocytes for 10 min at 37 C prior to 0.33 Hz cyclical
mechanical stimulation for 20 minutes.
Antibody alone had no any effect on resting membrane potential. Monoclonal Ab anti-
CD 147,8G6, had no effect on depolarisation response ofOA chondrocytes after 0.33 Hz
cyclical mechanical stimulation (Table 5.2), Anti-CD 147 mAb, 8G6, had no effect on
the electrophysiological response ofOA chondrocytes after 0.33 Hz cyclical mechanical
stimulation.
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Table 5.2. Effect of function blocking monclonal anti-CD147 (EMMPRIN) antibody
(8G6), at 1.5 pl/ml on the depolarisation response ofOA cultured chondrocytes to 0.33
Hz cyclical mechanical stimulation
Membrane potential (-mV)
(mean ± SEM)
Reagent n Resting Anti-CD 147 Anti-CD147 + % change P value
alone 0.33 Hz MS
Nil 5 30± 1.9 - 17.411.3 -42 0.0001
8G6 5 28.210.86 30.41 1.5 17.811.15 -36 0.0001
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5.3. DISCUSSION
5.3.1 Role for CD98 in human articular chondrocyte
Pretreatment of both normal and OA cultured chondrocytes with a panel of antibodies
against CD98 showed that these antibodies had no effect on electrophysiological
response chondrocyte to 0.33 Hz cyclical mechanical stimulation.
It has been shown that CD98 to function in a variety of cellular activities including cell
fusion, cell aggregation and intracellular calcium concentration (Michalak et al 1986;
Posillico et al 1987; Freidman et al 1994). Warren et al (1996) have previously shown
that the heavy chain of CD98 (recognized by Juror 177 mAb) can transduce signals into
the cell that was manifested in the tyrosine phosphorylation of ppl25FAK in
hematopoietic cells. Since CD98 HC protein lacks protein tyrosine kinase catalytic sites,
they suggested that Joro 177 mAb binding to CD98 stimulates a tyrosine kinase that in
turn phosphorylates the ppl25FAK protein. CD98 has been characterized as an amino
acid transporter and the function and specificity for certain amino acids is determined by
the CD98 light chain (LC) (Mastroberardino et al 1998; Verrey et al 1999). Recently,
Fenczik et al (2001) demonstrated in a Chinese hamster ovary (CHO) cell model that the
two functions of CD98 (regulation of integrin affinity and amino acid transport) are
independent of each other.
CD98 physically and functionally interacts with integrin receptors in multiple cell types.
Studies have shown that CD98 modulates activity of (31 integrin (Fenczik et al 1997;
Chandrasekaran et al 1999; Deves et al 2000). The transmembrane and specific
cytoplasmic regions of CD98 HC are required to interact with integrin [31A cytoplasmic
domains and this interaction is sufficient for the complementation of dominant
suppression of integrins (Fenczik et al 1997) while the extra cellular domains are
important for amino acid transport function (Pineda et al 1999).
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Further studies are required to investigate the potential physical association of CD98
with chondrocyte integrins including a5pi integrin and involvement of CD98 in critical
chondrocyte intracellular signalling pathways such as tyrosine phosphorylation. In
summary, results from this study do not exclude that CD98 might be involved in the
other biological functions and/or intracellular signalling events of chondrocytes.
5.3.2. Role for CD147 (EMMPRIN) in human articular chondrocyte
CD 147 is expressed by chondrocytes in articular cartilage sections obtained from both
normal and OA cartilage. CD 147 is also expressed by cultured c hondrocytes i solated
from normal and OA articular cartilage. Normal and OA cultured chondrocytes did not
show detectable differences in the CD147 expression. Cultured chondrocytes isolated
from ankle, however expressed significantly stronger band in comparison to normal and
OA chondrocytes. The antibody against CD 147 did not show any effect on
electrophysiological response ofOA chondrocytes to mechanical stimulation.
CD 147, is a 45-60 kD highly glycosylated transmembrane protein, and also is a cell
type-specific molecule, showing differential molecular weight in various cell types (Li et
al 2001). These differences in molecular weight of EMMPRIN are mainly due to
varying extent of glycosylation since the protein backbone ofEMMPRIN corresponds to
an approximate molecular weight of 27-32 kD (Biswas et al 1995). Enzymatic
deglycosylation by N-glycosidase F produced a polypeptide of ~32 kD in a variety of
tissues, indicating that the observed differences in electrophoretic mobility were due to
differences in N-linked glycans (Fadool and Linser 1993). Based on these data, the
molecular weight of CD147 in chondrocyte is in a broad range of 35-50 kD, which is
almost the same as that of EMMPRIN expressed in other human cells such as 46 kD in
brain (Fadool and Linser 1993; Sameshima et al 2000).
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It has been shown that CD 147 is expressed on a variety of cells including endothelial
cells, hematopoietic and non-hematopoietic cells. The expression level of this molecule
is dependent on the cellular state such as differentiation (Kirsch et al 1997).
Cho et al (2001) have shown for the first time that antibodies to CD 147 can neutralize
CD98-induced cell aggregation. There are also some striking parallels between CD 147
and CD98. CD 147 is physically associated with pi integrin in the cell membrane
(Berditchevski et al 1997), as is CD98 with isolated cytoplasmic pi domains (Zent et al
2000). Antibodies to both molecules can induce aggregation of U937 cells, and the
aggregation appears to be mediated in part by p2 integrin activation (Kasinrek et al
1999). Levels of CD98 and CD147 correlate on T cells, with high levels in the thymus,
low levels in resting mature T cells, and higher levels on activated mature T cells
(Kirsch et al 1997).
Thus, it appears that CD 147, like CD98, is acting as a chaperone for multimembrane-
spanning transporter molecules. In the case of CD98, these are amino acid transporters
(Pfeiffer etal 1999), in the case of CD147, they are the monocarboxylate transporter
family of proton-linked monocarboxylic acid transporters (Halestrap and Price 1 999).
These data have suggested that CD98 forms one component of a "sensory complex",
containing pi integrins, CD98, and CD147, together with all their associated molecules
(Cho etal 2001).
A possible role/s for CD147 in chondrocytes includes the production and activation of
several MMPs including MMP3 (Guo et al 1997; Sun and Hemler 2001; Sameshima et
al 2000). The EMMPRIN expression in chondrocytes may play a role in healthy
cartilage metabolism under physiologic conditions and progression of degenerating
processes under pathologic conditions such as OA and RA. In this regard, Tomita et al
(2002), by analysing synovial tissue, have recently shown that EMMPRIN may be one
of the important factors in progressive joint destruction in RA.
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Second, a recent work by Toole (2003) and his colleagues to identify binding partners
for CD147, has shown that annexin II can interact with CD147. It has been demonstrated
previously that OA chondrocytes express annexin II and V (Mollenhauer et al 1999;
Kirsch etal 2000). Annexin II belongs to the annexin protein family. These proteins
enable to form Ca2+ channels and influx Ca2+ into the chondrocytes, suggesting possible
roles in controlling or altering Ca2+ homeostasis in cartilage (Kirsch et al 2000). Thus,
studying the interactions between CD147 and annexin II during the early events of OA
can in part demonstrate the mechanism/s underlying OA cartilage degeneration.





Previous studies have demonstrated that chondrocytes from human articular cartilage
show changes in membrane potential following cyclical mechanical stimulation. The
hyperpolarisation response of normal chondrocytes to cyclical mechanical stimulation at
0.33 Hz is associated with opening of small conductance (SK) calcium-dependent K+
channels and mediated via a5pi integrin. The signal transduction pathway leading to
this response involves cell interactions with ECM ligands via a5pi integrin, stretch-
activated ion channels (SACs) and a number of integrin-associated signalling molecules
including involvement of the actin cytoskeleton and tyrosine phosphorylation of the
focal adhesion complex molecules ppl25FAK, paxillin and P-catenin. Subsequently,
there is secretion of IL-4, increase levels of aggrecan and decrease levels ofMMP-3.
In contrast, OA chondrocytes following 0.33 Hz cyclical mechanical stimulation show a
membrane depolarisation as a result of tetrodotoxin-sensitive Na+ channels. This
response involves a5pi integrin, SAC, tyrosine phosphorylation and cytokine secretion
but the actin cytoskeleton and PKC, which are important in membrane hyperpolarisation
in normal chondrocytes, are not necessary for depolarisation in OA following
mechanical stimulation.
It has been previously suggested that a5pi integrin acts as a mechanoreceptor in human
articular cartilage (Wright et al 1997; Salter et al 2001). Since integrins, such as
a5pi integrin have no intrinsic enzymatic activity of their own, and also are not
phosphorylated, they must interact with other proteins to generate signals (Damsky and
Werb 1992). A well-established principle of signal transduction is the regulated specific
interactions of several individual proteins to form a complex with new functions (Brown
and Frazier 2001). Thus, to better understand how a5pi integrin involves in mechano-
induced response of chondrocyte following mechanical stimulation, it is necessary to
know which molecules in cell membrane and/or ECM can physically and functionally
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associate with this integrin. Therefore, to find partner/s for a5pi integrin in human
articular cartilage mechanotransduction, this thesis focused on CD47/IAP, CD98 and
galectin-3. The interest in studying these molecules was their association with different
integrins in multiple cell types and also their important role in critical cellular functions.
CD47, CD98 and galectin 3 are shown, for the first time, to be expressed by
chondrocytes in both normal and OA cartilage. Using the changes in membrane potential
as an indicator of chondrocyte response to mechanical stimulation initial investigations
showed CD98 and EMMPRIN (CD 147) had no identifiable role in chondrocyte
mechanotransduction, whereas CD47 and its ligands, TSP1 and SIRPa, showed critical
functions. Antibodies to CD47, TSP1 and SIRPa completely inhibited the
electrophysiological response of normal and OA chondrocytes to 0.33 Hz cyclical
mechanical stimulation.
The findings of the present study showed that CD47 expressed in cartilage and is
involved in a5pi integrin-mediated chondrocyte mechanotransduction. First, CD47
expression pattern was similar to a5pi integrin expression in human articular cartilage,
showing strong expression in all zones of both normal and OA cartilage. Second, the
inhibition of a5pi integrin-mediated electrophysiological response, tyrosine
phosphorylation, and PKCa activation by function blocking anti-CD47 mAb Bricl26
implies that CD47 induces signalling through a mechanism shared with a5piintegrin.
Third, coimmunoprecipitation and western blotting analysis provided evidence for CD47
and a5pi integrin physical association on the chondrocyte cell surface. In addition, an
important known ligand for CD47, TSP1, was physically associated with CD47 and
pi integrin and involved in the chondrocyte mechanotransduction.
Several previous studies have shown that CD47-TSP1 complex ligation causes an
increase in the affinity /avidity (by clustering) of various integrins. Jalali et al (2001)
have also shown that the activation of mechano-sensitive integrins requires the
formation of dynamic new connections with ECM ligands. This study has demonstrated
that TSP1, an ECM molecule, is involved in integrin-mediated chondrocyte
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mechanotransduction and co-immunoprecipitated with both CD47 and pi integrin. Thus
TSP1, both directly (via pi integrin) and indirectly (via CD47) is associated with
a5pi integrin. These data suggest that TSP1, as an ECM ligand for CD47/a5pi integrin,
may play a critical role in signal transduction from ECM into the intracellular space.
It is shown previously that a5pi integrin acts as a classic receptor for fibronectin and is
physically associated with integrin subunit a.5 (Pytela et al 1985). Both TSP1 and
fibronectin recognize a5pi integrin on chondrocytes. Miller and McDevitt (1995) have
also previously shown that the mechanism of attachment of TSP-1 to chondrocytes was
similar to that of fibronectin and RGD-dependent. The results of this thesis suggest that
TSP1 binds to a5pi integrin to promote the mechanical stimulation through ECM. It
seems that a5pi integrin associates with fibronection to exert structural functions and
associates with TSP1 to act as a mechanoreceptor.
Thus, although Fn and TSP1 are associated with a5pi integrin on chondrocytes, their
effects on chondrocyte behaviour differ. In addition, CD47, which is required for
chondrocyte mechanotransduction, is a receptor for TSP1 but not for Fn. Additionally,
TSP1 has interaction with Ca2+ that plays a critical role in cell signalling.
The results of this study suggest that CD47-TSP1 complex may have an auxiliary role
by binding to a5 integrin, altering a5pi integrin conformation in a way that facilitates
its activation of the signal transduction cascade. It is shown previously that different
integrin ap h eterodimers a ssociating w ith C D47 c an c ouple t o G i p rotein- d ependent
pathways by a 7TMS model. CD47/integrin holds that the five membrane-spanning
segments of CD47 and two membrane-spanning domains of the heterodimeric integrin
form a seven-transmembrane receptor. Ligation of this complex with an adhesive ligand
or TSP could activate GTPase activity in a manner analogous to that of conventional
heptaspanins (Gao et al 1996; Frazier et al 1999; Brown and Frazier, 2001). In articular
chondrocytes CD47 binding to a5pi integrin may produce a 7TMS model that promote
the signalling process via a Gi-mediated pathway following 0.33 Hz cycilical
mechanical stimulation.
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CD47-TSP1 is linked to a5pl-integrin and forms a signal transducing complex, similar
to a complex observed in fibroblast and endothelial cells. Graf et al (2002, 2003) have
found the molecular mechanism that consists of a CD47 /TSP1 complex which build up
together with a member of integrin family such as aVp3, can act as a mechanosensitive
complex and leading intracellular signalling following mechanical stimulation. They
have demonstrated that the different external forces induce the same biochemical
response inside each cell. They have been suggested that this molecular mechanism is a
general part of mechanotransduction in various cell types. The results of the present
thesis clearly are consistent with the findings of Jalali et al (2001) and Graf et al (2002,
2003).
In conclusion, this study identified important partner/s for a5pi integrin in articular
chondrocyte mechanotransduction. These data clearly indicated that CD47 and its ligand
TSP1 are required for a5pi-integrin mediated chondrocyte mechanotransduction. This
function is likely to be through modulation of a5pl integrin signalling. A complex of
TSP1-CD47 and a5pi-integrin is involved in 0.33 Hz cyclical mechanical stimulation of
chondrocytes and led to alterations in membrane potential, tyrosine phosphorylation and
PKCa translocation. In addition, since CD47 is physically associated with TSP1, it may
involve in chondrocyte mechanotransduction in an integrin-independent mechanism as
well. More understanding of CD47 functions in chondrocyte biomechanical activities
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APPENDIX I
1. Monoclonal antibodies used in this study
ANTIBODY CLONE TYPE SOURCE





Anti-CD47 CC2C6 Mouse monoclonal




























Anti-CD98 4F2 Mouse monoclonal Serotec
Anti-CD98 BU89 Mouse monoclonal
IgGl
Dr D Hardie
Anti-CD98 BU53 Mouse monoclonal
IgG2a
Dr D Hardie
Anti-Sirpa SE5A5 Mouse monoclonal




Anti-Sirpa SE12B6 Mouse monoclonal




Anti-Sirpa SE7C2 Mouse monoclonal


















Anti-CD 147 8G6 Mouse monoclonal
(Berditchevski et al
1997)
Dr Martin E. Hemler
Harvard Medical
School


























2. Polyclonal antibodies used in this study
ANTIBODY TYPE SOURCE
Anti-CD47 Goat polyclonal Santa Cruz,USA
Anti-CD98 Goat polyclonal, Santa Cruz,USA
Anti-Sirpa Rabbit polyclonal Affinity bioreagents
Inc (ABR)
Anti-integrina5 Rabbit polyclonal Chemicon International
Anti-FAK Rabbit polyclonal SantaCruz, USA
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APPENDIX II
Solutions used in this study
Solution used in immunohistochemistrv (IHQ
DAB solution buffer
DAB 0.2ml











pH adjusted to 8.00 with IN NaOH and IN HC1
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Solutions used in isolation and culture of chondrocytes
Anti-microbial solution
To 100 ml sterile PBS was added 5 ml each ofPenicillin-Streptomycin (10000 IU/ml - 10000
pg/ml) (Gibco), L-Glutamine (200 mM) (100X) (Gibco), and Fungizone (250 pg/ml) (Gibco).
Collagenase
Type H collagenase (Sigma): 30 mg per sample was made up in 10 ml of serum free Iscove's
modified Dulbecco's medium (Gibco) and filter sterilised.
Solutions used for cell lysis
Lysis buffer (final volume 10 ml)
1 % Igepal (Sigma)
100 pM Na3VC>4 (Sigma)
one protease inhibitor cocktail tablet (Boehringer Mannheim)
made up in ice-cold sterile PBS
Lysis buffer A for sonication (Buffer A)






Protease inhibitor cocktail tablet (1 tablet/10ml)
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Lysis buffer B for sonication (Buffer B)






Protease inhibitor cocktail tablet (1 tablet/10ml)
Solutions used for Lowry determination of protein concentration
Alkaline carbonate solution
To 5 ml 1% copper sulphate solution was added 5 ml 2% sodium potassium tartrate and 490
ml alkaline carbonate stock solution.
Copper sulphate solution 1 g CuS04 in 100 ml dH20
Sodium potassium tartrate 2 g NaKtartrate in 100 ml dH20
Alkaline carbonate stock solution 20 g NaHC03, 4 g NaOH in 1 litre dH20
0.1N NaOH
4 g NaOH in 1 litre dH20
Folin's reagent
A mixture of dH20 : Folin & Ciocalteu's phenol reagent (Sigma) (1:1), solution stored in the
dark.
BSA Standards
The stock BSA was diluted with 0.1 N NaOH to give final concentrations.
Stock BSA: 1 mg BSA in 1 ml dH20.
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SI 0 0 200
S2 10 2 198
S3 25 5 195
S4 50 10 190
S5 75 15 185
S6 100 20 180
S7 150 30 170
S8 200 40 160
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Solutions used for SDS PAGE
Separating gel composition (10ml)
Final (%)
Acrylamide Cone. 6 8 10 15
dH20 (ml) 5.3 4.6 4.0 2.3
1.5M tris-HCl
pH 8.8 (ml)
2.5 2.5 2.5 2.5
10% (W/V)
SDS (pi)
100 100 100 100
30% Acrylamide (ml) 2 2.7 3.3 5.0
10% APS (pi)* 100 100 100 100
TEMED (pi) 8 6 4 4
*Ammonium persulphate (APS) (Amersham UK) was freshly prepared using dH20.










30% Acrylamide (ml) 0.83
10% APS (pi) 50
TEMED (pi) 5
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1.5M Tris-HCl pH 8.8
18.15 g Tris dissolved in 50 ml dH20
pH adjusted to 8.8 with 2 N HC1
Make up to 100 ml with dH20
0.5M Tris-HCl pH 6.8
6 g Tris in 50 ml dH20
pH adjusted to 6.8 with 2 N HC1
Make up to 100 ml dH20
10% Sodium Dodecyl Sulphate (SDS)
10 g SDS was dissolved in dH20 and make up to 100 ml
10X electrode buffer (stock)
30.3 g Tris
144 g Glycine
made up to 1000 ml with dH20 and stored at 4°C
IX Running electrode buffer
890 ml dH20
10 ml 10% SDS
100 ml electrode buffer 1 OX (stock)
2X Reducing Electrophoresis Sample Buffer (ESB)(for 10 ml)
2.5 ml 0.5 M Tris pH 6.8
0.4 g SDS
1 ml 2-Mercaptoethanol (Sigma)
2.0 ml glycerol
0.01 g (w/v) bromophenol blue
made up to 10 ml with dH20
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2X Non-reducing Electrophoresis Sample Buffer (ESB)(for 10 ml)
2.5 ml 0.5 M Tris pH 6.8
0.4 g SDS
2.0 ml glycerol
0.02 g (w/v) bromophenol blue
made up to 10 ml with dH20
Solutions used for electrophoretic transfer to PVDF membrane
Transfer buffer
made up fresh each time.
700 ml dH20
200 ml methanol
100 ml electrode buffer 10X





pH adjusted to pH 7.6
made up to 1000 ml with dH20
TBS Tween20 (TBST)
900 ml dH20




2 % BSA in TBST: 0.2 g BSA was dissolved in 10 ml TBST
5% dried milk (Marvel) in TBST: 0.5g milk in 10 ml TBST




pH adjusted to 7.6 with concentrated HC1
made up to 1000 ml with dH20
Stripping buffer (stripping buffer stock + lOOmM 2-mercaptoethanol)
(50 ml per blot)
made up fresh each time.




Original data from which the results given in the Tables of Chapter 4 and 5 are calculated. The
Table number corresponds to that in the results sections.
Table 4.2a - Effect of 1 pg/ml anti-CD47 Brie 126 on the membrane hyperpolarisation
response of normal cultured chondrocytes to 0.33 Hz cyclical mechanical stimulation
Membrane potential (-mV)
Donor Regagent Resting Antibody alone Post MS*
F/82 (13878) Nil 13,17,13,18,13 - 24,26,20,30,20
Brie 126 16,2018,17,22 17,20,21,22,17 22,18,17,20,20
F/57 (13904) Nil 35,31,22,30,36 - 57,42,42,43,47
Brie 126 28,37,32,35,36 26,29,26,34,31 29,28,30,37,28
M/92(13876) Nil 12,11,14,11,15 - 19,16,18,19,24
Brie 126 14,11,13,12,14 15,11,12,14,13 12,15,11,14,13
*, MS: mechanical stimulation
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Table 4.2.b. Effect of 1 pg/ml anti-CD47 Brie 126 on the depolarisation response ofOA
cultured chondrocytes to 0.33 Hz cyclical mechanical stimulation
Membrane potential (-mV)
Donor Regagent Resting Antibody alone Post MS
F/88 (13902) Nil 55,42,46,45,42 - 22,30,23,17,19
Brie 126 42,34,36,43,49 35,38,41,45,45 37,47,39,47,41
F/64( 13959) Nil 33,37,24,28,31 - 22,19,20,15,24
Brie 126 31,25,28,24,32 31,33,26,21,29 34,26,28,25,24
N/R(13964) Nil 32,26,25,23,27 - 15,21,13,20,18
Brie 126 25,24,2625,31 28,23,25,35,27 26,27,24,29,32
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Table 4.3. Effect of 1.5 pg/ml anti-TSP mAb (Chemicon) on the depolarization response of
OA cultured chondrocytes to 0.33 Hz cyclical mechanical stimulation
Membrane potential (-mV)
Donor Regagent Resting Antibody alone Post MS
M/-(13983) Nil 36,28,26,33,27 - 17,14,22,16,18
Anti-TSP 27,31,36,29,26 29,27,29,28,32 29,32,27,26,35
F/78(13962) Nil 27,33,29,35,26 - 22,19,23,21,24
Anti-TSP 29,37,32,28,27 27,28,31,29,34 33,30,29,36,36
M/-(13983) Nil 35,29,31,28,29 - 19,21,17,19,22
Anti-TSP 29,23,27,33,35 28,25,32,33,29 32,29,26,28,34
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Table 4.4. Effect of function blocking anti-SIRPa antibodies, SE5A5 and SE7C2, at 1:1000,
on the depolarisation response ofOA cultured chondrocytes to 0.33 Hz cyclical mechanical
stimulation
Membrane potential (-mV)
































Table 5.1.a. Effect of polyclonal anti-CD98 antibody (Santa Cruz), at 1.5 pg/ml on the
hyperpolarisation response ofnormal cultured chondrocytes to 0.33 Hz cyclical mechanical
stimulation
Membrane potential (-mV)
Donor Regagent Resting Antibody alone Post MS
M/72(13941) Nil 24,25,22,26,21 - 35,34,36,27,36
Anti-CD98 25,28,19,24,21 28,24,21,20,23 38,34,30,35,33
M/-(13949) Nil 22,25,23,21,20 - 36,33,38,31,33
Anti-CD98 25,21,27,23,19 21,23,25,20,26 35,37,33,29,31
F/57 (13904) Nil 22,19,25,23,24 - 37,29,31,33,38
Anti-CD98 21,25,19,20,23 23,18,21,24,25 33,29,31,37,35
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Table 5.1.b. Effect ofpolyclonal anti-CD98 antibody (SantaCruz), at 1.5 pg/ml on the
depolarisation response ofOA cultured chondrocytes to 0.33 Hz cyclical mechanical
stimulation
Membrane potential (-mV)
Donor Regagent Resting Antibody alone Post MS
M/-( 13949) Nil 37,33,35,31,29 - 21,25,22,19,28
Anti-CD98 36,33,29,37,31 29,31,28,37,33 21,27,25,28,19
M/-(13983) Nil 36,31,29,28,32 - 25,18,24,16,21
Anti-CD98 37,27,33,32,38 28,27,33,31,36 25,19,18,22,23
M/66(13943) Nil 40,43,34,35,42 - 22,24,26,23,25
Anti-CD98 35,31,43,37,32 32,28,38,37,47 23,27,24,25,22
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Table 5.1.c. Effect of function blocking anti-CD98 antibodies, BU89 and BU53 at 1:100, on
the depolarisation response ofOA cultured chondrocytes to 0.33 Hz cyclical mechanical
stimulation
Membrane potential (-mV)


























Table 5.2. Effect of function blocking monclonal anti-CD147 (EMMPRIN) antibody (8G6), at
1.5 jul/ml on the depolarisation response ofOA cultured chondrocytes to 0.33 Hz cyclical
mechanical stimulation
Membrane potential (-mV)
Donor Regagent Resting Antibody alone Post MS
M/-(13983) Nil 36,28,26,33,27 - 17,14,22,16,18
8G6 27,31,36,29,26 29,27,29,28,32 29,32,27,26,35
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